{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1366, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:52:22Z", "timestamp": 1574506342142}, "reference-count": 10, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1095, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Liver Disease"], "published-print": {"date-parts": [[2012, 9]]}, "DOI": "10.1002/cld.80", "type": "journal-article", "created": {"date-parts": [[2012, 9, 26]], "date-time": "2012-09-26T07:20:03Z", "timestamp": 1348644003000}, "page": "119-121", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Management of nonalcoholic fatty liver disease: Role of bariatric surgery"], "prefix": "10.1002", "volume": "1", "author": [{"given": "Julia", "family": "Wattacheril", "sequence": "first", "affiliation": [{"name": "Columbia University College of Physicians and Surgeons; New York NY"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Division of Gastroenterology and Hepatology; Indiana University School of Medicine; Indianapolis IN"}]}], "member": "311", "published-online": {"date-parts": [[2012, 9, 25]]}, "reference": [{"key": "10.1002/cld.80-BIB0001|cld80-cit-0001", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1111/j.1365-2036.2011.04724.x", "article-title": "Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults", "volume": "34", "author": "Vernon", "year": "2011", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/cld.80-BIB0002|cld80-cit-0002", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/cld.80-BIB0003|cld80-cit-0003", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1002/hep.22603", "article-title": "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management", "volume": "49", "author": "Vuppalanchi", "year": "2009", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/cld.80-BIB0004|cld80-cit-0004", "author": "Chavez-Tapia", "year": "2010", "article-title": "Bariatric surgery for non-alcoholic steatohepatitis in obese patients", "journal-title": "Cochrane Database Syst Rev", "DOI": "10.1002/14651858.CD007340.pub2", "doi-asserted-by": "crossref"}, {"key": "10.1002/cld.80-BIB0005|cld80-cit-0005", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1002/hep.24127", "article-title": "Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings", "volume": "53", "author": "Brunt", "year": "2011", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/cld.80-BIB0006|cld80-cit-0006", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1002/hep.20701", "article-title": "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", "volume": "41", "author": "Kleiner", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/cld.80-BIB0007|cld80-cit-0007", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1053/j.gastro.2009.04.052", "article-title": "Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease", "volume": "137", "author": "Mathurin", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/cld.80-BIB0008|cld80-cit-0008", "doi-asserted-by": "crossref", "first-page": "1396", "DOI": "10.1016/j.cgh.2008.08.012", "article-title": "Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis", "volume": "6", "author": "Mummadi", "year": "2008", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/cld.80-BIB0009|cld80-cit-0009", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1016/j.cgh.2011.07.007", "article-title": "Increased perioperative mortality following bariatric surgery among patients with cirrhosis", "volume": "9", "author": "Mosko", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/cld.80-BIB0010|cld80-cit-0010", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1381/096089204772787284", "article-title": "Results of laparoscopic gastric bypass in patients with cirrhosis", "volume": "14", "author": "Dallal", "year": "2004", "journal-title": "Obes Surg"}], "container-title": ["Clinical Liver Disease"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.80", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T00:40:01Z", "timestamp": 1498005601000}, "score": 69.002655, "subtitle": ["Management of NAFLD: Role of Bariatric Surgery"], "issued": {"date-parts": [[2012, 9]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2012, 9]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/cld.80", "relation": {"cites": []}, "ISSN": ["2046-2484"], "issn-type": [{"value": "2046-2484", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T06:21:58Z", "timestamp": 1574749318121}, "publisher-location": "Cham", "reference-count": 233, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319205373", "type": "print"}, {"value": "9783319205380", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-20538-0_16", "type": "book-chapter", "created": {"date-parts": [[2015, 12, 10]], "date-time": "2015-12-10T06:36:33Z", "timestamp": 1449729393000}, "page": "313-337", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Current and Emerging Therapies for Nonalcoholic Fatty Liver Disease"], "prefix": "10.1007", "author": [{"given": "Samer", "family": "Gawrieh", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "2", "key": "16_CR1", "doi-asserted-by": "publisher", "first-page": "413", "DOI": "10.1053/jhep.2003.50316", "volume": "38", "author": "M Kugelmas", "year": "2003", "unstructured": "Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003;38(2):413\u20139.", "journal-title": "Hepatology"}, {"issue": "5", "key": "16_CR2", "doi-asserted-by": "publisher", "first-page": "1075", "DOI": "10.2337/dc06-2169", "volume": "30", "author": "MC Ryan", "year": "2007", "unstructured": "Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care. 2007;30(5):1075\u201380.", "journal-title": "Diabetes Care"}, {"issue": "1", "key": "16_CR3", "doi-asserted-by": "publisher", "first-page": "119", "DOI": "10.1002/hep.22336", "volume": "48", "author": "V Nobili", "year": "2008", "unstructured": "Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48(1):119\u201328.", "journal-title": "Hepatology"}, {"issue": "9", "key": "16_CR4", "doi-asserted-by": "publisher", "first-page": "1280", "DOI": "10.1111/j.1478-3231.2008.01742.x", "volume": "28", "author": "D Catalano", "year": "2008", "unstructured": "Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int. 2008;28(9):1280\u20137.", "journal-title": "Liver Int"}, {"issue": "6", "key": "16_CR5", "doi-asserted-by": "publisher", "first-page": "1355", "DOI": "10.1038/oby.2008.201", "volume": "16", "author": "DE Larson-Meyer", "year": "2008", "unstructured": "Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring, MD). 2008;16(6):1355\u201362.", "journal-title": "Obesity (Silver Spring, MD)"}, {"issue": "5", "key": "16_CR6", "doi-asserted-by": "publisher", "first-page": "1246", "DOI": "10.2337/db07-1476", "volume": "57", "author": "X Zhang", "year": "2008", "unstructured": "Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246\u201353.", "journal-title": "Diabetes"}, {"issue": "10", "key": "16_CR7", "doi-asserted-by": "publisher", "first-page": "2156", "DOI": "10.2337/dc10-0856", "volume": "33", "author": "M Lazo", "year": "2010", "unstructured": "Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care. 2010;33(10):2156\u201363.", "journal-title": "Diabetes Care"}, {"issue": "1", "key": "16_CR8", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1002/hep.23276", "volume": "51", "author": "K Promrat", "year": "2010", "unstructured": "Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121\u20139.", "journal-title": "Hepatology"}, {"issue": "11-12", "key": "16_CR9", "doi-asserted-by": "publisher", "first-page": "1094", "DOI": "10.1016/j.nut.2009.09.001", "volume": "26", "author": "MC Elias", "year": "2010", "unstructured": "Elias MC, Parise ER, de Carvalho L, Szejnfeld D, Netto JP. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition. 2010;26(11-12):1094\u20139.", "journal-title": "Nutrition"}, {"issue": "5", "key": "16_CR10", "doi-asserted-by": "publisher", "first-page": "1048", "DOI": "10.3945/ajcn.110.007674", "volume": "93", "author": "JD Browning", "year": "2011", "unstructured": "Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011;93(5):1048\u201352.", "journal-title": "Am J Clin Nutr"}, {"issue": "9", "key": "16_CR11", "doi-asserted-by": "publisher", "first-page": "1278", "DOI": "10.1136/gut.2011.242073", "volume": "60", "author": "K Hallsworth", "year": "2011", "unstructured": "Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut. 2011;60(9):1278\u201383.", "journal-title": "Gut"}, {"issue": "4", "key": "16_CR12", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.3945/ajcn.112.038695", "volume": "96", "author": "K Sevastianova", "year": "2012", "unstructured": "Sevastianova K, Santos A, Kotronen A, Hakkarainen A, Makkonen J, Silander K, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr. 2012;96(4):727\u201334.", "journal-title": "Am J Clin Nutr"}, {"issue": "11", "key": "16_CR13", "first-page": "1313", "volume": "24", "author": "A Piano de", "year": "2012", "unstructured": "de Piano A, de Mello MT, Sanches Pde L, da Silva PL, Campos RM, Carnier J, et al. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents. Eur J Gastroenterol Hepatol. 2012;24(11):1313\u201324.", "journal-title": "Eur J Gastroenterol Hepatol"}, {"issue": "6", "key": "16_CR14", "doi-asserted-by": "publisher", "first-page": "1738", "DOI": "10.1002/hep.25548", "volume": "55", "author": "S Sullivan", "year": "2012", "unstructured": "Sullivan S, Kirk EP, Mittendorfer B, Patterson BW, Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology. 2012;55(6):1738\u201345.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR15", "doi-asserted-by": "publisher", "first-page": "536", "DOI": "10.1016/j.jhep.2013.04.013", "volume": "59", "author": "VW Wong", "year": "2013", "unstructured": "Wong VW, Chan RS, Wong GL, Cheung BH, Chu WC, Yeung DK, et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013;59(3):536\u201342.", "journal-title": "J Hepatol"}, {"issue": "4", "key": "16_CR16", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1016/j.clinre.2012.10.009", "volume": "37", "author": "F Scaglioni", "year": "2013", "unstructured": "Scaglioni F, Marino M, Ciccia S, Procaccini A, Busacchi M, Loria P, et al. Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD). Clin Res Hepatol Gastroenterol. 2013;37(4):353\u20138.", "journal-title": "Clin Res Hepatol Gastroenterol"}, {"issue": "1", "key": "16_CR17", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/S0168-8278(97)80287-5", "volume": "27", "author": "T Ueno", "year": "1997", "unstructured": "Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103\u20137.", "journal-title": "J Hepatol"}, {"issue": "10", "key": "16_CR18", "doi-asserted-by": "publisher", "first-page": "999", "DOI": "10.1111/j.1365-2036.2009.04122.x", "volume": "30", "author": "E Vilar Gomez", "year": "2009", "unstructured": "Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, Arus Soler E, Llanio Navarro R, Calzadilla Bertot L, et al. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2009;30(10):999\u20131009.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "1", "key": "16_CR19", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/j.jhep.2011.06.010", "volume": "56", "author": "C Thoma", "year": "2012", "unstructured": "Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol. 2012;56(1):255\u201366.", "journal-title": "J Hepatol"}, {"issue": "1", "key": "16_CR20", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1002/hep.22575", "volume": "49", "author": "SA Harrison", "year": "2009", "unstructured": "Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology. 2009;49(1):80\u20136.", "journal-title": "Hepatology"}, {"issue": "5", "key": "16_CR21", "doi-asserted-by": "publisher", "first-page": "639", "DOI": "10.1016/j.cgh.2006.02.004", "volume": "4", "author": "S Zelber-Sagi", "year": "2006", "unstructured": "Zelber-Sagi S, Kessler A, Brazowsky E, Webb M, Lurie Y, Santo M, et al. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2006;4(5):639\u201344.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "7", "key": "16_CR22", "doi-asserted-by": "publisher", "first-page": "1592", "DOI": "10.1053/j.gastro.2012.04.001", "volume": "142", "author": "N Chalasani", "year": "2012", "unstructured": "Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592\u2013609.", "journal-title": "Gastroenterology"}, {"issue": "2", "key": "16_CR23", "first-page": "367-378.e5", "volume": "149", "author": "Eduardo Vilar-Gomez", "year": "2015", "unstructured": "Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, et al. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology. 2015;149(2):367\u201378 e5.", "journal-title": "Gastroenterology"}, {"issue": "10", "key": "16_CR24", "doi-asserted-by": "publisher", "first-page": "4093", "DOI": "10.3390/nu5104093", "volume": "5", "author": "BA Conlon", "year": "2013", "unstructured": "Conlon BA, Beasley JM, Aebersold K, Jhangiani SS, Wylie-Rosett J. Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD). Nutrients. 2013;5(10):4093\u2013114.", "journal-title": "Nutrients"}, {"issue": "9", "key": "16_CR25", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1056/NEJMoa0804748", "volume": "360", "author": "FM Sacks", "year": "2009", "unstructured": "Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360(9):859\u201373.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "16_CR26", "doi-asserted-by": "publisher", "first-page": "993", "DOI": "10.1016/j.jhep.2008.02.011", "volume": "48", "author": "X Ouyang", "year": "2008", "unstructured": "Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48(6):993\u20139.", "journal-title": "J Hepatol"}, {"issue": "6", "key": "16_CR27", "doi-asserted-by": "publisher", "first-page": "1961", "DOI": "10.1002/hep.23535", "volume": "51", "author": "MF Abdelmalek", "year": "2010", "unstructured": "Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(6):1961\u201371.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR28", "doi-asserted-by": "publisher", "first-page": "952", "DOI": "10.1002/hep.25741", "volume": "56", "author": "MF Abdelmalek", "year": "2012", "unstructured": "Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology. 2012;56(3):952\u201360.", "journal-title": "Hepatology"}, {"issue": "5", "key": "16_CR29", "doi-asserted-by": "publisher", "first-page": "1016", "DOI": "10.1053/j.gastro.2013.07.012", "volume": "145", "author": "RD Johnston", "year": "2013", "unstructured": "Johnston RD, Stephenson MC, Crossland H, Cordon SM, Palcidi E, Cox EF, et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology. 2013;145(5):1016\u201325.e2.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "16_CR30", "doi-asserted-by": "publisher", "first-page": "804", "DOI": "10.3945/ajcn.113.079277", "volume": "99", "author": "RC Mollard", "year": "2014", "unstructured": "Mollard RC, Senechal M, MacIntosh AC, Hay J, Wicklow BA, Wittmeier KD, et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am J Clin Nutr. 2014;99(4):804\u201312.", "journal-title": "Am J Clin Nutr"}, {"issue": "1", "key": "16_CR31", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1016/j.jhep.2012.02.023", "volume": "57", "author": "SE Keating", "year": "2012", "unstructured": "Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;57(1):157\u201366.", "journal-title": "J Hepatol"}, {"issue": "9", "key": "16_CR32", "doi-asserted-by": "publisher", "first-page": "1281", "DOI": "10.1136/gut.2008.151977", "volume": "58", "author": "K Kantartzis", "year": "2009", "unstructured": "Kantartzis K, Thamer C, Peter A, Machann J, Schick F, Schraml C, et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut. 2009;58(9):1281\u20138.", "journal-title": "Gut"}, {"issue": "3", "key": "16_CR33", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1111/j.1440-1746.2008.05694.x", "volume": "24", "author": "A St George", "year": "2009", "unstructured": "St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol. 2009;24(3):399\u2013407.", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "4", "key": "16_CR34", "doi-asserted-by": "publisher", "first-page": "1105", "DOI": "10.1002/hep.23129", "volume": "50", "author": "NA Johnson", "year": "2009", "unstructured": "Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50(4):1105\u201312.", "journal-title": "Hepatology"}, {"issue": "10", "key": "16_CR35", "doi-asserted-by": "publisher", "first-page": "1755", "DOI": "10.1016/j.jada.2007.07.017", "volume": "107", "author": "MJ Franz", "year": "2007", "unstructured": "Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007;107(10):1755\u201367.", "journal-title": "J Am Diet Assoc"}, {"issue": "5", "key": "16_CR36", "doi-asserted-by": "publisher", "first-page": "893", "DOI": "10.1097/SLA.0000000000000945", "volume": "260", "author": "R Caiazzo", "year": "2014", "unstructured": "Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893\u20139.", "journal-title": "Ann Surg"}, {"issue": "9", "key": "16_CR37", "doi-asserted-by": "publisher", "first-page": "934", "DOI": "10.1001/jama.2014.10706", "volume": "312", "author": "N Puzziferri", "year": "2014", "unstructured": "Puzziferri N, Roshek 3rd TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934\u201342.", "journal-title": "JAMA"}, {"issue": "1", "key": "16_CR38", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1093/ajcp/104.1.23", "volume": "104", "author": "EM Silverman", "year": "1995", "unstructured": "Silverman EM, Sapala JA, Appelman HD. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol. 1995;104(1):23\u201331.", "journal-title": "Am J Clin Pathol"}, {"issue": "7", "key": "16_CR39", "doi-asserted-by": "publisher", "first-page": "1180", "DOI": "10.1038/oby.2005.140", "volume": "13", "author": "JM Clark", "year": "2005", "unstructured": "Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res. 2005;13(7):1180\u20136.", "journal-title": "Obes Res"}, {"issue": "4", "key": "16_CR40", "first-page": "610", "volume": "242", "author": "SG Mattar", "year": "2005", "unstructured": "Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005;242(4):610\u20137. Discussion 8\u201320.", "journal-title": "Ann Surg"}, {"issue": "6", "key": "16_CR41", "doi-asserted-by": "publisher", "first-page": "1617", "DOI": "10.1053/j.gastro.2006.02.024", "volume": "130", "author": "P Mathurin", "year": "2006", "unstructured": "Mathurin P, Gonzalez F, Kerdraon O, Leteurtre E, Arnalsteen L, Hollebecque A, et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology. 2006;130(6):1617\u201324.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "16_CR42", "doi-asserted-by": "publisher", "first-page": "486", "DOI": "10.1007/s11695-007-9086-2", "volume": "17", "author": "X Liu", "year": "2007", "unstructured": "Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA. Resolution of nonalcoholic steatohepatitis after gastric bypass surgery. Obes Surg. 2007;17(4):486\u201392.", "journal-title": "Obes Surg"}, {"issue": "6", "key": "16_CR43", "doi-asserted-by": "publisher", "first-page": "1647", "DOI": "10.1002/hep.20251", "volume": "39", "author": "JB Dixon", "year": "2004", "unstructured": "Dixon JB, Bhathal PS, Hughes NR, O\u2019Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39(6):1647\u201354.", "journal-title": "Hepatology"}, {"issue": "2", "key": "16_CR44", "doi-asserted-by": "publisher", "first-page": "532", "DOI": "10.1053/j.gastro.2009.04.052", "volume": "137", "author": "P Mathurin", "year": "2009", "unstructured": "Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532\u201340.", "journal-title": "Gastroenterology"}, {"issue": "12", "key": "16_CR45", "doi-asserted-by": "publisher", "first-page": "1396", "DOI": "10.1016/j.cgh.2008.08.012", "volume": "6", "author": "RR Mummadi", "year": "2008", "unstructured": "Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396\u2013402.", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "16_CR46", "unstructured": "Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;(1):Cd007340.", "DOI": "10.1002/14651858.CD007340.pub2", "doi-asserted-by": "crossref"}, {"issue": "5", "key": "16_CR47", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1381/096089206776944904", "volume": "16", "author": "A Csendes", "year": "2006", "unstructured": "Csendes A, Smok G, Burgos AM. Histological findings in the liver before and after gastric bypass. Obes Surg. 2006;16(5):607\u201311.", "journal-title": "Obes Surg"}, {"issue": "1", "key": "16_CR48", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1016/j.surg.2003.10.003", "volume": "135", "author": "JG Kral", "year": "2004", "unstructured": "Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135(1):48\u201358.", "journal-title": "Surgery"}, {"issue": "8", "key": "16_CR49", "doi-asserted-by": "publisher", "first-page": "1154", "DOI": "10.1381/0960892055002239", "volume": "15", "author": "C Stratopoulos", "year": "2005", "unstructured": "Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V, et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005;15(8):1154\u201360.", "journal-title": "Obes Surg"}, {"issue": "17", "key": "16_CR50", "doi-asserted-by": "publisher", "first-page": "995", "DOI": "10.1056/NEJM198304283081703", "volume": "308", "author": "MP Hocking", "year": "1983", "unstructured": "Hocking MP, Duerson MC, O\u2019Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity. Late follow-up in 100 cases. N Engl J Med. 1983;308(17):995\u20139.", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "16_CR51", "doi-asserted-by": "publisher", "first-page": "128", "DOI": "10.1002/hep.510270121", "volume": "27", "author": "MD Weltman", "year": "1998", "unstructured": "Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology. 1998;27(1):128\u201333.", "journal-title": "Hepatology"}, {"issue": "5", "key": "16_CR52", "doi-asserted-by": "publisher", "first-page": "1183", "DOI": "10.1053/gast.2001.23256", "volume": "120", "author": "AJ Sanyal", "year": "2001", "unstructured": "Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183\u201392.", "journal-title": "Gastroenterology"}, {"issue": "8", "key": "16_CR53", "doi-asserted-by": "publisher", "first-page": "1497", "DOI": "10.1111/j.1572-0241.2004.30159.x", "volume": "99", "author": "N Chalasani", "year": "2004", "unstructured": "Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99(8):1497\u2013502.", "journal-title": "Am J Gastroenterol"}, {"issue": "8", "key": "16_CR54", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1097/00042871-200412000-00022", "volume": "52", "author": "S Gawrieh", "year": "2004", "unstructured": "Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med. 2004;52(8):506\u201314.", "journal-title": "J Investig Med"}, {"issue": "5", "key": "16_CR55", "doi-asserted-by": "publisher", "first-page": "1495", "DOI": "10.1002/hep.22183", "volume": "47", "author": "Z Li", "year": "2008", "unstructured": "Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 2008;47(5):1495\u2013503.", "journal-title": "Hepatology"}, {"issue": "1", "key": "16_CR56", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1080/00365520701559003", "volume": "43", "author": "MV Machado", "year": "2007", "unstructured": "Machado MV, Ravasco P, Jesus L, Marques-Vidal P, Oliveira CR, Proenca T, et al. Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. Scand J Gastroenterol. 2007;43(1):95\u2013102.", "journal-title": "Scand J Gastroenterol"}, {"issue": "1", "key": "16_CR57", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1016/j.freeradbiomed.2007.03.024", "volume": "43", "author": "MG Traber", "year": "2007", "unstructured": "Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007;43(1):4\u201315.", "journal-title": "Free Radic Biol Med"}, {"issue": "10", "key": "16_CR58", "doi-asserted-by": "publisher", "first-page": "1667", "DOI": "10.1046/j.1365-2036.2001.01083.x", "volume": "15", "author": "T Hasegawa", "year": "2001", "unstructured": "Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001;15(10):1667\u201372.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "11", "key": "16_CR59", "doi-asserted-by": "publisher", "first-page": "2485", "DOI": "10.1111/j.1572-0241.2003.08699.x", "volume": "98", "author": "SA Harrison", "year": "2003", "unstructured": "Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003;98(11):2485\u201390.", "journal-title": "Am J Gastroenterol"}, {"issue": "12", "key": "16_CR60", "doi-asserted-by": "publisher", "first-page": "1107", "DOI": "10.1016/S1542-3565(04)00457-4", "volume": "2", "author": "AJ Sanyal", "year": "2004", "unstructured": "Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, et al. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2004;2(12):1107\u201315.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "3", "key": "16_CR61", "doi-asserted-by": "publisher", "first-page": "266", "DOI": "10.1016/S0011-393X(04)80077-8", "volume": "65", "author": "F Yakaryilmaz", "year": "2004", "unstructured": "Yakaryilmaz F, Guliter S, Ozenirler S, Erdem O, Akyol G. Vitamin E treatment in patients with nonalcoholic steatohepatitis: a six-month, open-label study of sixteen patients. Curr Ther Res Clin Exp. 2004;65(3):266\u201377.", "journal-title": "Curr Ther Res Clin Exp"}, {"issue": "12", "key": "16_CR62", "doi-asserted-by": "publisher", "first-page": "1537", "DOI": "10.1016/j.cgh.2006.09.025", "volume": "4", "author": "JF Dufour", "year": "2006", "unstructured": "Dufour JF, Oneta CM, Gonvers JJ, Bihl F, Cerny A, Cereda JM, et al. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2006;4(12):1537\u201343.", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "16_CR63", "doi-asserted-by": "publisher", "first-page": "1675", "DOI": "10.1056/NEJMoa0907929", "volume": "362", "author": "AJ Sanyal", "year": "2010", "unstructured": "Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675\u201385.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "16_CR64", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1016/j.clinre.2011.10.011", "volume": "36", "author": "F Pietu", "year": "2012", "unstructured": "Pietu F, Guillaud O, Walter T, Vallin M, Hervieu V, Scoazec JY, et al. Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results. Clin Res Hepatol Gastroenterol. 2012;36(2):146\u201355.", "journal-title": "Clin Res Hepatol Gastroenterol"}, {"issue": "10", "key": "16_CR65", "doi-asserted-by": "publisher", "first-page": "1598", "DOI": "10.3748/wjg.14.1598", "volume": "14", "author": "CL Wang", "year": "2008", "unstructured": "Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ, et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol. 2008;14(10):1598\u2013602.", "journal-title": "World J Gastroenterol"}, {"issue": "16", "key": "16_CR66", "doi-asserted-by": "publisher", "first-page": "1659", "DOI": "10.1001/jama.2011.520", "volume": "305", "author": "JE Lavine", "year": "2011", "unstructured": "Lavine JE, Schwimmer JB, Van Natta ML, Molleston JP, Murray KF, Rosenthal P, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011;305(16):1659\u201368.", "journal-title": "JAMA"}, {"issue": "6", "key": "16_CR67", "doi-asserted-by": "publisher", "first-page": "641", "DOI": "10.1097/MCO.0b013e328357f747", "volume": "15", "author": "T Pacana", "year": "2012", "unstructured": "Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15(6):641\u20138.", "journal-title": "Curr Opin Clin Nutr Metab Care"}, {"issue": "1", "key": "16_CR68", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.7326/0003-4819-142-1-200501040-00110", "volume": "142", "author": "ER Miller 3rd", "year": "2005", "unstructured": "Miller 3rd ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37\u201346.", "journal-title": "Ann Intern Med"}, {"issue": "8", "key": "16_CR69", "doi-asserted-by": "publisher", "first-page": "842", "DOI": "10.1001/jama.297.8.842", "volume": "297", "author": "G Bjelakovic", "year": "2007", "unstructured": "Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842\u201357.", "journal-title": "JAMA"}, {"issue": "Suppl", "key": "16_CR70", "first-page": "OL1111", "volume": "55", "author": "J Gerss", "year": "2009", "unstructured": "Gerss J, Kopcke W. The questionable association of vitamin E supplementation and mortality\u2014inconsistent results of different meta-analytic approaches. Cell Mol Biol. 2009;55(Suppl):OL1111\u201320.", "journal-title": "Cell Mol Biol"}, {"issue": "1", "key": "16_CR71", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.1177/1740774508101279", "volume": "6", "author": "D Berry", "year": "2009", "unstructured": "Berry D, Wathen JK, Newell M. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin Trials. 2009;6(1):28\u201341.", "journal-title": "Clin Trials"}, {"issue": "2", "key": "16_CR72", "doi-asserted-by": "publisher", "first-page": "549", "DOI": "10.1016/j.atherosclerosis.2008.12.019", "volume": "205", "author": "M Dietrich", "year": "2009", "unstructured": "Dietrich M, Jacques PF, Pencina MJ, Lanier K, Keyes MJ, Kaur G, et al. Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: does the underlying health status play a role? Atherosclerosis. 2009;205(2):549\u201353.", "journal-title": "Atherosclerosis"}, {"issue": "14", "key": "16_CR73", "doi-asserted-by": "publisher", "first-page": "1549", "DOI": "10.1001/jama.2011.1437", "volume": "306", "author": "EA Klein", "year": "2011", "unstructured": "Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549\u201356.", "journal-title": "JAMA"}, {"issue": "11", "key": "16_CR74", "doi-asserted-by": "publisher", "first-page": "1106", "DOI": "10.1056/NEJMra041001", "volume": "351", "author": "H Yki-Jarvinen", "year": "2004", "unstructured": "Yki-Jarvinen H. Thiazolidinediones. N Engl J Med. 2004;351(11):1106\u201318.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "16_CR75", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1210/jc.2006-1268", "volume": "92", "author": "AM Sharma", "year": "2007", "unstructured": "Sharma AM, Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue\u2014understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab. 2007;92(2):386\u201395.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "4a", "key": "16_CR76", "doi-asserted-by": "publisher", "first-page": "27b", "DOI": "10.1016/j.amjcard.2006.11.004", "volume": "99", "author": "P Libby", "year": "2007", "unstructured": "Libby P, Plutzky J. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol. 2007;99(4a):27b\u201340.", "journal-title": "Am J Cardiol"}, {"issue": "6", "key": "16_CR77", "doi-asserted-by": "publisher", "first-page": "2201", "DOI": "10.1210/en.2003-0288", "volume": "144", "author": "CH Lee", "year": "2003", "unstructured": "Lee CH, Olson P, Evans RM. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 2003;144(6):2201\u20137.", "journal-title": "Endocrinology"}, {"issue": "10", "key": "16_CR78", "doi-asserted-by": "publisher", "first-page": "869", "DOI": "10.1016/j.jacc.2008.04.055", "volume": "52", "author": "G Orasanu", "year": "2008", "unstructured": "Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice. J Am Coll Cardiol. 2008;52(10):869\u201381.", "journal-title": "J Am Coll Cardiol"}, {"issue": "4", "key": "16_CR79", "doi-asserted-by": "publisher", "first-page": "1008", "DOI": "10.1002/hep.1840380427", "volume": "38", "author": "BA Neuschwander-Tetri", "year": "2003", "unstructured": "Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology. 2003;38(4):1008\u201317.", "journal-title": "Hepatology"}, {"issue": "8", "key": "16_CR80", "doi-asserted-by": "publisher", "first-page": "2169", "DOI": "10.2337/diabetes.53.8.2169", "volume": "53", "author": "M Tiikkainen", "year": "2004", "unstructured": "Tiikkainen M, Hakkinen AM, Korsheninnikova E, Nyman T, Makimattila S, Yki-Jarvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes. 2004;53(8):2169\u201376.", "journal-title": "Diabetes"}, {"issue": "1", "key": "16_CR81", "doi-asserted-by": "publisher", "first-page": "100", "DOI": "10.1053/j.gastro.2008.03.078", "volume": "135", "author": "V Ratziu", "year": "2008", "unstructured": "Ratziu V, Giral P, Jacqueminet S, Charlotte F, Hartemann-Heurtier A, Serfaty L, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology. 2008;135(1):100\u201310.", "journal-title": "Gastroenterology"}, {"issue": "2", "key": "16_CR82", "doi-asserted-by": "publisher", "first-page": "445", "DOI": "10.1002/hep.23270", "volume": "51", "author": "V Ratziu", "year": "2010", "unstructured": "Ratziu V, Charlotte F, Bernhardt C, Giral P, Halbron M, Lenaour G, et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial. Hepatology. 2010;51(2):445\u201353.", "journal-title": "Hepatology"}, {"issue": "1", "key": "16_CR83", "doi-asserted-by": "publisher", "first-page": "18", "DOI": "10.1097/MEG.0b013e32832e2baf", "volume": "22", "author": "Z Omer", "year": "2010", "unstructured": "Omer Z, Cetinkalp S, Akyildiz M, Yilmaz F, Batur Y, Yilmaz C, et al. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2010;22(1):18\u201323.", "journal-title": "Eur J Gastroenterol Hepatol"}, {"issue": "5", "key": "16_CR84", "doi-asserted-by": "publisher", "first-page": "1631", "DOI": "10.1002/hep.24558", "volume": "54", "author": "DM Torres", "year": "2011", "unstructured": "Torres DM, Jones FJ, Shaw JC, Williams CD, Ward JA, Harrison SA. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open-label trial. Hepatology. 2011;54(5):1631\u20139.", "journal-title": "Hepatology"}, {"issue": "1", "key": "16_CR85", "doi-asserted-by": "publisher", "first-page": "188", "DOI": "10.1002/hep.20012", "volume": "39", "author": "K Promrat", "year": "2004", "unstructured": "Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 2004;39(1):188\u201396.", "journal-title": "Hepatology"}, {"issue": "22", "key": "16_CR86", "doi-asserted-by": "publisher", "first-page": "2297", "DOI": "10.1056/NEJMoa060326", "volume": "355", "author": "R Belfort", "year": "2006", "unstructured": "Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 2006;355(22):2297\u2013307.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "16_CR87", "doi-asserted-by": "publisher", "first-page": "1176", "DOI": "10.1053/j.gastro.2008.06.047", "volume": "135", "author": "GP Aithal", "year": "2008", "unstructured": "Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD, Spendlove I, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology. 2008;135(4):1176\u201384.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "16_CR88", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1111/j.1365-2036.2011.04912.x", "volume": "35", "author": "E Boettcher", "year": "2012", "unstructured": "Boettcher E, Csako G, Pucino F, Wesley R, Loomba R. Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2012;35(1):66\u201375.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "16_CR89", "doi-asserted-by": "publisher", "first-page": "424", "DOI": "10.1002/hep.21661", "volume": "46", "author": "G Lutchman", "year": "2007", "unstructured": "Lutchman G, Modi A, Kleiner DE, Promrat K, Heller T, Ghany M, et al. The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis. Hepatology. 2007;46(2):424\u20139.", "journal-title": "Hepatology"}, {"key": "16_CR90", "doi-asserted-by": "publisher", "first-page": "e3645", "DOI": "10.1136/bmj.e3645", "volume": "344", "author": "L Azoulay", "year": "2012", "unstructured": "Azoulay L, Yin H, Filion KB, Assayag J, Majdan A, Pollak MN, et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ. 2012;344:e3645.", "journal-title": "BMJ"}, {"issue": "9", "key": "16_CR91", "doi-asserted-by": "publisher", "first-page": "602", "DOI": "10.7326/0003-4819-154-9-201105030-00336", "volume": "154", "author": "WL Bennett", "year": "2011", "unstructured": "Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011;154(9):602\u201313.", "journal-title": "Ann Intern Med"}, {"issue": "10", "key": "16_CR92", "doi-asserted-by": "publisher", "first-page": "1180", "DOI": "10.1001/jama.298.10.1180", "volume": "298", "author": "AM Lincoff", "year": "2007", "unstructured": "Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA. 2007;298(10):1180\u20138.", "journal-title": "JAMA"}, {"issue": "5418", "key": "16_CR93", "doi-asserted-by": "publisher", "first-page": "1362", "DOI": "10.1126/science.284.5418.1362", "volume": "284", "author": "M Makishima", "year": "1999", "unstructured": "Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science. 1999;284(5418):1362\u20135.", "journal-title": "Science"}, {"issue": "5418", "key": "16_CR94", "doi-asserted-by": "publisher", "first-page": "1365", "DOI": "10.1126/science.284.5418.1365", "volume": "284", "author": "DJ Parks", "year": "1999", "unstructured": "Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;284(5418):1365\u20138.", "journal-title": "Science"}, {"issue": "17-18", "key": "16_CR95", "doi-asserted-by": "publisher", "first-page": "988", "DOI": "10.1016/j.drudis.2012.05.012", "volume": "17", "author": "L Adorini", "year": "2012", "unstructured": "Adorini L, Pruzanski M, Shapiro D. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov Today. 2012;17(17-18):988\u201397.", "journal-title": "Drug Discov Today"}, {"issue": "9", "key": "16_CR96", "doi-asserted-by": "publisher", "first-page": "1631", "DOI": "10.1007/s00018-014-1805-y", "volume": "72", "author": "C Mazuy", "year": "2015", "unstructured": "Mazuy C, Helleboid A, Staels B, Lefebvre P. Nuclear bile acid signaling through the farnesoid X receptor. Cell Mol Life Sci. 2015;72(9):1631\u201350.", "journal-title": "Cell Mol Life Sci"}, {"issue": "3", "key": "16_CR97", "doi-asserted-by": "publisher", "first-page": "574", "DOI": "10.1053/j.gastro.2013.05.042", "volume": "145", "author": "S Mudaliar", "year": "2013", "unstructured": "Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology. 2013;145(3):574\u201382.e1.", "journal-title": "Gastroenterology"}, {"issue": "9972", "key": "16_CR98", "doi-asserted-by": "publisher", "first-page": "956", "DOI": "10.1016/S0140-6736(14)61933-4", "volume": "385", "author": "BA Neuschwander-Tetri", "year": "2015", "unstructured": "Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385(9972):956\u201365.", "journal-title": "Lancet"}, {"issue": "4", "key": "16_CR99", "doi-asserted-by": "publisher", "first-page": "1249", "DOI": "10.1053/j.gastro.2011.06.061", "volume": "141", "author": "MR Charlton", "year": "2011", "unstructured": "Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249\u201353.", "journal-title": "Gastroenterology"}, {"issue": "5", "key": "16_CR100", "doi-asserted-by": "publisher", "first-page": "755", "DOI": "10.1097/TP.0b013e31827afb3a", "volume": "95", "author": "AK Singal", "year": "2013", "unstructured": "Singal AK, Guturu P, Hmoud B, Kuo YF, Salameh H, Wiesner RH. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation. 2013;95(5):755\u201360.", "journal-title": "Transplantation"}, {"issue": "4", "key": "16_CR101", "doi-asserted-by": "publisher", "first-page": "624", "DOI": "10.1097/SLA.0b013e31826b4b7e", "volume": "256", "author": "VG Agopian", "year": "2012", "unstructured": "Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg. 2012;256(4):624\u201333.", "journal-title": "Ann Surg"}, {"issue": "3", "key": "16_CR102", "doi-asserted-by": "publisher", "first-page": "547", "DOI": "10.1053/j.gastro.2014.11.039", "volume": "148", "author": "RJ Wong", "year": "2015", "unstructured": "Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547\u201355.", "journal-title": "Gastroenterology"}, {"issue": "8", "key": "16_CR103", "doi-asserted-by": "publisher", "first-page": "700", "DOI": "10.1016/j.cgh.2011.04.007", "volume": "9", "author": "JG O\u2019Leary", "year": "2011", "unstructured": "O\u2019Leary JG, Landaverde C, Jennings L, Goldstein RM, Davis GL. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. Clin Gastroenterol Hepatol. 2011;9(8):700\u20134.e1.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "1", "key": "16_CR104", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1002/lt.22435", "volume": "18", "author": "A Afzali", "year": "2012", "unstructured": "Afzali A, Berry K, Ioannou GN. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl. 2012;18(1):29\u201337.", "journal-title": "Liver Transpl"}, {"issue": "10", "key": "16_CR105", "doi-asserted-by": "publisher", "first-page": "E3", "DOI": "10.1111/hepr.12200", "volume": "44", "author": "T Tanaka", "year": "2014", "unstructured": "Tanaka T, Sugawara Y, Tamura S, Kaneko J, Takazawa Y, Aoki T, et al. Living donor liver transplantation for non-alcoholic steatohepatitis: a single center experience. Hepatol Res. 2014;44(10):E3\u201310.", "journal-title": "Hepatol Res"}, {"issue": "5", "key": "16_CR106", "doi-asserted-by": "publisher", "first-page": "E505", "DOI": "10.1111/ctr.12014", "volume": "26", "author": "MM Atrache El", "year": "2012", "unstructured": "El Atrache MM, Abouljoud MS, Divine G, Yoshida A, Kim DY, Kazimi MM, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant. 2012;26(5):E505\u201312.", "journal-title": "Clin Transplant"}, {"issue": "6", "key": "16_CR107", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1097/TP.0b013e31820b6b84", "volume": "91", "author": "P Dureja", "year": "2011", "unstructured": "Dureja P, Mellinger J, Agni R, Chang F, Avey G, Lucey M, et al. NAFLD recurrence in liver transplant recipients. Transplantation. 2011;91(6):684\u20139.", "journal-title": "Transplantation"}, {"issue": "4", "key": "16_CR108", "doi-asserted-by": "publisher", "first-page": "484", "DOI": "10.1136/gutjnl-2011-300886", "volume": "61", "author": "PN Newsome", "year": "2012", "unstructured": "Newsome PN, Allison ME, Andrews PA, Auzinger G, Day CP, Ferguson JW, et al. Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis. Gut. 2012;61(4):484\u2013500.", "journal-title": "Gut"}, {"issue": "48", "key": "16_CR109", "doi-asserted-by": "publisher", "first-page": "9146", "DOI": "10.3748/wjg.v19.i48.9146", "volume": "19", "author": "A Said", "year": "2013", "unstructured": "Said A. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances. World J Gastroenterol. 2013;19(48):9146\u201355.", "journal-title": "World J Gastroenterol"}, {"issue": "6", "key": "16_CR110", "doi-asserted-by": "publisher", "first-page": "1294", "DOI": "10.1210/jcem-73-6-1294", "volume": "73", "author": "RA DeFronzo", "year": "1991", "unstructured": "DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1991;73(6):1294\u2013301.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "7", "key": "16_CR111", "doi-asserted-by": "publisher", "first-page": "856", "DOI": "10.1053/meta.2001.24192", "volume": "50", "author": "CJ Glueck", "year": "2001", "unstructured": "Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism. 2001;50(7):856\u201361.", "journal-title": "Metabolism"}, {"issue": "3", "key": "16_CR112", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1038/nrendo.2013.256", "volume": "10", "author": "I Pernicova", "year": "2014", "unstructured": "Pernicova I, Korbonits M. Metformin\u2014mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10(3):143\u201356.", "journal-title": "Nat Rev Endocrinol"}, {"issue": "5", "key": "16_CR113", "doi-asserted-by": "publisher", "first-page": "1082", "DOI": "10.1111/j.1572-0241.2005.41583.x", "volume": "100", "author": "E Bugianesi", "year": "2005", "unstructured": "Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005;100(5):1082\u201390.", "journal-title": "Am J Gastroenterol"}, {"issue": "2", "key": "16_CR114", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1111/j.1365-2036.2008.03723.x", "volume": "28", "author": "R Idilman", "year": "2008", "unstructured": "Idilman R, Mizrak D, Corapcioglu D, Bektas M, Doganay B, Sayki M, et al. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2008;28(2):200\u20138.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "9", "key": "16_CR115", "doi-asserted-by": "publisher", "first-page": "1762", "DOI": "10.1038/oby.2010.21", "volume": "18", "author": "J Krakoff", "year": "2010", "unstructured": "Krakoff J, Clark JM, Crandall JP, Wilson C, Molitch ME, Brancati FL, et al. Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity. 2010;18(9):1762\u20137.", "journal-title": "Obesity"}, {"issue": "2", "key": "16_CR116", "doi-asserted-by": "publisher", "first-page": "172", "DOI": "10.1111/j.1365-2036.2008.03869.x", "volume": "29", "author": "R Loomba", "year": "2009", "unstructured": "Loomba R, Lutchman G, Kleiner DE, Ricks M, Feld JJ, Borg BB, et al. Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2009;29(2):172\u201382.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "16_CR117", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1007/s00592-008-0067-2", "volume": "46", "author": "A Nar", "year": "2009", "unstructured": "Nar A, Gedik O. The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. Acta Diabetol. 2009;46(2):113\u20138.", "journal-title": "Acta Diabetol"}, {"issue": "9", "key": "16_CR118", "doi-asserted-by": "publisher", "first-page": "1278", "DOI": "10.1016/j.metabol.2011.01.011", "volume": "60", "author": "E Sofer", "year": "2011", "unstructured": "Sofer E, Boaz M, Matas Z, Mashavi M, Shargorodsky M. Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Metabolism. 2011;60(9):1278\u201384.", "journal-title": "Metabolism"}, {"issue": "5", "key": "16_CR119", "doi-asserted-by": "publisher", "first-page": "537", "DOI": "10.1111/j.1365-2036.2004.01888.x", "volume": "19", "author": "A Uygun", "year": "2004", "unstructured": "Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2004;19(5):537\u201344.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "7", "key": "16_CR120", "doi-asserted-by": "publisher", "first-page": "853", "DOI": "10.1080/00365520902845268", "volume": "44", "author": "JW Haukeland", "year": "2009", "unstructured": "Haukeland JW, Konopski Z, Eggesbo HB, von Volkmann HL, Raschpichler G, Bjoro K, et al. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. Scand J Gastroenterol. 2009;44(7):853\u201360.", "journal-title": "Scand J Gastroenterol"}, {"issue": "1", "key": "16_CR121", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1111/j.1365-2036.2004.02025.x", "volume": "20", "author": "S Nair", "year": "2004", "unstructured": "Nair S, Diehl AM, Wiseman M, Farr Jr GH, Perrillo RP. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther. 2004;20(1):23\u20138.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "16_CR122", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1177/1756283X09105462", "volume": "2", "author": "WW Shields", "year": "2009", "unstructured": "Shields WW, Thompson KE, Grice GA, Harrison SA, Coyle WJ. The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial. Ther Adv Gastroenterol. 2009;2(3):157\u201363.", "journal-title": "Ther Adv Gastroenterol"}, {"issue": "10", "key": "16_CR123", "doi-asserted-by": "publisher", "first-page": "1211", "DOI": "10.1111/j.1365-2036.2010.04467.x", "volume": "32", "author": "MO Rakoski", "year": "2010", "unstructured": "Rakoski MO, Singal AG, Rogers MA, Conjeevaram H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2010;32(10):1211\u201321.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "1", "key": "16_CR124", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1016/S0168-8278(01)00092-7", "volume": "35", "author": "KN Lazaridis", "year": "2001", "unstructured": "Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019. J Hepatol. 2001;35(1):134\u201346.", "journal-title": "J Hepatol"}, {"issue": "6", "key": "16_CR125", "doi-asserted-by": "publisher", "first-page": "1464", "DOI": "10.1002/hep.510230624", "volume": "23", "author": "J Laurin", "year": "1996", "unstructured": "Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology. 1996;23(6):1464\u20137.", "journal-title": "Hepatology"}, {"issue": "5", "key": "16_CR126", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1016/j.jhep.2010.08.030", "volume": "54", "author": "V Ratziu", "year": "2011", "unstructured": "Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, et al. A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis. J Hepatol. 2011;54(5):1011\u20139.", "journal-title": "J Hepatol"}, {"issue": "2", "key": "16_CR127", "doi-asserted-by": "publisher", "first-page": "472", "DOI": "10.1002/hep.23727", "volume": "52", "author": "UF Leuschner", "year": "2010", "unstructured": "Leuschner UF, Lindenthal B, Herrmann G, Arnold JC, Rossle M, Cordes HJ, et al. High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology. 2010;52(2):472\u20139.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR128", "doi-asserted-by": "publisher", "first-page": "770", "DOI": "10.1002/hep.20092", "volume": "39", "author": "KD Lindor", "year": "2004", "unstructured": "Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology. 2004;39(3):770\u20138.", "journal-title": "Hepatology"}, {"issue": "9841", "key": "16_CR129", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1016/S0140-6736(12)60367-5", "volume": "380", "author": "B Mihaylova", "year": "2012", "unstructured": "Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581\u201390.", "journal-title": "Lancet"}, {"issue": "22", "key": "16_CR130", "doi-asserted-by": "publisher", "first-page": "2451", "DOI": "10.1001/jama.2013.281348", "volume": "310", "author": "FC Taylor", "year": "2013", "unstructured": "Taylor FC, Huffman M, Ebrahim S. Statin therapy for primary prevention of cardiovascular disease. JAMA. 2013;310(22):2451\u20132.", "journal-title": "JAMA"}, {"issue": "5", "key": "16_CR131", "doi-asserted-by": "publisher", "first-page": "873", "DOI": "10.1185/030079906X104696", "volume": "22", "author": "VG Athyros", "year": "2006", "unstructured": "Athyros VG, Mikhailidis DP, Didangelos TP, Giouleme OI, Liberopoulos EN, Karagiannis A, et al. Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin. 2006;22(5):873\u201383.", "journal-title": "Curr Med Res Opin"}, {"issue": "4", "key": "16_CR132", "doi-asserted-by": "publisher", "first-page": "340", "DOI": "10.1016/j.jacl.2012.01.009", "volume": "6", "author": "KH Han", "year": "2012", "unstructured": "Han KH, Rha SW, Kang HJ, Bae JW, Choi BJ, Choi SY, et al. Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage). J Clin Lipidol. 2012;6(4):340\u201351.", "journal-title": "J Clin Lipidol"}, {"issue": "4", "key": "16_CR133", "first-page": "131", "volume": "23", "author": "A Hatzitolios", "year": "2004", "unstructured": "Hatzitolios A, Savopoulos C, Lazaraki G, Sidiropoulos I, Haritanti P, Lefkopoulos A, et al. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Indian J Gastroenterol. 2004;23(4):131\u20134.", "journal-title": "Indian J Gastroenterol"}, {"issue": "12", "key": "16_CR134", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1155/2003/857869", "volume": "17", "author": "M Kiyici", "year": "2003", "unstructured": "Kiyici M, Gulten M, Gurel S, Nak SG, Dolar E, Savci G, et al. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can J Gastroenterol. 2003;17(12):713\u20138.", "journal-title": "Can J Gastroenterol"}, {"issue": "1", "key": "16_CR135", "doi-asserted-by": "publisher", "first-page": "71", "DOI": "10.1038/ajg.2010.299", "volume": "106", "author": "T Foster", "year": "2011", "unstructured": "Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol. 2011;106(1):71\u20137.", "journal-title": "Am J Gastroenterol"}, {"issue": "1", "key": "16_CR136", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/j.jhep.2007.02.013", "volume": "47", "author": "M Ekstedt", "year": "2007", "unstructured": "Ekstedt M, Franzen LE, Mathiesen UL, Holmqvist M, Bodemar G, Kechagias S. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. J Hepatol. 2007;47(1):135\u201341.", "journal-title": "J Hepatol"}, {"issue": "12", "key": "16_CR137", "doi-asserted-by": "publisher", "first-page": "1711", "DOI": "10.1016/j.metabol.2008.07.030", "volume": "57", "author": "H Hyogo", "year": "2008", "unstructured": "Hyogo H, Tazuma S, Arihiro K, Iwamoto K, Nabeshima Y, Inoue M, et al. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Metabolism. 2008;57(12):1711\u20138.", "journal-title": "Metabolism"}, {"issue": "10", "key": "16_CR138", "doi-asserted-by": "publisher", "first-page": "990", "DOI": "10.1097/MCG.0b013e31819c392e", "volume": "43", "author": "A Nelson", "year": "2009", "unstructured": "Nelson A, Torres DM, Morgan AE, Fincke C, Harrison SA. A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial. J Clin Gastroenterol. 2009;43(10):990\u20134.", "journal-title": "J Clin Gastroenterol"}, {"issue": "9756", "key": "16_CR139", "doi-asserted-by": "publisher", "first-page": "1916", "DOI": "10.1016/S0140-6736(10)61272-X", "volume": "376", "author": "VG Athyros", "year": "2010", "unstructured": "Athyros VG, Tziomalos K, Gossios TD, Griva T, Anagnostis P, Kargiotis K, et al. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet. 2010;376(9756):1916\u201322.", "journal-title": "Lancet"}, {"issue": "5", "key": "16_CR140", "doi-asserted-by": "publisher", "first-page": "1287", "DOI": "10.1053/j.gastro.2004.02.015", "volume": "126", "author": "N Chalasani", "year": "2004", "unstructured": "Chalasani N, Aljadhey H, Kesterson J, Murray MD, Hall SD. Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity. Gastroenterology. 2004;126(5):1287\u201392.", "journal-title": "Gastroenterology"}, {"issue": "5", "key": "16_CR141", "doi-asserted-by": "publisher", "first-page": "1453", "DOI": "10.1002/hep.21848", "volume": "46", "author": "JH Lewis", "year": "2007", "unstructured": "Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Hepatology. 2007;46(5):1453\u201363.", "journal-title": "Hepatology"}, {"issue": "19", "key": "16_CR142", "doi-asserted-by": "publisher", "first-page": "2088", "DOI": "10.1161/01.CIR.98.19.2088", "volume": "98", "author": "B Staels", "year": "1998", "unstructured": "Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98(19):2088\u201393.", "journal-title": "Circulation"}, {"issue": "2", "key": "16_CR143", "doi-asserted-by": "publisher", "first-page": "829", "DOI": "10.1210/jc.2009-1487", "volume": "95", "author": "R Belfort", "year": "2010", "unstructured": "Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clin Endocrinol Metab. 2010;95(2):829\u201336.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "3", "key": "16_CR144", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1016/S0009-9236(03)00170-X", "volume": "74", "author": "GL Vega", "year": "2003", "unstructured": "Vega GL, Cater NB, Hadizadeh 3rd DR, Meguro S, Grundy SM. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. Clin Pharmacol Ther. 2003;74(3):236\u201344.", "journal-title": "Clin Pharmacol Ther"}, {"issue": "2", "key": "16_CR145", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1016/S0168-8278(99)80243-8", "volume": "31", "author": "M Basaranoglu", "year": "1999", "unstructured": "Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol. 1999;31(2):384.", "journal-title": "J Hepatol"}, {"issue": "3", "key": "16_CR146", "doi-asserted-by": "publisher", "first-page": "200", "DOI": "10.1016/j.dld.2007.10.002", "volume": "40", "author": "C Fernandez-Miranda", "year": "2008", "unstructured": "Fernandez-Miranda C, Perez-Carreras M, Colina F, Lopez-Alonso G, Vargas C, Solis-Herruzo JA. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. Dig Liver Dis. 2008;40(3):200\u20135.", "journal-title": "Dig Liver Dis"}, {"issue": "6", "key": "16_CR147", "doi-asserted-by": "publisher", "first-page": "2727", "DOI": "10.1210/jc.2009-2622", "volume": "95", "author": "E Fabbrini", "year": "2010", "unstructured": "Fabbrini E, Mohammed BS, Korenblat KM, Magkos F, McCrea J, Patterson BW, et al. Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2010;95(6):2727\u201335.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "1", "key": "16_CR148", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1042/CS20070456", "volume": "116", "author": "P Flachs", "year": "2009", "unstructured": "Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009;116(1):1\u201316.", "journal-title": "Clin Sci (Lond)"}, {"issue": "Suppl 1", "key": "16_CR149", "first-page": "S93", "volume": "63", "author": "P Flachs", "year": "2014", "unstructured": "Flachs P, Rossmeisl M, Kopecky J. The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. Physiol Res. 2014;63 Suppl 1:S93\u2013118.", "journal-title": "Physiol Res"}, {"issue": "6", "key": "16_CR150", "doi-asserted-by": "publisher", "first-page": "2451", "DOI": "10.1210/jc.2012-3899", "volume": "98", "author": "JH Wu", "year": "2013", "unstructured": "Wu JH, Cahill LE, Mozaffarian D. Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2013;98(6):2451\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"key": "16_CR151", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1186/1475-2891-13-31", "volume": "13", "author": "Y Papanikolaou", "year": "2014", "unstructured": "Papanikolaou Y, Brooks J, Reider C, Fulgoni VL. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr J. 2014;13:31.", "journal-title": "Nutr J"}, {"issue": "2", "key": "16_CR152", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1136/gutjnl-2012-303179", "volume": "63", "author": "C Lopez-Vicario", "year": "2014", "unstructured": "Lopez-Vicario C, Gonzalez-Periz A, Rius B, Moran-Salvador E, Garcia-Alonso V, Lozano JJ, et al. Molecular interplay between Delta5/Delta6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut. 2014;63(2):344\u201355.", "journal-title": "Gut"}, {"issue": "8", "key": "16_CR153", "doi-asserted-by": "publisher", "first-page": "1143", "DOI": "10.1111/j.1365-2036.2006.02885.x", "volume": "23", "author": "M Capanni", "year": "2006", "unstructured": "Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther. 2006;23(8):1143\u201351.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "16_CR154", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1016/j.dld.2007.10.003", "volume": "40", "author": "L Spadaro", "year": "2008", "unstructured": "Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C, et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis. 2008;40(3):194\u20139.", "journal-title": "Dig Liver Dis"}, {"issue": "4", "key": "16_CR155", "doi-asserted-by": "publisher", "first-page": "413", "DOI": "10.1097/MCG.0b013e31815591aa", "volume": "42", "author": "N Tanaka", "year": "2008", "unstructured": "Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42(4):413\u20138.", "journal-title": "J Clin Gastroenterol"}, {"issue": "41", "key": "16_CR156", "doi-asserted-by": "publisher", "first-page": "6395", "DOI": "10.3748/wjg.14.6395", "volume": "14", "author": "FS Zhu", "year": "2008", "unstructured": "Zhu FS, Liu S, Chen XM, Huang ZG, Zhang DW. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World J Gastroenterol. 2008;14(41):6395\u2013400.", "journal-title": "World J Gastroenterol"}, {"issue": "8", "key": "16_CR157", "doi-asserted-by": "publisher", "first-page": "792", "DOI": "10.3109/09637486.2010.487480", "volume": "61", "author": "F Sofi", "year": "2010", "unstructured": "Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, et al. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study. Int J Food Sci Nutr. 2010;61(8):792\u2013802.", "journal-title": "Int J Food Sci Nutr"}, {"issue": "11", "key": "16_CR158", "doi-asserted-by": "publisher", "first-page": "1066", "DOI": "10.1016/j.numecd.2012.10.010", "volume": "23", "author": "V Nobili", "year": "2013", "unstructured": "Nobili V, Alisi A, Della Corte C, Rise P, Galli C, Agostoni C, et al. Docosahexaenoic acid for the treatment of fatty liver: randomised controlled trial in children. Nutr Metab Cardiovasc Dis. 2013;23(11):1066\u201370.", "journal-title": "Nutr Metab Cardiovasc Dis"}, {"issue": "4", "key": "16_CR159", "doi-asserted-by": "publisher", "first-page": "944", "DOI": "10.1016/j.jhep.2011.08.018", "volume": "56", "author": "HM Parker", "year": "2012", "unstructured": "Parker HM, Johnson NA, Burdon CA, Cohn JS, O\u2019Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944\u201351.", "journal-title": "J Hepatol"}, {"issue": "2", "key": "16_CR160", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1097/MCG.0000000000000099", "volume": "49", "author": "S Dasarathy", "year": "2015", "unstructured": "Dasarathy S, Dasarathy J, Khiyami A, Yerian L, Hawkins C, Sargent R, et al. Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis. J Clin Gastroenterol. 2015;49(2):137\u201344.", "journal-title": "J Clin Gastroenterol"}, {"issue": "4", "key": "16_CR161", "doi-asserted-by": "publisher", "first-page": "1211", "DOI": "10.1002/hep.27289", "volume": "60", "author": "E Scorletti", "year": "2014", "unstructured": "Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, et al. Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: results from the *WELCOME study. Hepatology. 2014;60(4):1211\u201321.", "journal-title": "Hepatology"}, {"issue": "2", "key": "16_CR162", "doi-asserted-by": "publisher", "first-page": "377", "DOI": "10.1053/j.gastro.2014.04.046", "volume": "147", "author": "AJ Sanyal", "year": "2014", "unstructured": "Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings OW, Chojkier M. No significant effects of ethyl-eicosapentaenoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroenterology. 2014;147(2):377\u201384.e1.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "16_CR163", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1016/j.jhep.2014.08.036", "volume": "62", "author": "CK Argo", "year": "2015", "unstructured": "Argo CK, Patrie JT, Lackner C, Henry TD, de Lange EE, Weltman AL, et al. Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol. 2015;62(1):190\u20137.", "journal-title": "J Hepatol"}, {"issue": "6", "key": "16_CR164", "doi-asserted-by": "publisher", "first-page": "1529", "DOI": "10.1016/j.hep.2003.09.028", "volume": "38", "author": "M Sekiya", "year": "2003", "unstructured": "Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology. 2003;38(6):1529\u201339.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR165", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.3945/jn.112.171322", "volume": "143", "author": "CM Depner", "year": "2013", "unstructured": "Depner CM, Philbrick KA, Jump DB. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. J Nutr. 2013;143(3):315\u201323.", "journal-title": "J Nutr"}, {"issue": "7", "key": "16_CR166", "doi-asserted-by": "publisher", "first-page": "2334", "DOI": "10.1053/j.gastro.2009.02.081", "volume": "136", "author": "F Oakley", "year": "2009", "unstructured": "Oakley F, Teoh V, Ching ASG, Bataller R, Colmenero J, Jonsson JR, et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology. 2009;136(7):2334\u201344.e1.", "journal-title": "Gastroenterology"}, {"issue": "3", "key": "16_CR167", "doi-asserted-by": "publisher", "first-page": "942", "DOI": "10.1002/hep.23421", "volume": "51", "author": "M Moreno", "year": "2010", "unstructured": "Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology. 2010;51(3):942\u201352.", "journal-title": "Hepatology"}, {"key": "16_CR168", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1016/j.peptides.2014.10.005", "volume": "62c", "author": "SM Macedo", "year": "2014", "unstructured": "Macedo SM, Antunes Guimaraes T, Feltenberger JD, Santos SH. The role of renin-angiotensin system modulation on treatment and prevention of liver diseases. Peptides. 2014;62c:189\u201396.", "journal-title": "Peptides"}, {"issue": "3", "key": "16_CR169", "doi-asserted-by": "publisher", "first-page": "979", "DOI": "10.1111/liv.12611", "volume": "35", "author": "GB Goh", "year": "2014", "unstructured": "Goh GB, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, et al. Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. Liver Int. 2014;35(3):979\u201385.", "journal-title": "Liver Int"}, {"issue": "2", "key": "16_CR170", "doi-asserted-by": "publisher", "first-page": "164", "DOI": "10.1097/MEG.0b013e32834ba188", "volume": "24", "author": "R Fogari", "year": "2012", "unstructured": "Fogari R, Maffioli P, Mugellini A, Zoppi A, Lazzari P, Derosa G. Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis. Eur J Gastroenterol Hepatol. 2012;24(2):164\u201371.", "journal-title": "Eur J Gastroenterol Hepatol"}, {"issue": "8", "key": "16_CR171", "doi-asserted-by": "publisher", "first-page": "942", "DOI": "10.3748/wjg.15.942", "volume": "15", "author": "EF Georgescu", "year": "2009", "unstructured": "Georgescu EF, Ionescu R, Niculescu M, Mogoanta L, Vancica L. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. World J Gastroenterol. 2009;15(8):942\u201354.", "journal-title": "World J Gastroenterol"}, {"issue": "4", "key": "16_CR172", "doi-asserted-by": "publisher", "first-page": "592", "DOI": "10.1016/j.jhep.2004.06.030", "volume": "41", "author": "SW Koppe", "year": "2004", "unstructured": "Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J Hepatol. 2004;41(4):592\u20138.", "journal-title": "J Hepatol"}, {"issue": "3", "key": "16_CR173", "doi-asserted-by": "publisher", "first-page": "1230", "DOI": "10.1016/S0006-291X(88)81271-3", "volume": "155", "author": "RM Strieter", "year": "1988", "unstructured": "Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch 3rd JP, Larrick J, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun. 1988;155(3):1230\u20136.", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "4", "key": "16_CR174", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1002/hep.25778", "volume": "56", "author": "CO Zein", "year": "2012", "unstructured": "Zein CO, Lopez R, Fu X, Kirwan JP, Yerian LM, McCullough AJ, et al. Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. Hepatology. 2012;56(4):1291\u20139.", "journal-title": "Hepatology"}, {"issue": "10", "key": "16_CR175", "doi-asserted-by": "publisher", "first-page": "1946", "DOI": "10.1111/j.1572-0241.2004.40220.x", "volume": "99", "author": "SK Satapathy", "year": "2004", "unstructured": "Satapathy SK, Garg S, Chauhan R, Sakhuja P, Malhotra V, Sharma BC, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99(10):1946\u201352.", "journal-title": "Am J Gastroenterol"}, {"issue": "12", "key": "16_CR176", "doi-asserted-by": "publisher", "first-page": "2365", "DOI": "10.1111/j.1572-0241.2004.40064.x", "volume": "99", "author": "LA Adams", "year": "2004", "unstructured": "Adams LA, Zein CO, Angulo P, Lindor KD. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99(12):2365\u20138.", "journal-title": "Am J Gastroenterol"}, {"issue": "1", "key": "16_CR177", "first-page": "39", "volume": "16", "author": "EF Georgescu", "year": "2007", "unstructured": "Georgescu EF, Georgescu M. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. J Gastrointest Liver Dis. 2007;16(1):39\u201346.", "journal-title": "J Gastrointest Liver Dis"}, {"issue": "5", "key": "16_CR178", "doi-asserted-by": "publisher", "first-page": "1610", "DOI": "10.1002/hep.24544", "volume": "54", "author": "CO Zein", "year": "2011", "unstructured": "Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE, et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology. 2011;54(5):1610\u20139.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR179", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1016/S1665-2681(19)31539-X", "volume": "10", "author": "LB Wagner Van", "year": "2011", "unstructured": "Van Wagner LB, Koppe SW, Brunt EM, Gottstein J, Gardikiotes K, Green RM, et al. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. Ann Hepatol. 2011;10(3):277\u201386.", "journal-title": "Ann Hepatol"}, {"issue": "8", "key": "16_CR180", "doi-asserted-by": "publisher", "first-page": "5788", "DOI": "10.1167/iovs.13-11696", "volume": "54", "author": "T Bergen Van", "year": "2013", "unstructured": "Van Bergen T, Marshall D, Van de Veire S, Vandewalle E, Moons L, Herman J, et al. The role of LOX and LOXL2 in scar formation after glaucoma surgery. Invest Ophthalmol Vis Sci. 2013;54(8):5788\u201396.", "journal-title": "Invest Ophthalmol Vis Sci"}, {"issue": "12", "key": "16_CR181", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0083481", "volume": "8", "author": "PG Traber", "year": "2013", "unstructured": "Traber PG, Zomer E. Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS One. 2013;8(12), e83481.", "journal-title": "PLoS One"}, {"issue": "10", "key": "16_CR182", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0075361", "volume": "8", "author": "PG Traber", "year": "2013", "unstructured": "Traber PG, Chou H, Zomer E, Hong F, Klyosov A, Fiel MI, et al. Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease. PLoS One. 2013;8(10), e75361.", "journal-title": "PLoS One"}, {"key": "16_CR183", "doi-asserted-by": "publisher", "first-page": "224A", "DOI": "10.1002/hep.27457", "volume": "60", "author": "S Harrison", "year": "2014", "unstructured": "Harrison S, Chalasani N, Lawitz E, Marri S, Noureddin M, Sanyal A, et al. Early phase 1 clinical trial results of GR-MD-02, a galectin-3 inhibitor, in patients having non-alcoholic steatohepatitis (NASH) with advanced fibrosis. Hepatology. 2014;60:224A\u20137.", "journal-title": "Hepatology"}, {"issue": "7", "key": "16_CR184", "doi-asserted-by": "publisher", "first-page": "3082", "DOI": "10.1210/jc.2002-021545", "volume": "88", "author": "OG Kolterman", "year": "2003", "unstructured": "Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2003;88(7):3082\u20139.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "9", "key": "16_CR185", "doi-asserted-by": "publisher", "DOI": "10.1371/journal.pone.0025269", "volume": "6", "author": "S Sharma", "year": "2011", "unstructured": "Sharma S, Mells JE, Fu PP, Saxena NK, Anania FA. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLoS One. 2011;6(9), e25269.", "journal-title": "PLoS One"}, {"issue": "12", "key": "16_CR186", "doi-asserted-by": "publisher", "first-page": "2310", "DOI": "10.1038/oby.2011.152", "volume": "19", "author": "P Sathyanarayana", "year": "2011", "unstructured": "Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M. Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. Obesity. 2011;19(12):2310\u20135.", "journal-title": "Obesity"}, {"issue": "12", "key": "16_CR187", "doi-asserted-by": "publisher", "first-page": "3093", "DOI": "10.1007/s00125-011-2317-z", "volume": "54", "author": "SL Samson", "year": "2011", "unstructured": "Samson SL, Sathyanarayana P, Jogi M, Gonzalez EV, Gutierrez A, Krishnamurthy R, et al. Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011;54(12):3093\u2013100.", "journal-title": "Diabetologia"}, {"issue": "2", "key": "16_CR188", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1053/j.gastro.2013.10.059", "volume": "146", "author": "Y Li", "year": "2014", "unstructured": "Li Y, Wong K, Giles A, Jiang J, Lee JW, Adams AC, et al. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology. 2014;146(2):539\u201349 e7.", "journal-title": "Gastroenterology"}, {"issue": "12", "key": "16_CR189", "doi-asserted-by": "publisher", "first-page": "2707", "DOI": "10.1038/ajg.2010.363", "volume": "105", "author": "PR Kenny", "year": "2010", "unstructured": "Kenny PR, Brady DE, Torres DM, Ragozzino L, Chalasani N, Harrison SA. Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series. Am J Gastroenterol. 2010;105(12):2707\u20139.", "journal-title": "Am J Gastroenterol"}, {"issue": "4", "key": "16_CR190", "first-page": "359", "volume": "10", "author": "A Kharitonenkov", "year": "2009", "unstructured": "Kharitonenkov A, Shanafelt AB. FGF21: a novel prospect for the treatment of metabolic diseases. Curr Opin Investig Drugs. 2009;10(4):359\u201364.", "journal-title": "Curr Opin Investig Drugs"}, {"issue": "6", "key": "16_CR191", "doi-asserted-by": "publisher", "first-page": "1627", "DOI": "10.1172/JCI23606", "volume": "115", "author": "A Kharitonenkov", "year": "2005", "unstructured": "Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627\u201335.", "journal-title": "J Clin Invest"}, {"issue": "12", "key": "16_CR192", "doi-asserted-by": "publisher", "first-page": "6018", "DOI": "10.1210/en.2008-0816", "volume": "149", "author": "T Coskun", "year": "2008", "unstructured": "Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018\u201327.", "journal-title": "Endocrinology"}, {"issue": "1", "key": "16_CR193", "doi-asserted-by": "publisher", "first-page": "250", "DOI": "10.2337/db08-0392", "volume": "58", "author": "J Xu", "year": "2009", "unstructured": "Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58(1):250\u20139.", "journal-title": "Diabetes"}, {"issue": "5", "key": "16_CR194", "doi-asserted-by": "publisher", "first-page": "1073", "DOI": "10.1053/j.gastro.2014.07.044", "volume": "147", "author": "FM Fisher", "year": "2014", "unstructured": "Fisher FM, Chui PC, Nasser IA, Popov Y, Cunniff JC, Lundasen T, et al. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology. 2014;147(5):1073\u201383.", "journal-title": "Gastroenterology"}, {"key": "16_CR195", "doi-asserted-by": "publisher", "first-page": "247A", "DOI": "10.1002/hep.27464", "volume": "60", "author": "S Gawrieh", "year": "2014", "unstructured": "Gawrieh S, Alloosh M, Sheridan R, Liang R, Masuoka H, Chalasani N, et al. Fibroblast growth factor 21 treatment improves atherogenic diet-induced liver injury and metabolic syndrome in Ossabaw miniature swine. Hepatology. 2014;60:247A\u20139.", "journal-title": "Hepatology"}, {"issue": "S1", "key": "16_CR196", "doi-asserted-by": "publisher", "first-page": "219A", "DOI": "10.1002/hep.26795", "volume": "58", "author": "E Lefebvre", "year": "2013", "unstructured": "Lefebvre E, Hashiguchi T, Jenkins H, Nabhan A, Yoneyama H, Friedman S, et al. Anti-fibrotic and anti-inflammatory activity of the dual CCR2 and CCR5 antagonist cenicriviroc in a mouse model of NASH. Hepatology. 2013;58(S1):219A\u201322.", "journal-title": "Hepatology"}, {"issue": "10", "key": "16_CR197", "doi-asserted-by": "publisher", "first-page": "1441", "DOI": "10.1517/13543784.2014.954034", "volume": "23", "author": "B Cariou", "year": "2014", "unstructured": "Cariou B, Staels B. GFT505 for the treatment of nonalcoholic steatohepatitis and type 2 diabetes. Expert Opin Investig Drugs. 2014;23(10):1441\u20138.", "journal-title": "Expert Opin Investig Drugs"}, {"issue": "6", "key": "16_CR198", "doi-asserted-by": "publisher", "first-page": "1881", "DOI": "10.1002/hep.26582", "volume": "58", "author": "P Quintero", "year": "2013", "unstructured": "Quintero P, Arrese M. Nuclear control of inflammation and fibrosis in nonalcoholic steatohepatitis: therapeutic potential of dual peroxisome proliferator-activated receptor alpha/delta agonism. Hepatology. 2013;58(6):1881\u20134.", "journal-title": "Hepatology"}, {"issue": "6", "key": "16_CR199", "doi-asserted-by": "publisher", "first-page": "1941", "DOI": "10.1002/hep.26461", "volume": "58", "author": "B Staels", "year": "2013", "unstructured": "Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, et al. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology. 2013;58(6):1941\u201352.", "journal-title": "Hepatology"}, {"issue": "7858", "key": "16_CR200", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1016/S0140-6736(74)92649-X", "volume": "1", "author": "LF Prescott", "year": "1974", "unstructured": "Prescott LF, Newton RW, Swainson CP, Wright N, Forrest AR, Matthew H. Successful treatment of severe paracetamol overdosage with cysteamine. Lancet. 1974;1(7858):588\u201392.", "journal-title": "Lancet"}, {"issue": "7977", "key": "16_CR201", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1016/S0140-6736(76)92842-7", "volume": "2", "author": "LF Prescott", "year": "1976", "unstructured": "Prescott LF, Sutherland GR, Park J, Smith IJ, Proudfoot AT. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet. 1976;2(7977):109\u201313.", "journal-title": "Lancet"}, {"issue": "9", "key": "16_CR202", "doi-asserted-by": "publisher", "first-page": "1036", "DOI": "10.1111/j.1365-2036.2011.04626.x", "volume": "33", "author": "R Dohil", "year": "2011", "unstructured": "Dohil R, Schmeltzer S, Cabrera BL, Wang T, Durelle J, Duke KB, et al. Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;33(9):1036\u201344.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "8", "key": "16_CR203", "doi-asserted-by": "publisher", "first-page": "1844", "DOI": "10.2337/diabetes.50.8.1844", "volume": "50", "author": "G Marchesini", "year": "2001", "unstructured": "Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844\u201350.", "journal-title": "Diabetes"}, {"issue": "5", "key": "16_CR204", "doi-asserted-by": "publisher", "first-page": "450", "DOI": "10.1016/S0002-9343(99)00271-5", "volume": "107", "author": "G Marchesini", "year": "1999", "unstructured": "Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107(5):450\u20135.", "journal-title": "Am J Med"}, {"issue": "2", "key": "16_CR205", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1053/jhep.2002.30690", "volume": "35", "author": "G Pagano", "year": "2002", "unstructured": "Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology. 2002;35(2):367\u201372.", "journal-title": "Hepatology"}, {"issue": "14", "key": "16_CR206", "doi-asserted-by": "publisher", "first-page": "1341", "DOI": "10.1056/NEJMra0912063", "volume": "363", "author": "G Targher", "year": "2010", "unstructured": "Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363(14):1341\u201350.", "journal-title": "N Engl J Med"}, {"issue": "8", "key": "16_CR207", "doi-asserted-by": "publisher", "first-page": "2119", "DOI": "10.2337/dc07-0349", "volume": "30", "author": "G Targher", "year": "2007", "unstructured": "Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007;30(8):2119\u201321.", "journal-title": "Diabetes Care"}, {"issue": "5", "key": "16_CR208", "doi-asserted-by": "publisher", "first-page": "1212", "DOI": "10.2337/dc06-2247", "volume": "30", "author": "G Targher", "year": "2007", "unstructured": "Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212\u20138.", "journal-title": "Diabetes Care"}, {"issue": "8", "key": "16_CR209", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.3109/07853890.2010.518623", "volume": "43", "author": "G Musso", "year": "2011", "unstructured": "Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617\u201349.", "journal-title": "Ann Med"}, {"issue": "4", "key": "16_CR210", "doi-asserted-by": "publisher", "first-page": "1093", "DOI": "10.1210/jc.2010-2190", "volume": "96", "author": "KC Sung", "year": "2011", "unstructured": "Sung KC, Kim SH. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab. 2011;96(4):1093\u20137.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "4", "key": "16_CR211", "doi-asserted-by": "publisher", "first-page": "608", "DOI": "10.1016/j.jhep.2008.06.018", "volume": "49", "author": "JP Ong", "year": "2008", "unstructured": "Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49(4):608\u201312.", "journal-title": "J Hepatol"}, {"issue": "2", "key": "16_CR212", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1016/j.cgh.2008.11.005", "volume": "7", "author": "N Rafiq", "year": "2009", "unstructured": "Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009;7(2):234\u20138.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "7", "key": "16_CR213", "doi-asserted-by": "publisher", "first-page": "1077", "DOI": "10.1016/j.cgh.2013.08.014", "volume": "12", "author": "KE Corey", "year": "2014", "unstructured": "Corey KE, Chalasani N. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12(7):1077\u201384. Quiz e59\u201360.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "4", "key": "16_CR214", "doi-asserted-by": "publisher", "first-page": "885", "DOI": "10.1007/s00125-011-2446-4", "volume": "55", "author": "G Musso", "year": "2012", "unstructured": "Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia. 2012;55(4):885\u2013904.", "journal-title": "Diabetologia"}, {"issue": "4", "key": "16_CR215", "doi-asserted-by": "publisher", "first-page": "859", "DOI": "10.1016/j.jhep.2013.05.044", "volume": "59", "author": "F Nascimbeni", "year": "2013", "unstructured": "Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859\u201371.", "journal-title": "J Hepatol"}, {"issue": "4", "key": "16_CR216", "doi-asserted-by": "publisher", "first-page": "690", "DOI": "10.1002/hep.20671", "volume": "41", "author": "N Chalasani", "year": "2005", "unstructured": "Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology. 2005;41(4):690\u20135.", "journal-title": "Hepatology"}, {"key": "16_CR217", "doi-asserted-by": "publisher", "first-page": "765473", "DOI": "10.1155/2011/765473", "volume": "2011", "author": "WK Karcz", "year": "2011", "unstructured": "Karcz WK, Krawczykowski D, Kuesters S, Marjanovic G, Kulemann B, Grobe H, et al. Influence of sleeve gastrectomy on NASH and type 2 diabetes mellitus. J Obes. 2011;2011:765473.", "journal-title": "J Obes"}, {"issue": "9", "key": "16_CR218", "doi-asserted-by": "publisher", "first-page": "3637", "DOI": "10.1210/jc.2013-1519", "volume": "98", "author": "KC Sung", "year": "2013", "unstructured": "Sung KC, Wild SH, Byrne CD. Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab. 2013;98(9):3637\u201343.", "journal-title": "J Clin Endocrinol Metab"}, {"issue": "5813", "key": "16_CR219", "doi-asserted-by": "publisher", "first-page": "848", "DOI": "10.1126/science.1136678", "volume": "315", "author": "BE Stranger", "year": "2007", "unstructured": "Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315(5813):848\u201353.", "journal-title": "Science"}, {"issue": "19", "key": "16_CR220", "doi-asserted-by": "publisher", "first-page": "1245", "DOI": "10.1056/NEJM199505113321901", "volume": "332", "author": "CS Fuchs", "year": "1995", "unstructured": "Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and mortality among women. N Engl J Med. 1995;332(19):1245\u201350.", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "16_CR221", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1001/jama.282.3.239", "volume": "282", "author": "CT Valmadrid", "year": "1999", "unstructured": "Valmadrid CT, Klein R, Moss SE, Klein BE, Cruickshanks KJ. Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA. 1999;282(3):239\u201346.", "journal-title": "JAMA"}, {"issue": "22", "key": "16_CR222", "doi-asserted-by": "publisher", "first-page": "2437", "DOI": "10.1001/archinte.166.22.2437", "volume": "166", "author": "A Castelnuovo Di", "year": "2006", "unstructured": "Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de Gaetano G. Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006;166(22):2437\u201345.", "journal-title": "Arch Intern Med"}, {"issue": "19", "key": "16_CR223", "doi-asserted-by": "publisher", "first-page": "2559", "DOI": "10.1001/jama.287.19.2559", "volume": "287", "author": "MJ Davies", "year": "2002", "unstructured": "Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287(19):2559\u201362.", "journal-title": "JAMA"}, {"issue": "9", "key": "16_CR224", "doi-asserted-by": "publisher", "first-page": "808", "DOI": "10.1097/MCG.0b013e318223bd53", "volume": "45", "author": "T Gunji", "year": "2011", "unstructured": "Gunji T, Matsuhashi N, Sato H, Iijima K, Fujibayashi K, Okumura M, et al. Alcohol consumption is inversely correlated with insulin resistance, independent of metabolic syndrome factors and fatty liver diseases. J Clin Gastroenterol. 2011;45(9):808\u201313.", "journal-title": "J Clin Gastroenterol"}, {"issue": "9", "key": "16_CR225", "doi-asserted-by": "publisher", "first-page": "2189", "DOI": "10.1038/ajg.2009.361", "volume": "104", "author": "T Gunji", "year": "2009", "unstructured": "Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104(9):2189\u201395.", "journal-title": "Am J Gastroenterol"}, {"issue": "2", "key": "16_CR226", "doi-asserted-by": "publisher", "first-page": "156", "DOI": "10.3748/wjg.v18.i2.156", "volume": "18", "author": "M Hamaguchi", "year": "2012", "unstructured": "Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol. 2012;18(2):156\u201367.", "journal-title": "World J Gastroenterol"}, {"issue": "6", "key": "16_CR227", "doi-asserted-by": "publisher", "first-page": "1947", "DOI": "10.1002/hep.22292", "volume": "47", "author": "W Dunn", "year": "2008", "unstructured": "Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology. 2008;47(6):1947\u201354.", "journal-title": "Hepatology"}, {"issue": "3", "key": "16_CR228", "doi-asserted-by": "publisher", "first-page": "530", "DOI": "10.1136/gutjnl-2013-305718", "volume": "63", "author": "S Sookoian", "year": "2014", "unstructured": "Sookoian S, Castano GO, Pirola CJ. Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals. Gut. 2014;63(3):530\u20132.", "journal-title": "Gut"}, {"issue": "2", "key": "16_CR229", "doi-asserted-by": "publisher", "first-page": "384", "DOI": "10.1016/j.jhep.2012.03.024", "volume": "57", "author": "W Dunn", "year": "2012", "unstructured": "Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol. 2012;57(2):384\u201391.", "journal-title": "J Hepatol"}, {"issue": "7", "key": "16_CR230", "doi-asserted-by": "publisher", "first-page": "545", "DOI": "10.3109/07853890.2011.588246", "volume": "43", "author": "S Kechagias", "year": "2011", "unstructured": "Kechagias S, Zanjani S, Gjellan S, Leinhard OD, Kihlberg J, Smedby O, et al. Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study. Ann Med. 2011;43(7):545\u201354.", "journal-title": "Ann Med"}, {"issue": "5", "key": "16_CR231", "doi-asserted-by": "publisher", "first-page": "1025", "DOI": "10.1002/hep.510230513", "volume": "23", "author": "U Becker", "year": "1996", "unstructured": "Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23(5):1025\u20139.", "journal-title": "Hepatology"}, {"issue": "24", "key": "16_CR232", "doi-asserted-by": "publisher", "first-page": "1705", "DOI": "10.1056/NEJM199712113372401", "volume": "337", "author": "MJ Thun", "year": "1997", "unstructured": "Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath Jr CW, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337(24):1705\u201314.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "16_CR233", "doi-asserted-by": "publisher", "first-page": "1972", "DOI": "10.1002/hep.23527", "volume": "51", "author": "MS Ascha", "year": "2010", "unstructured": "Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51(6):1972\u20138.", "journal-title": "Hepatology"}], "container-title": ["Alcoholic and Non-Alcoholic Fatty Liver Disease"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-20538-0_16", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 2]], "date-time": "2019-09-02T09:25:27Z", "timestamp": 1567416327000}, "score": 67.90747, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319205373", "9783319205380"], "references-count": 233, "URL": "http://dx.doi.org/10.1007/978-3-319-20538-0_16", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:37:59Z", "timestamp": 1574728679462}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "03", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Semin Liver Dis"], "DOI": "10.1055/s-0035-1562951", "type": "journal-article", "created": {"date-parts": [[2015, 9, 18]], "date-time": "2015-09-18T08:11:43Z", "timestamp": 1442563903000}, "page": "338-348", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Pharmacotherapy for Nonalcoholic Fatty Liver Disease"], "prefix": "10.1055", "volume": "35", "author": [{"given": "Samer", "family": "Gawrieh", "sequence": "first", "affiliation": [{"name": "Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana"}]}], "member": "194", "published-online": {"date-parts": [[2015, 9, 17]]}, "container-title": ["Seminars in Liver Disease"], "language": "en", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0035-1562951.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 22]], "date-time": "2017-05-22T23:29:56Z", "timestamp": 1495495796000}, "score": 67.56734, "issued": {"date-parts": [[2015, 9, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 9, 17]]}, "issue": "03"}, "URL": "http://dx.doi.org/10.1055/s-0035-1562951", "ISSN": ["0272-8087", "1098-8971"], "issn-type": [{"value": "0272-8087", "type": "print"}, {"value": "1098-8971", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T09:18:18Z", "timestamp": 1574846298688}, "reference-count": 36, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 2, 1]], "date-time": "2018-02-01T00:00:00Z", "timestamp": 1517443200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "theclinics.com", "clinicalkey.com.au", "clinicalkey.fr", "liver.theclinics.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Clinics in Liver Disease"], "published-print": {"date-parts": [[2018, 2]]}, "DOI": "10.1016/j.cld.2017.08.013", "type": "journal-article", "created": {"date-parts": [[2017, 10, 13]], "date-time": "2017-10-13T03:31:31Z", "timestamp": 1507865491000}, "page": "189-199", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis"], "prefix": "10.1016", "volume": "22", "author": [{"given": "Samer", "family": "Gawrieh", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinics in Liver Disease"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1089326117300740?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1089326117300740?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 27]], "date-time": "2018-08-27T00:23:05Z", "timestamp": 1535329385000}, "score": 67.50972, "issued": {"date-parts": [[2018, 2]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2018, 2]]}, "issue": "1"}, "alternative-id": ["S1089326117300740"], "URL": "http://dx.doi.org/10.1016/j.cld.2017.08.013", "ISSN": ["1089-3261"], "issn-type": [{"value": "1089-3261", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis", "name": "articletitle", "label": "Article Title"}, {"value": "Clinics in Liver Disease", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.cld.2017.08.013", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T01:43:13Z", "timestamp": 1576719793643}, "reference-count": 70, "publisher": "American Physiological Society", "issue": "1", "funder": [{"DOI": "10.13039/100000738", "name": "U.S. Department of Veterans Affairs", "doi-asserted-by": "publisher", "award": ["1I01CX000361"]}, {"DOI": "10.13039/100000027", "name": "National Institute on Alcohol Abuse and Alcoholism", "doi-asserted-by": "crossref", "award": ["R01 AA025208", "U01AA018989"]}, {"DOI": "10.13039/100000062", "name": "National Institute of Diabetes and Digestive and Kidney Diseases", "doi-asserted-by": "crossref", "award": ["R01 DK107682"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["American Journal of Physiology-Gastrointestinal and Liver Physiology"], "published-print": {"date-parts": [[2019, 1, 1]]}, "abstract": "<jats:p> Nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of histopathological phenotypes ranging from simple steatosis to more severe liver disease associated with cell injury, including nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. Only a subset of patients with NAFLD develop NASH from yet incompletely understood mechanisms. Emerging data suggest lipid species other than triglycerides as contributors to the pathogenesis of NASH. In this mini review, we focus on the recent data on the mechanisms of NASH, focusing on these lipid mediators and their potential as therapeutic targets in NASH. </jats:p>", "DOI": "10.1152/ajpgi.00170.2018", "type": "journal-article", "created": {"date-parts": [[2018, 11, 1]], "date-time": "2018-11-01T16:40:53Z", "timestamp": 1541090453000}, "page": "G75-G81", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Lipid mediators of liver injury in nonalcoholic fatty liver disease"], "prefix": "10.1152", "volume": "316", "author": [{"given": "Suthat", "family": "Liangpunsakul", "sequence": "first", "affiliation": [{"name": "Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"}, {"name": "Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana"}, {"name": "Roudebush Veterans Administration Medical Center, Indianapolis, Indiana"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"}]}], "member": "24", "reference": [{"key": "B1", "DOI": "10.1056/NEJMoa1712191", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1016/j.jhep.2010.01.003", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1002/hep.27695", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1016/0005-2760(78)90125-X", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1113/jphysiol.2009.177758", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1016/j.jhep.2008.12.016", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1002/hep.29367", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1016/j.jhep.2015.05.006", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1172/JCI23621", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1007/s11897-013-0133-0", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1210/en.2003-0410", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1016/S0168-8278(03)00460-4", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1210/en.2010-0250", "doi-asserted-by": "publisher"}, {"key": "B14", "DOI": "10.1016/j.jhep.2014.07.024", "doi-asserted-by": "publisher"}, {"key": "B15", "DOI": "10.1371/journal.pone.0022775", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1053/j.gastro.2015.12.037", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1172/JCI0215593", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1038/oby.2011.107", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1194/jlr.M034876", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1194/jlr.M072454", "doi-asserted-by": "publisher"}, {"key": "B21", "DOI": "10.1194/jlr.M063412", "doi-asserted-by": "publisher"}, {"key": "B22", "DOI": "10.1152/ajpgi.00301.2011", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1194/jlr.P076034", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1073/pnas.1113359108", "doi-asserted-by": "publisher"}, {"key": "B25", "DOI": "10.1016/S0168-8278(17)30328-8", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.1371/journal.pone.0107658", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1074/jbc.M807616200", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1073/pnas.0630588100", "doi-asserted-by": "publisher"}, {"key": "B29", "DOI": "10.1002/hep.29634", "doi-asserted-by": "publisher"}, {"key": "B30", "DOI": "10.1038/nrgastro.2013.171", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1194/jlr.M800101-JLR200", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1016/j.jhep.2016.01.002", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1073/pnas.1323785111", "doi-asserted-by": "publisher"}, {"key": "B34", "DOI": "10.1002/hep.28823", "doi-asserted-by": "publisher"}, {"key": "B35", "DOI": "10.1136/gut.2006.118059", "doi-asserted-by": "publisher"}, {"key": "B36", "DOI": "10.1016/j.cmet.2006.07.006", "doi-asserted-by": "publisher"}, {"key": "B37", "DOI": "10.1016/j.jhep.2017.11.014", "doi-asserted-by": "publisher"}, {"key": "B38", "DOI": "10.1124/jpet.111.184341", "doi-asserted-by": "publisher"}, {"key": "B39", "DOI": "10.1016/j.cmet.2007.05.005", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1016/j.metabol.2006.11.004", "doi-asserted-by": "publisher"}, {"key": "B41", "DOI": "10.1016/j.cmet.2005.06.006", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1016/j.cell.2010.07.041", "doi-asserted-by": "publisher"}, {"key": "B43", "DOI": "10.1016/j.jhep.2008.02.011", "doi-asserted-by": "publisher"}, {"key": "B44", "DOI": "10.1016/j.tem.2012.04.005", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1016/j.jhep.2012.07.030", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1194/jlr.P089953", "doi-asserted-by": "publisher"}, {"key": "B47", "DOI": "10.4093/dmj.2016.40.1.1", "doi-asserted-by": "publisher"}, {"key": "B48", "DOI": "10.1016/j.jcmgh.2015.07.007", "doi-asserted-by": "publisher"}, {"key": "B49", "DOI": "10.1042/BJ20040139", "doi-asserted-by": "publisher"}, {"key": "B50", "DOI": "10.1111/j.1872-034X.2011.00815.x", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1002/hep.21763", "doi-asserted-by": "publisher"}, {"key": "B52", "DOI": "10.1053/j.gastro.2007.10.039", "doi-asserted-by": "publisher"}, {"key": "B53", "DOI": "10.1016/j.cmet.2014.09.015", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1002/1521-4141(200104)31:4<1150:AID-IMMU1150>3.0.CO;2-V", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1016/j.jdiacomp.2017.07.014", "doi-asserted-by": "publisher"}, {"key": "B56", "DOI": "10.1016/S1097-2765(02)00734-7", "doi-asserted-by": "publisher"}, {"key": "B57", "DOI": "10.1074/jbc.M112.419978", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1074/jbc.273.10.5916", "doi-asserted-by": "publisher"}, {"key": "B59", "DOI": "10.1172/JCI28898", "doi-asserted-by": "publisher"}, {"key": "B60", "DOI": "10.1177/1535370216657447", "doi-asserted-by": "publisher"}, {"key": "B61", "DOI": "10.1002/hep.25630", "doi-asserted-by": "publisher"}, {"key": "B62", "DOI": "10.1126/science.1153124", "doi-asserted-by": "publisher"}, {"key": "B63", "DOI": "10.1016/j.cmet.2014.08.002", "doi-asserted-by": "publisher"}, {"key": "B64", "DOI": "10.1053/j.gastro.2011.06.040", "doi-asserted-by": "publisher"}, {"key": "B65", "DOI": "10.1097/01.mcg.0000225515.28536.3a", "doi-asserted-by": "publisher"}, {"key": "B66", "DOI": "10.1055/s-2004-823104", "doi-asserted-by": "publisher"}, {"key": "B67", "DOI": "10.1152/ajpendo.00644.2005", "doi-asserted-by": "publisher"}, {"key": "B68", "DOI": "10.1038/nrm2335", "doi-asserted-by": "publisher"}, {"key": "B69", "DOI": "10.1002/hep.21655", "doi-asserted-by": "publisher"}, {"key": "B70", "DOI": "10.1074/jbc.M200958200", "doi-asserted-by": "publisher"}], "container-title": ["American Journal of Physiology-Gastrointestinal and Liver Physiology"], "language": "en", "link": [{"URL": "https://www.physiology.org/doi/pdf/10.1152/ajpgi.00170.2018", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 1]], "date-time": "2019-10-01T22:39:28Z", "timestamp": 1569969568000}, "score": 67.08743, "issued": {"date-parts": [[2019, 1, 1]]}, "references-count": 70, "journal-issue": {"published-print": {"date-parts": [[2019, 1, 1]]}, "issue": "1"}, "alternative-id": ["10.1152/ajpgi.00170.2018"], "URL": "http://dx.doi.org/10.1152/ajpgi.00170.2018", "relation": {"cites": []}, "ISSN": ["0193-1857", "1522-1547"], "issn-type": [{"value": "0193-1857", "type": "print"}, {"value": "1522-1547", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T10:44:00Z", "timestamp": 1576838640965}, "reference-count": 287, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 9, 29]], "date-time": "2017-09-29T00:00:00Z", "timestamp": 1506643200000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 9, 29]], "date-time": "2017-09-29T00:00:00Z", "timestamp": 1506643200000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/100005347", "name": "American Association for the Study of Liver Diseases", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2018, 1]]}, "DOI": "10.1002/hep.29367", "type": "journal-article", "created": {"date-parts": [[2017, 7, 17]], "date-time": "2017-07-17T05:52:51Z", "timestamp": 1500270771000}, "page": "328-357", "source": "Crossref", "is-referenced-by-count": 663, "title": ["The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases"], "prefix": "10.1002", "volume": "67", "author": [{"given": "Naga", "family": "Chalasani", "sequence": "first", "affiliation": [{"name": "Indiana University School of Medicine; Indianapolis IN"}]}, {"ORCID": "http://orcid.org/0000-0001-9313-577X", "authenticated-orcid": false, "given": "Zobair", "family": "Younossi", "sequence": "additional", "affiliation": [{"name": "Center for Liver Disease and Department of Medicine; Inova Fairfax Hospital; Falls Church VA"}]}, {"given": "Joel E.", "family": "Lavine", "sequence": "additional", "affiliation": [{"name": "Columbia University; New York NY"}]}, {"given": "Michael", "family": "Charlton", "sequence": "additional", "affiliation": [{"name": "University of Chicago; Chicago IL"}]}, {"given": "Kenneth", "family": "Cusi", "sequence": "additional", "affiliation": [{"name": "University of Florida; Gainesville FL"}]}, {"given": "Mary", "family": "Rinella", "sequence": "additional", "affiliation": [{"name": "Northwestern University; Chicago IL"}]}, {"given": "Stephen A.", "family": "Harrison", "sequence": "additional", "affiliation": [{"name": "Pinnacle Clinical Research; San Antonio TX"}]}, {"given": "Elizabeth M.", "family": "Brunt", "sequence": "additional", "affiliation": [{"name": "Washington University School of Medicine; St. Louis MO"}]}, {"given": "Arun J.", "family": "Sanyal", "sequence": "additional", "affiliation": [{"name": "Virginia Commonwealth University; Richmond VA"}]}], "member": "311", "published-online": {"date-parts": [[2017, 9, 29]]}, "reference": [{"key": "10.1002/hep.29367-BIB0001|hep29367-cit-0001", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1002/hep.25762", "article-title": "The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", "volume": "55", "author": "Chalasani", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0002|hep29367-cit-0002", "author": "Eddy", "year": "1992", "volume-title": "A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach"}, {"key": "10.1002/hep.29367-BIB0003|hep29367-cit-0003", "doi-asserted-by": "crossref", "first-page": "924", "DOI": "10.1136/bmj.39489.470347.AD", "article-title": "GRADE: an emerging consensus on rating quality of evidence and strength of recommendations", "volume": "336", "author": "Guyatt", "year": "2008", "journal-title": "BMJ"}, {"key": "10.1002/hep.29367-BIB0004|hep29367-cit-0004", "doi-asserted-by": "crossref", "first-page": "196", "DOI": "10.1038/nrgastro.2016.3", "article-title": "Management of NAFLD: a stage-based approach", "volume": "13", "author": "Rinella", "year": "2016", "journal-title": "Nat Rev Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0005|hep29367-cit-0005", "doi-asserted-by": "crossref", "first-page": "2234", "DOI": "10.1002/hep.28699", "article-title": "Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", "volume": "64", "author": "Hannah", "year": "2016", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0006|hep29367-cit-0006", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1055/s-0035-1562951", "article-title": "Pharmacotherapy for nonalcoholic fatty liver disease", "volume": "35", "author": "Gawrieh", "year": "2015", "journal-title": "Semin Liver Dis"}, {"key": "10.1002/hep.29367-BIB0007|hep29367-cit-0007", "doi-asserted-by": "crossref", "first-page": "1208", "DOI": "10.1016/j.metabol.2016.02.013", "article-title": "Non-alcoholic fatty liver disease and liver transplantation", "volume": "65", "author": "Khan", "year": "2016", "journal-title": "Metabolism"}, {"key": "10.1002/hep.29367-BIB0008|hep29367-cit-0008", "doi-asserted-by": "crossref", "first-page": "1811", "DOI": "10.1053/j.gastro.2016.03.008", "article-title": "Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease", "volume": "150", "author": "Bedossa", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0009|hep29367-cit-0009", "doi-asserted-by": "crossref", "first-page": "2062", "DOI": "10.1016/j.cgh.2015.07.029", "article-title": "Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes", "volume": "13", "author": "Ahmed", "year": "2015", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0010|hep29367-cit-0010", "doi-asserted-by": "crossref", "first-page": "1040", "DOI": "10.1016/j.jhep.2014.01.009", "article-title": "Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension", "volume": "60", "author": "Sung", "year": "2014", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0011|hep29367-cit-0011", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1038/hr.2010.45", "article-title": "Fatty liver incidence and predictive variables", "volume": "33", "author": "Tsuneto", "year": "2010", "journal-title": "Hypertens Res"}, {"key": "10.1002/hep.29367-BIB0012|hep29367-cit-0012", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1016/j.jhep.2014.08.041", "article-title": "Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy", "volume": "62", "author": "Wong", "year": "2015", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0013|hep29367-cit-0013", "doi-asserted-by": "crossref", "first-page": "1133", "DOI": "10.1038/ajg.2016.178", "article-title": "Metabolically healthy obesity and the development of nonalcoholic fatty liver disease", "volume": "111", "author": "Chang", "year": "2016", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0014|hep29367-cit-0014", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.7861/clinmedicine.7-2-119", "article-title": "Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs", "volume": "7", "author": "Whalley", "year": "2007", "journal-title": "Clin Med"}, {"key": "10.1002/hep.29367-BIB0015|hep29367-cit-0015", "doi-asserted-by": "crossref", "first-page": "1145", "DOI": "10.1016/j.jhep.2011.12.011", "article-title": "Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up", "volume": "56", "author": "Zelber-Sagi", "year": "2012", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0016|hep29367-cit-0016", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1002/hep.28431", "article-title": "Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes", "volume": "64", "author": "Younossi", "year": "2016", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0017|hep29367-cit-0017", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1586/17474124.2016.1099433", "article-title": "Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis", "volume": "10", "author": "Golabi", "year": "2016", "journal-title": "Expert Rev Gastroenterol Hepatol"}, {"issue": "1 Suppl", "key": "10.1002/hep.29367-BIB0018|hep29367-cit-0018", "doi-asserted-by": "crossref", "first-page": "S47", "DOI": "10.1016/j.jhep.2014.12.012", "article-title": "NAFLD: a multisystem disease", "volume": "62", "author": "Byrne", "year": "2015", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0019|hep29367-cit-0019", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1016/j.cld.2009.07.005", "article-title": "Epidemiology and natural history of non-alcoholic steatohepatitis", "volume": "13", "author": "Argo", "year": "2009", "journal-title": "Clin Liver Dis"}, {"key": "10.1002/hep.29367-BIB0020|hep29367-cit-0020", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1016/j.cgh.2011.03.020", "article-title": "Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008", "volume": "9", "author": "Younossi", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0021|hep29367-cit-0021", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.1111/dom.12502", "article-title": "Current and emerging medications for overweight or obesity in people with comorbidities", "volume": "17", "author": "Fujioka", "year": "2015", "journal-title": "Diabetes Obes Metab"}, {"key": "10.1002/hep.29367-BIB0022|hep29367-cit-0022", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1007/s11901-016-0295-9", "article-title": "Extrahepatic manifestations of nonalcoholic fatty liver disease", "volume": "15", "author": "VanWagner", "year": "2016", "journal-title": "Curr Hepatol Rep"}, {"key": "10.1002/hep.29367-BIB0023|hep29367-cit-0023", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.3389/fendo.2014.00164", "article-title": "Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments", "volume": "5", "author": "Sasaki", "year": "2014", "journal-title": "Front Endocrinol."}, {"key": "10.1002/hep.29367-BIB0024|hep29367-cit-0024", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/j.soard.2014.06.015", "article-title": "Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery", "volume": "11", "author": "Subichin", "year": "2015", "journal-title": "Surg Obes Relat Dis"}, {"key": "10.1002/hep.29367-BIB0025|hep29367-cit-0025", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1111/j.1478-3231.2008.01718.x", "article-title": "Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus", "volume": "29", "author": "Leite", "year": "2009", "journal-title": "Liver Int"}, {"key": "10.1002/hep.29367-BIB0026|hep29367-cit-0026", "first-page": "205", "article-title": "Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus", "volume": "57", "author": "Prashanth", "year": "2009", "journal-title": "J Assoc Physicians India"}, {"key": "10.1002/hep.29367-BIB0027|hep29367-cit-0027", "doi-asserted-by": "crossref", "first-page": "3805372", "DOI": "10.1155/2016/3805372", "article-title": "Sex-specific association between serum uric acid and nonalcoholic fatty liver disease in type 2 diabetic patients", "volume": "2016", "author": "Fan", "year": "2016", "journal-title": "J Diabetes Res"}, {"key": "10.1002/hep.29367-BIB0028|hep29367-cit-0028", "doi-asserted-by": "crossref", "first-page": "22933", "DOI": "10.3390/ijms141122933", "article-title": "Nonalcoholic fatty liver: a possible new target for type 2 diabetes prevention and treatment", "volume": "14", "author": "Fruci", "year": "2013", "journal-title": "Int J Mol Sci"}, {"key": "10.1002/hep.29367-BIB0029|hep29367-cit-0029", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1023/A:1005661516165", "article-title": "Fatty infiltration of liver in hyperlipidemic patients", "volume": "45", "author": "Assy", "year": "2000", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.29367-BIB0030|hep29367-cit-0030", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1016/j.jacl.2015.12.026", "article-title": "Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol", "volume": "10", "author": "Wu", "year": "2016", "journal-title": "J Clin Lipidol"}, {"key": "10.1002/hep.29367-BIB0031|hep29367-cit-0031", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1038/ajg.2008.57", "article-title": "Chronic liver disease among Alaska-Native people, 2003-2004", "volume": "104", "author": "Fischer", "year": "2009", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0032|hep29367-cit-0032", "doi-asserted-by": "crossref", "first-page": "949", "DOI": "10.1097/MCG.0b013e318054492a", "article-title": "Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003", "volume": "42", "author": "Bialek", "year": "2008", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0033|hep29367-cit-0033", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.15171/mejdd.2016.18", "article-title": "The prevalence of metabolic syndrome in non-alcoholic fatty liver disease; a population-based study", "volume": "8", "author": "Fattahi", "year": "2016", "journal-title": "Middle East J Dig Dis"}, {"key": "10.1002/hep.29367-BIB0034|hep29367-cit-0034", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.3904/kjim.2004.19.1.19", "article-title": "Factors associated or related to with pathological severity of nonalcoholic fatty liver disease", "volume": "19", "author": "Park", "year": "2004", "journal-title": "Korean J Intern Med"}, {"key": "10.1002/hep.29367-BIB0035|hep29367-cit-0035", "doi-asserted-by": "crossref", "first-page": "1305", "DOI": "10.1016/j.jhep.2012.07.028", "article-title": "Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study", "volume": "57", "author": "Koehler", "year": "2012", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0036|hep29367-cit-0036", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1111/j.1478-3231.2004.0969.x", "article-title": "Non-alcoholic fatty liver disease-a common and benign finding in octogenarian patients", "volume": "24", "author": "Kagansky", "year": "2004", "journal-title": "Liver Int"}, {"key": "10.1002/hep.29367-BIB0037|hep29367-cit-0037", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1159/000235677", "article-title": "Non-alcoholic fatty liver disease in older people", "volume": "55", "author": "Frith", "year": "2009", "journal-title": "Gerontology"}, {"key": "10.1002/hep.29367-BIB0038|hep29367-cit-0038", "doi-asserted-by": "crossref", "first-page": "856", "DOI": "10.1111/j.1478-3231.2006.01311.x", "article-title": "Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures", "volume": "26", "author": "Zelber-Sagi", "year": "2006", "journal-title": "Liver Int"}, {"key": "10.1002/hep.29367-BIB0039|hep29367-cit-0039", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1111/nyas.12016", "article-title": "Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals", "volume": "1281", "author": "Masuoka", "year": "2013", "journal-title": "Ann N Y Acad Sci"}, {"key": "10.1002/hep.29367-BIB0040|hep29367-cit-0040", "doi-asserted-by": "crossref", "first-page": "5219", "DOI": "10.2174/13816128113199990381", "article-title": "Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment", "volume": "19", "author": "Dongiovanni", "year": "2013", "journal-title": "Curr Pharm Des"}, {"key": "10.1002/hep.29367-BIB0041|hep29367-cit-0041", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1159/000282081", "article-title": "The natural history of non-alcoholic fatty liver disease", "volume": "28", "author": "Caldwell", "year": "2010", "journal-title": "Dig Dis"}, {"key": "10.1002/hep.29367-BIB0042|hep29367-cit-0042", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1002/hep.510300604", "article-title": "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", "volume": "30", "author": "Angulo", "year": "1999", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0043|hep29367-cit-0043", "doi-asserted-by": "crossref", "first-page": "1644", "DOI": "10.1002/hep.26465", "article-title": "Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients", "volume": "58", "author": "Noureddin", "year": "2013", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0044|hep29367-cit-0044", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.1053/j.gastro.2015.04.043", "article-title": "Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease", "volume": "149", "author": "Angulo", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0045|hep29367-cit-0045", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1053/j.gastro.2011.06.061", "article-title": "Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States", "volume": "141", "author": "Charlton", "year": "2011", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0046|hep29367-cit-0046", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1002/hep.21827", "article-title": "Incidence and natural course of fatty liver in the general population: the Dionysos study", "volume": "46", "author": "Bedogni", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0047|hep29367-cit-0047", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.3109/07853890.2010.518623", "article-title": "Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", "volume": "43", "author": "Musso", "year": "2011", "journal-title": "Ann Med"}, {"key": "10.1002/hep.29367-BIB0048|hep29367-cit-0048", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1111/j.1365-2036.2011.04724.x", "article-title": "Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults", "volume": "34", "author": "Vernon", "year": "2011", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0049|hep29367-cit-0049", "doi-asserted-by": "crossref", "first-page": "15532", "DOI": "10.3748/wjg.v20.i42.15532", "article-title": "Liver transplantation and non-alcoholic fatty liver disease", "volume": "20", "author": "Zezos", "year": "2014", "journal-title": "World J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0050|hep29367-cit-0050", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1002/hep.23314", "article-title": "Decreased survival of subjects with elevated liver function tests during a 28-year follow-up", "volume": "51", "author": "S\u00f6derberg", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0051|hep29367-cit-0051", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1136/gut.2003.019984", "article-title": "Long term prognosis of fatty liver: risk of chronic liver disease and death", "volume": "53", "author": "Dam-Larsen", "year": "2004", "journal-title": "Gut"}, {"key": "10.1002/hep.29367-BIB0052|hep29367-cit-0052", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.cgh.2008.11.005", "article-title": "Long-term follow-up of patients with nonalcoholic fatty liver", "volume": "7", "author": "Rafiq", "year": "2009", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0053|hep29367-cit-0053", "first-page": "254", "article-title": "Variables associated with inpatient and outpatient resource utilization among Medicare beneficiaries with nonalcoholic fatty liver disease with or without cirrhosis", "volume": "51", "author": "Sayiner", "year": "2017", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0054|hep29367-cit-0054", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0055|hep29367-cit-0055", "doi-asserted-by": "crossref", "first-page": "1778", "DOI": "10.1053/j.gastro.2016.03.005", "article-title": "Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality", "volume": "150", "author": "Younossi", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0056|hep29367-cit-0056", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/j.cld.2015.10.001", "article-title": "Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world", "volume": "20", "author": "Sayiner", "year": "2016", "journal-title": "Clin Liver Dis"}, {"key": "10.1002/hep.29367-BIB0057|hep29367-cit-0057", "doi-asserted-by": "crossref", "first-page": "1459", "DOI": "10.1016/S0140-6736(16)31012-1", "article-title": "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015", "volume": "388", "author": "GBD 2015 Mortality and Causes of Death Collaborators", "year": "2016", "journal-title": "Lancet"}, {"key": "10.1002/hep.29367-BIB0058|hep29367-cit-0058", "doi-asserted-by": "crossref", "first-page": "1874", "DOI": "10.1002/hep.24268", "article-title": "Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality", "volume": "53", "author": "Younossi", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0059|hep29367-cit-0059", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.3109/00365521.2010.539251", "article-title": "Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)", "volume": "46", "author": "Hossain", "year": "2011", "journal-title": "Scand J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0060|hep29367-cit-0060", "doi-asserted-by": "crossref", "first-page": "632", "DOI": "10.1007/s12072-015-9679-0", "article-title": "Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis", "volume": "10", "author": "Mohamad", "year": "2016", "journal-title": "Hepatol Int"}, {"key": "10.1002/hep.29367-BIB0061|hep29367-cit-0061", "doi-asserted-by": "crossref", "first-page": "1723", "DOI": "10.1002/hep.28123", "article-title": "Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009", "volume": "62", "author": "Younossi", "year": "2015", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0062|hep29367-cit-0062", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1016/j.cgh.2015.07.019", "article-title": "Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease", "volume": "14", "author": "Mittal", "year": "2016", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0063|hep29367-cit-0063", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1016/S1665-2681(19)31748-X", "article-title": "NASH and cryptogenic cirrhosis: a histological analysis", "volume": "8", "author": "Caldwell", "year": "2009", "journal-title": "Ann Hepatol"}, {"key": "10.1002/hep.29367-BIB0064|hep29367-cit-0064", "doi-asserted-by": "crossref", "first-page": "1080", "DOI": "10.1016/j.metabol.2015.11.008", "article-title": "Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis", "volume": "65", "author": "Brown", "year": "2016", "journal-title": "Metabolism"}, {"key": "10.1002/hep.29367-BIB0065|hep29367-cit-0065", "doi-asserted-by": "crossref", "first-page": "12989", "DOI": "10.3748/wjg.v21.i46.12989", "article-title": "Nonalcoholic fatty liver disease and hepatic cirrhosis: comparison with viral hepatitis-associated steatosis", "volume": "21", "author": "Haga", "year": "2015", "journal-title": "World J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0066|hep29367-cit-0066", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1002/lt.24507", "article-title": "Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among non-alcoholic steatohepatitis hepatocellular carcinoma", "volume": "22", "author": "Young", "year": "2016", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0067|hep29367-cit-0067", "doi-asserted-by": "crossref", "first-page": "547", "DOI": "10.1053/j.gastro.2014.11.039", "article-title": "Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States", "volume": "148", "author": "Wong", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0068|hep29367-cit-0068", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1002/hep.24376", "article-title": "Endpoints and clinical trial design for nonalcoholic steatohepatitis", "volume": "54", "author": "Sanyal", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0069|hep29367-cit-0069", "unstructured": "National Institute on Alcohol Abuse and Alcoholism What is a standard drink? https://pubs.niaaa.nih.gov/publications/practitioner/pocketguide/pocket_guide2.htm"}, {"key": "10.1002/hep.29367-BIB0070|hep29367-cit-0070", "doi-asserted-by": "crossref", "first-page": "976", "DOI": "10.1038/ajg.2012.20", "article-title": "What should we recommend to our patients with NAFLD regarding alcohol use?", "volume": "107", "author": "Liangpunsakul", "year": "2012", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0071|hep29367-cit-0071", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1007/s10620-014-3346-5", "article-title": "Gaps in recognition and evaluation of incidentally identified hepatic steatosis", "volume": "60", "author": "Wright", "year": "2015", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.29367-BIB0072|hep29367-cit-0072", "doi-asserted-by": "crossref", "first-page": "2231", "DOI": "10.1210/jc.2015-1966", "article-title": "High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels", "volume": "100", "author": "Portillo-Sanchez", "year": "2015", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/hep.29367-BIB0073|hep29367-cit-0073", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1002/hep.27981", "article-title": "Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study", "volume": "63", "author": "Koehler", "year": "2016", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0074|hep29367-cit-0074", "doi-asserted-by": "crossref", "first-page": "1359", "DOI": "10.1136/gutjnl-2015-309265", "article-title": "Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study", "volume": "65", "author": "Kwok", "year": "2016", "journal-title": "Gut"}, {"key": "10.1002/hep.29367-BIB0075|hep29367-cit-0075", "doi-asserted-by": "crossref", "first-page": "2108", "DOI": "10.1007/s10620-016-4044-2", "article-title": "Screening for nonalcoholic steatohepatitis in individuals with type 2 diabetes: a cost-effectiveness analysis", "volume": "61", "author": "Corey", "year": "2016", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.29367-BIB0076|hep29367-cit-0076", "doi-asserted-by": "crossref", "first-page": "1211", "DOI": "10.1016/j.jhep.2016.02.032", "article-title": "Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes", "volume": "64", "author": "Wong", "year": "2016", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0077|hep29367-cit-0077", "first-page": "1240", "article-title": "Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort", "volume": "17", "author": "Wagenknecht", "year": "2009", "journal-title": "Obesity (Silver Spring)"}, {"key": "10.1002/hep.29367-BIB0078|hep29367-cit-0078", "doi-asserted-by": "crossref", "first-page": "1162", "DOI": "10.1016/j.cgh.2006.06.001", "article-title": "Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease", "volume": "4", "author": "Abdelmalek", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0079|hep29367-cit-0079", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0002-9343(99)00315-0", "article-title": "Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds", "volume": "108", "author": "Struben", "year": "2000", "journal-title": "Am J Med"}, {"key": "10.1002/hep.29367-BIB0080|hep29367-cit-0080", "doi-asserted-by": "crossref", "first-page": "2957", "DOI": "10.1111/j.1572-0241.2001.04667.x", "article-title": "Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease", "volume": "96", "author": "Willner", "year": "2001", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0081|hep29367-cit-0081", "doi-asserted-by": "crossref", "first-page": "1585", "DOI": "10.1053/j.gastro.2009.01.050", "article-title": "Heritability of nonalcoholic fatty liver disease", "volume": "136", "author": "Schwimmer", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0082|hep29367-cit-0082", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1111/j.1478-3231.2012.02823.x", "article-title": "Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study", "volume": "32", "author": "Tarnoki", "year": "2012", "journal-title": "Liver Int"}, {"key": "10.1002/hep.29367-BIB0083|hep29367-cit-0083", "doi-asserted-by": "crossref", "first-page": "1035", "DOI": "10.1016/j.jhep.2008.12.025", "article-title": "Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins", "volume": "50", "author": "Makkonen", "year": "2009", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0084|hep29367-cit-0084", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1053/j.gastro.2015.08.011", "article-title": "Heritability of hepatic fibrosis and steatosis based on a prospective twin study", "volume": "149", "author": "Loomba", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0085|hep29367-cit-0085", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1002/hep.24706", "article-title": "Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease", "volume": "55", "author": "Kowdley", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0086|hep29367-cit-0086", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1053/j.gastro.2009.11.013", "article-title": "HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease", "volume": "138", "author": "Valenti", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0087|hep29367-cit-0087", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1007/s12072-011-9277-8", "article-title": "Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network", "volume": "6", "author": "Vuppalanchi", "year": "2012", "journal-title": "Hepatol Int"}, {"key": "10.1002/hep.29367-BIB0088|hep29367-cit-0088", "doi-asserted-by": "crossref", "first-page": "829", "DOI": "10.1016/j.jhep.2008.01.016", "article-title": "Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease", "volume": "48", "author": "Chalasani", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0089|hep29367-cit-0089", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1016/j.diabet.2016.04.002", "article-title": "Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: causal association or epiphenomenon?", "volume": "42", "author": "Targher", "year": "2016", "journal-title": "Diabetes Metab"}, {"key": "10.1002/hep.29367-BIB0090|hep29367-cit-0090", "doi-asserted-by": "crossref", "first-page": "e65210", "DOI": "10.1371/journal.pone.0065210", "article-title": "Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese", "volume": "8", "author": "Li", "year": "2013", "journal-title": "PLoS One"}, {"key": "10.1002/hep.29367-BIB0091|hep29367-cit-0091", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/j.atherosclerosis.2015.07.018", "article-title": "Liver fat, statin use, and incident diabetes: the multi-ethnic study of atherosclerosis", "volume": "242", "author": "Shah", "year": "2015", "journal-title": "Atherosclerosis"}, {"key": "10.1002/hep.29367-BIB0092|hep29367-cit-0092", "doi-asserted-by": "crossref", "first-page": "spcone", "DOI": "10.1002/jmri.22775", "article-title": "Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy", "volume": "34", "author": "Reeder", "year": "2011", "journal-title": "J Magn Reson Imaging"}, {"key": "10.1002/hep.29367-BIB0093|hep29367-cit-0093", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1177/0284185115580488", "article-title": "A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease", "volume": "57", "author": "Idilman", "year": "2016", "journal-title": "Acta Radiol"}, {"key": "10.1002/hep.29367-BIB0094|hep29367-cit-0094", "doi-asserted-by": "crossref", "first-page": "398", "DOI": "10.1002/jmri.25006", "article-title": "Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference", "volume": "43", "author": "Heba", "year": "2016", "journal-title": "J Magn Reson Imaging"}, {"key": "10.1002/hep.29367-BIB0095|hep29367-cit-0095", "doi-asserted-by": "crossref", "first-page": "1930", "DOI": "10.1002/hep.26455", "article-title": "Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials", "volume": "58", "author": "Noureddin", "year": "2013", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0096|hep29367-cit-0096", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1111/jgh.13219", "article-title": "Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease", "volume": "31", "author": "L\u00e9dinghen", "year": "2016", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0097|hep29367-cit-0097", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1002/hep.22603", "article-title": "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management", "volume": "49", "author": "Vuppalanchi", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0098|hep29367-cit-0098", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1053/jhep.2003.50161", "article-title": "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", "volume": "37", "author": "Marchesini", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0099|hep29367-cit-0099", "doi-asserted-by": "crossref", "first-page": "2247", "DOI": "10.1111/j.1572-0241.2006.00719.x", "article-title": "Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD", "volume": "101", "author": "Kang", "year": "2006", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0100|hep29367-cit-0100", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.2337/diacare.28.5.1222", "article-title": "Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease", "volume": "28", "author": "Ryan", "year": "2005", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.29367-BIB0101|hep29367-cit-0101", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1016/j.metabol.2012.08.005", "article-title": "In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not", "volume": "62", "author": "Younossi", "year": "2013", "journal-title": "Metabolism"}, {"key": "10.1002/hep.29367-BIB0102|hep29367-cit-0102", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/j.jhep.2013.07.042", "article-title": "Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease", "volume": "60", "author": "Cusi", "year": "2014", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0103|hep29367-cit-0103", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1111/hepr.12197", "article-title": "Serum cytokeratin-18 in the diagnosis of non-alcoholic steatohepatitis: a meta-analysis", "volume": "44", "author": "Chen", "year": "2014", "journal-title": "Hepatol Res"}, {"key": "10.1002/hep.29367-BIB0104|hep29367-cit-0104", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1007/s10620-016-4079-4", "article-title": "Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016", "volume": "61", "author": "Kaswala", "year": "2016", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.29367-BIB0105|hep29367-cit-0105", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1053/j.gastro.2015.11.048", "article-title": "Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography", "volume": "150", "author": "Imajo", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0106|hep29367-cit-0106", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1002/hep.21496", "article-title": "The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD", "volume": "45", "author": "Angulo", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0107|hep29367-cit-0107", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1038/ajg.2016.49", "article-title": "The performance of vibration controlled transient elastography in a US cohort of patients with nonalcoholic fatty liver disease", "volume": "111", "author": "Tapper", "year": "2016", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0108|hep29367-cit-0108", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1186/s12876-015-0409-9", "article-title": "Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution", "volume": "15", "author": "Nozaki", "year": "2015", "journal-title": "BMC Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0109|hep29367-cit-0109", "first-page": "1290A", "article-title": "Transient elastography is feasible with high success rate for evaluation of non-alcoholic fatty liver disease (NAFLD) in a multicenter setting", "volume": "62", "author": "Vuppalanchi", "year": "2015", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0110|hep29367-cit-0110", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1148/radiol.13121193", "article-title": "Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography", "volume": "268", "author": "Kim", "year": "2013", "journal-title": "Radiology"}, {"key": "10.1002/hep.29367-BIB0111|hep29367-cit-0111", "doi-asserted-by": "crossref", "first-page": "1920", "DOI": "10.1002/hep.27362", "article-title": "Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study", "volume": "60", "author": "Loomba", "year": "2014", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0112|hep29367-cit-0112", "doi-asserted-by": "crossref", "first-page": "e38322", "DOI": "10.1371/journal.pone.0038322", "article-title": "Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese", "volume": "7", "author": "Kawaguchi", "year": "2012", "journal-title": "PLoS One"}, {"key": "10.1002/hep.29367-BIB0113|hep29367-cit-0113", "doi-asserted-by": "crossref", "first-page": "1883", "DOI": "10.1002/hep.24283", "article-title": "Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease", "volume": "53", "author": "Sookoian", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0114|hep29367-cit-0114", "doi-asserted-by": "crossref", "first-page": "894", "DOI": "10.1002/hep.23759", "article-title": "The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease", "volume": "52", "author": "Rotman", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0115|hep29367-cit-0115", "doi-asserted-by": "crossref", "first-page": "904", "DOI": "10.1002/hep.23768", "article-title": "PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease", "volume": "52", "author": "Speliotes", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0116|hep29367-cit-0116", "doi-asserted-by": "crossref", "first-page": "4309", "DOI": "10.1038/ncomms5309", "article-title": "TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease", "volume": "5", "author": "Liu", "year": "2014", "journal-title": "Nat Commun"}, {"key": "10.1002/hep.29367-BIB0117|hep29367-cit-0117", "doi-asserted-by": "crossref", "first-page": "352", "DOI": "10.1038/ng.2901", "article-title": "Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease", "volume": "46", "author": "Kozlitina", "year": "2014", "journal-title": "Nat Genet"}, {"key": "10.1002/hep.29367-BIB0118|hep29367-cit-0118", "doi-asserted-by": "crossref", "first-page": "506", "DOI": "10.1002/hep.27490", "article-title": "Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease", "volume": "61", "author": "Dongiovanni", "year": "2015", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0119|hep29367-cit-0119", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1002/hep.28370", "article-title": "The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage", "volume": "63", "author": "Donati", "year": "2016", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0120|hep29367-cit-0120", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1053/j.gastro.2016.01.032", "article-title": "The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent", "volume": "150", "author": "Mancina", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0121|hep29367-cit-0121", "doi-asserted-by": "crossref", "first-page": "018002", "DOI": "10.1117/1.JBO.20.1.018002", "article-title": "Intrapulpal temperature changes during root surface irradiation with dual-wavelength laser (2780 and 940 nm): in vitro study", "volume": "20", "author": "Franzen", "year": "2015", "journal-title": "J Biomed Opt"}, {"key": "10.1002/hep.29367-BIB0122|hep29367-cit-0122", "doi-asserted-by": "crossref", "first-page": "1231", "DOI": "10.1053/j.gastro.2014.01.018", "article-title": "A histologic scoring system for prognosis of patients with alcoholic hepatitis", "volume": "146", "author": "Altamirano", "year": "2014", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0123|hep29367-cit-0123", "doi-asserted-by": "crossref", "first-page": "1961", "DOI": "10.1053/j.gastro.2008.08.050", "article-title": "Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis", "volume": "135", "author": "Patton", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0124|hep29367-cit-0124", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1002/hep.20842", "article-title": "Histopathology of pediatric nonalcoholic fatty liver disease", "volume": "42", "author": "Schwimmer", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0125|hep29367-cit-0125", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1016/j.cgh.2012.01.020", "article-title": "Association between puberty and features of nonalcoholic fatty liver disease", "volume": "10", "author": "Suzuki", "year": "2012", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0126|hep29367-cit-0126", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1055/s-0032-1306421", "article-title": "Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research", "volume": "32", "author": "Kleiner", "year": "2012", "journal-title": "Semin Liver Dis"}, {"key": "10.1002/hep.29367-BIB0127|hep29367-cit-0127", "doi-asserted-by": "crossref", "first-page": "754", "DOI": "10.1053/j.gastro.2014.07.056", "article-title": "Pathological features of fatty liver disease", "volume": "147", "author": "Yeh", "year": "2014", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0128|hep29367-cit-0128", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1002/hep.20701", "article-title": "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", "volume": "41", "author": "Kleiner", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0129|hep29367-cit-0129", "doi-asserted-by": "crossref", "first-page": "1751", "DOI": "10.1002/hep.25889", "article-title": "Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients", "volume": "56", "author": "Bedossa", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0130|hep29367-cit-0130", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1002/hep.27173", "article-title": "Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease", "volume": "60", "author": "Bedossa", "year": "2014", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0131|hep29367-cit-0131", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.1053/j.gastro.2005.03.084", "article-title": "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", "volume": "128", "author": "Ratziu", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0132|hep29367-cit-0132", "doi-asserted-by": "crossref", "first-page": "1329", "DOI": "10.1016/j.cgh.2007.06.005", "article-title": "Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass", "volume": "5", "author": "Larson", "year": "2007", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0133|hep29367-cit-0133", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1016/j.cgh.2008.12.015", "article-title": "Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic fatty liver disease", "volume": "7", "author": "Vuppalanchi", "year": "2009", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0134|hep29367-cit-0134", "doi-asserted-by": "crossref", "first-page": "1017", "DOI": "10.1002/hep.22742", "article-title": "Liver biopsy", "volume": "49", "author": "Rockey", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0135|hep29367-cit-0135", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1007/s00125-011-2446-4", "article-title": "Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials", "volume": "55", "author": "Musso", "year": "2012", "journal-title": "Diabetologia"}, {"key": "10.1002/hep.29367-BIB0136|hep29367-cit-0136", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1053/j.gastro.2015.04.005", "article-title": "Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis", "volume": "149", "author": "Vilar-Gomez", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0137|hep29367-cit-0137", "doi-asserted-by": "crossref", "first-page": "6659", "DOI": "10.1073/pnas.0308291101", "article-title": "Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans", "volume": "101", "author": "Fontana", "year": "2004", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1002/hep.29367-BIB0138|hep29367-cit-0138", "doi-asserted-by": "crossref", "first-page": "1552", "DOI": "10.1053/j.gastro.2009.01.048", "article-title": "Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction", "volume": "136", "author": "Kirk", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0139|hep29367-cit-0139", "doi-asserted-by": "crossref", "first-page": "1504", "DOI": "10.1002/hep.24242", "article-title": "Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects", "volume": "53", "author": "Haufe", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0140|hep29367-cit-0140", "doi-asserted-by": "crossref", "first-page": "460", "DOI": "10.1038/ajg.2010.488", "article-title": "Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease", "volume": "106", "author": "Kistler", "year": "2011", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0141|hep29367-cit-0141", "doi-asserted-by": "crossref", "first-page": "2023", "DOI": "10.1053/j.gastro.2006.03.019", "article-title": "Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease", "volume": "130", "author": "Church", "year": "2006", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0142|hep29367-cit-0142", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1002/hep.22940", "article-title": "Independent effects of physical activity in patients with nonalcoholic fatty liver disease", "volume": "50", "author": "St George", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0143|hep29367-cit-0143", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1016/j.jhep.2016.05.026", "article-title": "Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver", "volume": "65", "author": "Sung", "year": "2016", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0144|hep29367-cit-0144", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1111/j.1467-789X.2008.00547.x", "article-title": "Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis", "volume": "10", "author": "Wu", "year": "2009", "journal-title": "Obes Rev"}, {"key": "10.1002/hep.29367-BIB0145|hep29367-cit-0145", "doi-asserted-by": "crossref", "first-page": "284", "DOI": "10.1177/1358863X11408747", "article-title": "Bilateral traumatic chylothorax treated by thoracic duct embolization: a rare treatment for an uncommon problem", "volume": "16", "author": "Kurklinsky", "year": "2011", "journal-title": "Vasc Med"}, {"key": "10.1002/hep.29367-BIB0146|hep29367-cit-0146", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1016/S0140-6736(01)06042-1", "article-title": "Metformin in non-alcoholic steatohepatitis", "volume": "358", "author": "Marchesini", "year": "2001", "journal-title": "Lancet"}, {"key": "10.1002/hep.29367-BIB0147|hep29367-cit-0147", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1111/j.1365-2036.2004.01888.x", "article-title": "Metformin in the treatment of patients with non-alcoholic steatohepatitis", "volume": "19", "author": "Uygun", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0148|hep29367-cit-0148", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1111/j.1365-2036.2004.02025.x", "article-title": "Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial", "volume": "20", "author": "Nair", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0149|hep29367-cit-0149", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1111/j.1572-0241.2005.41583.x", "article-title": "A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease", "volume": "100", "author": "Bugianesi", "year": "2005", "journal-title": "Am J Gastroenterol."}, {"key": "10.1002/hep.29367-BIB0150|hep29367-cit-0150", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1111/j.1365-2036.2008.03869.x", "article-title": "Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis", "volume": "29", "author": "Loomba", "year": "2009", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0151|hep29367-cit-0151", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1177/1756283X09105462", "article-title": "The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial", "volume": "2", "author": "Shields", "year": "2009", "journal-title": "Ther Adv Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0152|hep29367-cit-0152", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1080/00365520902845268", "article-title": "Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial", "volume": "44", "author": "Haukeland", "year": "2009", "journal-title": "Scand J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0153|hep29367-cit-0153", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1111/j.1365-2036.2008.03723.x", "article-title": "Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis", "volume": "28", "author": "Idilman", "year": "2008", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0154|hep29367-cit-0154", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1016/S1665-2681(19)31902-7", "article-title": "Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions", "volume": "6", "author": "Duseja", "year": "2007", "journal-title": "Ann. Hepatol"}, {"key": "10.1002/hep.29367-BIB0155|hep29367-cit-0155", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/s00592-008-0067-2", "article-title": "The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease", "volume": "46", "author": "Nar", "year": "2009", "journal-title": "Acta Diabetol"}, {"key": "10.1002/hep.29367-BIB0156|hep29367-cit-0156", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1097/MEG.0b013e32832e2baf", "article-title": "Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease", "volume": "22", "author": "Omer", "year": "2010", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0157|hep29367-cit-0157", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.3892/br.2012.18", "article-title": "Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis", "volume": "1", "author": "Li", "year": "2013", "journal-title": "Biomed Rep"}, {"key": "10.1002/hep.29367-BIB0158|hep29367-cit-0158", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1002/hep.23623", "article-title": "A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease", "volume": "52", "author": "Musso", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0159|hep29367-cit-0159", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1016/j.cmet.2014.08.005", "article-title": "Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes", "volume": "20", "author": "Soccio", "year": "2014", "journal-title": "Cell Metab"}, {"key": "10.1002/hep.29367-BIB0160|hep29367-cit-0160", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1053/j.gastro.2012.02.003", "article-title": "Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications", "volume": "142", "author": "Cusi", "year": "2012", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0161|hep29367-cit-0161", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1053/j.gastro.2008.03.078", "article-title": "Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial", "volume": "135", "author": "Ratziu", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0162|hep29367-cit-0162", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/hep.23270", "article-title": "Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial", "volume": "51", "author": "Ratziu", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0163|hep29367-cit-0163", "doi-asserted-by": "crossref", "first-page": "1285", "DOI": "10.1056/NEJMp1309610", "article-title": "The cardiovascular safety of diabetes drugs-insights from the rosiglitazone experience", "volume": "369", "author": "Hiatt", "year": "2013", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0164|hep29367-cit-0164", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1056/NEJMoa060326", "article-title": "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", "volume": "355", "author": "Belfort", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0165|hep29367-cit-0165", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.7326/M15-1774", "article-title": "Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial", "volume": "165", "author": "Cusi", "year": "2016", "journal-title": "Ann Intern Med"}, {"key": "10.1002/hep.29367-BIB0166|hep29367-cit-0166", "doi-asserted-by": "crossref", "first-page": "1176", "DOI": "10.1053/j.gastro.2008.06.047", "article-title": "Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis", "volume": "135", "author": "Aithal", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0167|hep29367-cit-0167", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1056/NEJMoa0907929", "article-title": "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis", "volume": "362", "author": "Sanyal", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0168|hep29367-cit-0168", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1053/j.gastro.2010.09.038", "article-title": "Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study", "volume": "140", "author": "Williams", "year": "2011", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0169|hep29367-cit-0169", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1007/s11892-013-0378-8", "article-title": "The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus", "volume": "13", "author": "Yau", "year": "2013", "journal-title": "Curr Diab Rep"}, {"key": "10.1002/hep.29367-BIB0170|hep29367-cit-0170", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1007/s00125-014-3456-9", "article-title": "Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis", "volume": "58", "author": "Levin", "year": "2015", "journal-title": "Diabetologia"}, {"key": "10.1002/hep.29367-BIB0171|hep29367-cit-0171", "doi-asserted-by": "crossref", "first-page": "i1541", "DOI": "10.1136/bmj.i1541", "article-title": "Pioglitazone use and risk of bladder cancer: population based cohort study", "volume": "352", "author": "Tuccori", "year": "2016", "journal-title": "BMJ"}, {"key": "10.1002/hep.29367-BIB0172|hep29367-cit-0172", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1001/jama.2015.7996", "article-title": "Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes", "volume": "314", "author": "Lewis", "year": "2015", "journal-title": "JAMA"}, {"key": "10.1002/hep.29367-BIB0173|hep29367-cit-0173", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1111/hepr.12351", "article-title": "Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)", "volume": "45", "author": "Eguchi", "year": "2015", "journal-title": "Hepatol Res"}, {"key": "10.1002/hep.29367-BIB0174|hep29367-cit-0174", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1016/S0140-6736(15)00803-X", "article-title": "Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study", "volume": "387", "author": "Armstrong", "year": "2016", "journal-title": "Lancet"}, {"key": "10.1002/hep.29367-BIB0175|hep29367-cit-0175", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1111/apt.12149", "article-title": "Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program", "volume": "37", "author": "Armstrong", "year": "2013", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0176|hep29367-cit-0176", "doi-asserted-by": "crossref", "first-page": "2707", "DOI": "10.1038/ajg.2010.363", "article-title": "Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case series", "volume": "105", "author": "Kenny", "year": "2010", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0177|hep29367-cit-0177", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/j.clinthera.2007.01.015", "article-title": "Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials", "volume": "29", "author": "Buse", "year": "2007", "journal-title": "Clin Ther"}, {"key": "10.1002/hep.29367-BIB0178|hep29367-cit-0178", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1046/j.1365-2036.2001.01083.x", "article-title": "Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study", "volume": "15", "author": "Hasegawa", "year": "2001", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0179|hep29367-cit-0179", "doi-asserted-by": "crossref", "first-page": "2485", "DOI": "10.1111/j.1572-0241.2003.08699.x", "article-title": "Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis", "volume": "98", "author": "Harrison", "year": "2003", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0180|hep29367-cit-0180", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1016/j.cgh.2006.09.025", "article-title": "Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis", "volume": "4", "author": "Dufour", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0181|hep29367-cit-0181", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1016/S1542-3565(04)00457-4", "article-title": "A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis", "volume": "2", "author": "Sanyal", "year": "2004", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0182|hep29367-cit-0182", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1111/j.1445-5994.2006.01295.x", "article-title": "Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study", "volume": "37", "author": "Yakaryilmaz", "year": "2007", "journal-title": "Intern Med J"}, {"key": "10.1002/hep.29367-BIB0183|hep29367-cit-0183", "doi-asserted-by": "crossref", "first-page": "1659", "DOI": "10.1001/jama.2011.520", "article-title": "Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial", "volume": "305", "author": "Lavine", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/hep.29367-BIB0184|hep29367-cit-0184", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1016/j.nut.2014.11.018", "article-title": "Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials", "volume": "31", "author": "Sato", "year": "2015", "journal-title": "Nutrition"}, {"key": "10.1002/hep.29367-BIB0185|hep29367-cit-0185", "first-page": "3924", "article-title": "Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis", "volume": "8", "author": "Xu", "year": "2015", "journal-title": "Int J Clin Exp Med"}, {"key": "10.1002/hep.29367-BIB0186|hep29367-cit-0186", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.7326/0003-4819-142-1-200501040-00110", "article-title": "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality", "volume": "142", "author": "Miller", "year": "2005", "journal-title": "Ann Intern Med"}, {"issue": "Suppl", "key": "10.1002/hep.29367-BIB0187|hep29367-cit-0187", "first-page": "OL1111", "article-title": "The questionable association of vitamin E supplementation and mortality-inconsistent results of different meta-analytic approaches", "volume": "55", "author": "Gerss", "year": "2009", "journal-title": "Cell Mol Biol"}, {"key": "10.1002/hep.29367-BIB0188|hep29367-cit-0188", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.2174/1874609811104020158", "article-title": "Vitamin E and all-cause mortality: a meta-analysis", "volume": "4", "author": "Abner", "year": "2011", "journal-title": "Curr Aging Sci"}, {"key": "10.1002/hep.29367-BIB0189|hep29367-cit-0189", "doi-asserted-by": "crossref", "first-page": "1549", "DOI": "10.1001/jama.2011.1437", "article-title": "Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)", "volume": "306", "author": "Klein", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1002/hep.29367-BIB0190|hep29367-cit-0190", "doi-asserted-by": "crossref", "first-page": "djt456", "DOI": "10.1093/jnci/djt456", "article-title": "Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk", "volume": "106", "author": "Kristal", "year": "2014", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/hep.29367-BIB0191|hep29367-cit-0191", "doi-asserted-by": "crossref", "first-page": "1050", "DOI": "10.1158/1055-9965.EPI-16-0104", "article-title": "Selenium- or vitamin E-related gene variants, interaction with supplementation, and risk of high-grade prostate cancer in SELECT", "volume": "25", "author": "Chan", "year": "2016", "journal-title": "Cancer Epidemiol Biomark Prev"}, {"key": "10.1002/hep.29367-BIB0192|hep29367-cit-0192", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1001/jama.2011.1914", "article-title": "Bariatric surgery and long-term cardiovascular events", "volume": "307", "author": "Sj\u00f6str\u00f6m", "year": "2012", "journal-title": "JAMA"}, {"key": "10.1002/hep.29367-BIB0193|hep29367-cit-0193", "doi-asserted-by": "crossref", "first-page": "484", "DOI": "10.1097/SLA.0b013e31820d98cb", "article-title": "Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass", "volume": "253", "author": "Pontiroli", "year": "2011", "journal-title": "Ann Surg"}, {"key": "10.1002/hep.29367-BIB0194|hep29367-cit-0194", "doi-asserted-by": "crossref", "first-page": "753", "DOI": "10.1056/NEJMoa066603", "article-title": "Long-term mortality after gastric bypass surgery", "volume": "357", "author": "Adams", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0195|hep29367-cit-0195", "doi-asserted-by": "crossref", "first-page": "741", "DOI": "10.1056/NEJMoa066254", "article-title": "Effects of bariatric surgery on mortality in Swedish obese subjects", "volume": "357", "author": "Sj\u00f6str\u00f6m", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0196|hep29367-cit-0196", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1053/j.gastro.2009.04.052", "article-title": "Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease", "volume": "137", "author": "Mathurin", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0197|hep29367-cit-0197", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1053/j.gastro.2015.04.014", "article-title": "Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients", "volume": "149", "author": "Lassailly", "year": "2015", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0198|hep29367-cit-0198", "doi-asserted-by": "crossref", "first-page": "2280", "DOI": "10.1007/s11695-015-1691-x", "article-title": "Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology", "volume": "25", "author": "Bower", "year": "2015", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.29367-BIB0199|hep29367-cit-0199", "doi-asserted-by": "crossref", "first-page": "897", "DOI": "10.1016/j.cgh.2011.07.007", "article-title": "Increased perioperative mortality following bariatric surgery among patients with cirrhosis", "volume": "9", "author": "Mosko", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0200|hep29367-cit-0200", "doi-asserted-by": "crossref", "first-page": "1518", "DOI": "10.1007/s11695-015-1727-2", "article-title": "A systematic review of bariatric surgery in patients with liver cirrhosis", "volume": "25", "author": "Jan", "year": "2015", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.29367-BIB0201|hep29367-cit-0201", "doi-asserted-by": "crossref", "first-page": "1464", "DOI": "10.1002/hep.510230624", "article-title": "Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study", "volume": "23", "author": "Laurin", "year": "1996", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0202|hep29367-cit-0202", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1002/hep.23727", "article-title": "High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial", "volume": "52", "author": "Leuschner", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0203|hep29367-cit-0203", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1002/hep.20092", "article-title": "Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial", "volume": "39", "author": "Lindor", "year": "2004", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0204|hep29367-cit-0204", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/j.jhep.2010.08.030", "article-title": "A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis", "volume": "54", "author": "Ratziu", "year": "2011", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0205|hep29367-cit-0205", "doi-asserted-by": "crossref", "first-page": "1143", "DOI": "10.1111/j.1365-2036.2006.02885.x", "article-title": "Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study", "volume": "23", "author": "Capanni", "year": "2006", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0206|hep29367-cit-0206", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1111/j.1365-2036.2009.04230.x", "article-title": "Review article: omega-3 fatty acids-a promising novel therapy for non-alcoholic fatty liver disease", "volume": "31", "author": "Masterton", "year": "2010", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0207|hep29367-cit-0207", "doi-asserted-by": "crossref", "first-page": "1211", "DOI": "10.1002/hep.27289", "article-title": "Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study", "volume": "60", "author": "Scorletti", "year": "2014", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0208|hep29367-cit-0208", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1053/j.gastro.2014.04.046", "article-title": "No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial", "volume": "147", "author": "Sanyal", "year": "2014", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0209|hep29367-cit-0209", "unstructured": "What's at-risk or heavy drinking?-rethinking drinking-NIAAA http://rethinkingdrinking.niaaa.nih.gov/How-much-is-too-much/Is-your-drinking-pattern-risky/whats-At-Risk-Or-Heavy-drinking.aspx"}, {"key": "10.1002/hep.29367-BIB0210|hep29367-cit-0210", "doi-asserted-by": "crossref", "first-page": "1947", "DOI": "10.1002/hep.22292", "article-title": "Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease", "volume": "47", "author": "Dunn", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0211|hep29367-cit-0211", "doi-asserted-by": "crossref", "first-page": "2189", "DOI": "10.1038/ajg.2009.361", "article-title": "Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population", "volume": "104", "author": "Gunji", "year": "2009", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0212|hep29367-cit-0212", "doi-asserted-by": "crossref", "first-page": "1912", "DOI": "10.1111/j.1572-0241.2007.01274.x", "article-title": "Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia", "volume": "102", "author": "Suzuki", "year": "2007", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0213|hep29367-cit-0213", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1111/j.1365-2036.2010.04520.x", "article-title": "Alcohol consumption appears to protect against non-alcoholic fatty liver disease", "volume": "33", "author": "Moriya", "year": "2011", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0214|hep29367-cit-0214", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1053/gast.2001.25540", "article-title": "Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese", "volume": "121", "author": "Dixon", "year": "2001", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0215|hep29367-cit-0215", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1097/MEG.0b013e328328f3ec", "article-title": "Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients", "volume": "21", "author": "Cotrim", "year": "2009", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0216|hep29367-cit-0216", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1016/j.jhep.2012.03.024", "article-title": "Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)", "volume": "57", "author": "Dunn", "year": "2012", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0217|hep29367-cit-0217", "doi-asserted-by": "crossref", "first-page": "1698", "DOI": "10.1053/j.gastro.2016.01.002", "article-title": "How safe is moderate alcohol consumption in overweight and obese individuals?", "volume": "150", "author": "Sookoian", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0218|hep29367-cit-0218", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1002/hep.21327", "article-title": "Long-term follow-up of patients with NAFLD and elevated liver enzymes", "volume": "44", "author": "Ekstedt", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0219|hep29367-cit-0219", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1016/j.jhep.2016.02.023", "article-title": "Fatty liver is an independent predictor of early carotid atherosclerosis", "volume": "65", "author": "Pais", "year": "2016", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0220|hep29367-cit-0220", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/j.jhep.2016.04.005", "article-title": "Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications", "volume": "65", "author": "Francque", "year": "2016", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0221|hep29367-cit-0221", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1186/1476-511X-13-100", "article-title": "Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile", "volume": "13", "author": "Corey", "year": "2014", "journal-title": "Lipids Health Dis"}, {"key": "10.1002/hep.29367-BIB0222|hep29367-cit-0222", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.1016/j.cgh.2014.10.008", "article-title": "Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile", "volume": "13", "author": "Siddiqui", "year": "2015", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0223|hep29367-cit-0223", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1210/jc.2015-3111", "article-title": "Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD", "volume": "101", "author": "Bril", "year": "2016", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/hep.29367-BIB0224|hep29367-cit-0224", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1016/S0140-6736(10)61272-X", "article-title": "Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis", "volume": "376", "author": "Athyros", "year": "2010", "journal-title": "Lancet"}, {"key": "10.1002/hep.29367-BIB0225|hep29367-cit-0225", "doi-asserted-by": "crossref", "first-page": "3846", "DOI": "10.1016/j.ijcard.2013.06.024", "article-title": "Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels", "volume": "168", "author": "Tikkanen", "year": "2013", "journal-title": "Int J Cardiol"}, {"issue": "25 Suppl 2", "key": "10.1002/hep.29367-BIB0226|hep29367-cit-0226", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1161/01.cir.0000437738.63853.7a", "article-title": "2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines", "volume": "129", "author": "Stone", "year": "2015", "journal-title": "Circulation"}, {"key": "10.1002/hep.29367-BIB0227|hep29367-cit-0227", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1053/j.gastro.2004.02.015", "article-title": "Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity", "volume": "126", "author": "Chalasani", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0228|hep29367-cit-0228", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1002/hep.21848", "article-title": "Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial", "volume": "46", "author": "Lewis", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0229|hep29367-cit-0229", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1038/ajg.2010.299", "article-title": "Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial", "volume": "106", "author": "Foster", "year": "2011", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0230|hep29367-cit-0230", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1007/s00535-010-0203-y", "article-title": "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH", "volume": "45", "author": "Kimura", "year": "2010", "journal-title": "J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0231|hep29367-cit-0231", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.jhep.2007.02.013", "article-title": "Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study", "volume": "47", "author": "Ekstedt", "year": "2007", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0232|hep29367-cit-0232", "doi-asserted-by": "crossref", "first-page": "1711", "DOI": "10.1016/j.metabol.2008.07.030", "article-title": "Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia", "volume": "57", "author": "Hyogo", "year": "2008", "journal-title": "Metabolism"}, {"key": "10.1002/hep.29367-BIB0233|hep29367-cit-0233", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1097/MCG.0b013e31819c392e", "article-title": "A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial", "volume": "43", "author": "Nelson", "year": "2009", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0234|hep29367-cit-0234", "doi-asserted-by": "crossref", "first-page": "956", "DOI": "10.1016/S0140-6736(14)61933-4", "article-title": "Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial", "volume": "385", "author": "Neuschwander-Tetri", "year": "2015", "journal-title": "Lancet"}, {"key": "10.1002/hep.29367-BIB0235|hep29367-cit-0235", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1053/j.gastro.2016.01.038", "article-title": "Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening", "volume": "150", "author": "Ratziu", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0236|hep29367-cit-0236", "doi-asserted-by": "crossref", "first-page": "555", "DOI": "10.1002/hep.24418", "article-title": "Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis", "volume": "54", "author": "Berzigotti", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0237|hep29367-cit-0237", "doi-asserted-by": "crossref", "first-page": "700", "DOI": "10.1016/j.cgh.2011.04.007", "article-title": "Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants", "volume": "9", "author": "O'Leary", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0238|hep29367-cit-0238", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1053/jhep.2002.30318", "article-title": "Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States", "volume": "35", "author": "Nair", "year": "2002", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0239|hep29367-cit-0239", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1002/lt.23618", "article-title": "Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom", "volume": "19", "author": "Hakeem", "year": "2013", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0240|hep29367-cit-0240", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1111/j.1600-6143.2007.02100.x", "article-title": "The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database", "volume": "8", "author": "Leonard", "year": "2008", "journal-title": "Am J Transplant"}, {"key": "10.1002/hep.29367-BIB0241|hep29367-cit-0241", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1111/j.1600-6143.2012.04318.x", "article-title": "Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease", "volume": "13", "author": "Heimbach", "year": "2013", "journal-title": "Am J Transplant"}, {"key": "10.1002/hep.29367-BIB0242|hep29367-cit-0242", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1111/j.1365-2265.2012.04433.x", "article-title": "Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study", "volume": "78", "author": "Kim", "year": "2013", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "10.1002/hep.29367-BIB0243|hep29367-cit-0243", "doi-asserted-by": "crossref", "first-page": "1209", "DOI": "10.1002/lt.23495", "article-title": "Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value", "volume": "18", "author": "Tandon", "year": "2012", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0244|hep29367-cit-0244", "doi-asserted-by": "crossref", "first-page": "1772", "DOI": "10.1002/hep.26716", "article-title": "Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study", "volume": "59", "author": "Hong", "year": "2014", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0245|hep29367-cit-0245", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1097/MCO.0b013e328356bbf4", "article-title": "Identifying sarcopenia", "volume": "15", "author": "Kan", "year": "2012", "journal-title": "Curr Opin Clin Nutr Metab Care"}, {"key": "10.1002/hep.29367-BIB0246|hep29367-cit-0246", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1002/lt.23863", "article-title": "Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation", "volume": "20", "author": "Montano-Loza", "year": "2014", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0247|hep29367-cit-0247", "doi-asserted-by": "crossref", "first-page": "1151", "DOI": "10.1016/j.jhep.2014.02.026", "article-title": "Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography", "volume": "60", "author": "Durand", "year": "2014", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0248|hep29367-cit-0248", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/j.nut.2004.02.002", "article-title": "Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients", "volume": "21", "author": "Alvares-da-Silva", "year": "2005", "journal-title": "Nutrition"}, {"key": "10.1002/hep.29367-BIB0249|hep29367-cit-0249", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1053/jlts.2000.9736", "article-title": "Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease", "volume": "6", "author": "Figueiredo", "year": "2000", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0250|hep29367-cit-0250", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1016/j.jhep.2010.04.030", "article-title": "Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes", "volume": "53", "author": "Targher", "year": "2010", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.29367-BIB0251|hep29367-cit-0251", "doi-asserted-by": "crossref", "first-page": "258", "DOI": "10.1016/j.atherosclerosis.2013.07.052", "article-title": "A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?", "volume": "230", "author": "Oni", "year": "2013", "journal-title": "Atherosclerosis"}, {"key": "10.1002/hep.29367-BIB0252|hep29367-cit-0252", "doi-asserted-by": "crossref", "first-page": "434", "DOI": "10.1016/j.jacc.2012.05.008", "article-title": "Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation", "volume": "60", "author": "Lentine", "year": "2012", "journal-title": "J Am Coll Cardiol"}, {"key": "10.1002/hep.29367-BIB0253|hep29367-cit-0253", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1097/TP.0000000000000945", "article-title": "Nonalcoholic steatohepatitis is the most rapidly growing indication for simultaneous liver kidney transplantation in the United States", "volume": "100", "author": "Singal", "year": "2016", "journal-title": "Transplantation"}, {"key": "10.1002/hep.29367-BIB0254|hep29367-cit-0254", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1056/NEJMoa1114248", "article-title": "Estimating glomerular filtration rate from serum creatinine and cystatin C", "volume": "367", "author": "Inker", "year": "2012", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.29367-BIB0255|hep29367-cit-0255", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1097/00007890-200007270-00009", "article-title": "Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases", "volume": "70", "author": "Maor-Kendler", "year": "2000", "journal-title": "Transplantation"}, {"key": "10.1002/hep.29367-BIB0256|hep29367-cit-0256", "doi-asserted-by": "crossref", "first-page": "613", "DOI": "10.1038/ajg.2009.717", "article-title": "Non-alcoholic fatty liver disease in liver transplant recipients: another story of \u201cseed and soil", "volume": "105", "author": "Dumortier", "year": "2010", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.29367-BIB0257|hep29367-cit-0257", "doi-asserted-by": "crossref", "first-page": "1867", "DOI": "10.1097/TP.0000000000001709", "article-title": "Long term outcomes in patients undergoing liver transplantation for nonalcoholic steatohepatitis related cirrhosis", "volume": "101", "author": "Bhati", "year": "2017", "journal-title": "Transplantation"}, {"key": "10.1002/hep.29367-BIB0258|hep29367-cit-0258", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1002/lt.500040402", "article-title": "Weight change and obesity after liver transplantation: incidence and risk factors", "volume": "4", "author": "Everhart", "year": "1998", "journal-title": "Liver Transpl Surg"}, {"key": "10.1002/hep.29367-BIB0259|hep29367-cit-0259", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1002/lt.22198", "article-title": "Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events", "volume": "17", "author": "Laish", "year": "2011", "journal-title": "Liver Transpl"}, {"key": "10.1002/hep.29367-BIB0260|hep29367-cit-0260", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1016/S0163-7258(02)00297-8", "article-title": "Mechanisms involved in the side effects of glucocorticoids", "volume": "96", "author": "Sch\u00e4cke", "year": "2002", "journal-title": "Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0261|hep29367-cit-0261", "doi-asserted-by": "crossref", "first-page": "136", "DOI": "10.1111/j.1476-5381.2010.01018.x", "article-title": "Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells", "volume": "162", "author": "\u00d8zbay", "year": "2011", "journal-title": "Br J Pharmacol"}, {"key": "10.1002/hep.29367-BIB0262|hep29367-cit-0262", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1002/hep.28906", "article-title": "Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases", "volume": "65", "author": "Garcia-Tsao", "year": "2017", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0263|hep29367-cit-0263", "author": "Heimbach", "year": "2017", "article-title": "AASLD guidelines for the treatment of hepatocellular carcinoma", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0264|hep29367-cit-0264", "doi-asserted-by": "crossref", "first-page": "1388", "DOI": "10.1542/peds.2006-1212", "article-title": "Prevalence of fatty liver in children and adolescents", "volume": "118", "author": "Schwimmer", "year": "2006", "journal-title": "Pediatrics"}, {"key": "10.1002/hep.29367-BIB0265|hep29367-cit-0265", "doi-asserted-by": "crossref", "first-page": "e0140908", "DOI": "10.1371/journal.pone.0140908", "article-title": "The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis", "volume": "10", "author": "Anderson", "year": "2015", "journal-title": "PLoS One"}, {"key": "10.1002/hep.29367-BIB0266|hep29367-cit-0266", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1016/j.jpeds.2013.10.072", "article-title": "Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease", "volume": "164", "author": "Sundaram", "year": "2014", "journal-title": "J Pediatr"}, {"key": "10.1002/hep.29367-BIB0267|hep29367-cit-0267", "doi-asserted-by": "crossref", "first-page": "707", "DOI": "10.1016/j.jpeds.2013.10.071", "article-title": "Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels", "volume": "164", "author": "Molleston", "year": "2014", "journal-title": "J Pediatr"}, {"key": "10.1002/hep.29367-BIB0268|hep29367-cit-0268", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.1111/apt.12518", "article-title": "Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease", "volume": "38", "author": "Schwimmer", "year": "2013", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0269|hep29367-cit-0269", "doi-asserted-by": "crossref", "first-page": "1538", "DOI": "10.1136/gut.2008.171280", "article-title": "The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years", "volume": "58", "author": "Feldstein", "year": "2009", "journal-title": "Gut"}, {"key": "10.1002/hep.29367-BIB0270|hep29367-cit-0270", "first-page": "905A", "article-title": "The natural history of nonalcoholic fatty liver disease in children and adolescents assessed in placebo recipients in the TONIC trial", "volume": "56", "author": "Lavine", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0271|hep29367-cit-0271", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1016/j.jpeds.2005.07.020", "article-title": "Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists", "volume": "147", "author": "Riley", "year": "2005", "journal-title": "J Pediatr"}, {"issue": "Suppl 4", "key": "10.1002/hep.29367-BIB0272|hep29367-cit-0272", "doi-asserted-by": "crossref", "first-page": "S164", "DOI": "10.1542/peds.2007-2329C", "article-title": "Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report", "volume": "120", "author": "Barlow", "year": "2007", "journal-title": "Pediatrics"}, {"key": "10.1002/hep.29367-BIB0273|hep29367-cit-0273", "doi-asserted-by": "crossref", "first-page": "1282", "DOI": "10.1002/hep.23119", "article-title": "Advances in pediatric nonalcoholic fatty liver disease", "volume": "50", "author": "Loomba", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0274|hep29367-cit-0274", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1007/s11894-015-0447-z", "article-title": "A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease", "volume": "17", "author": "Mansoor", "year": "2015", "journal-title": "Curr Gastroenterol Rep"}, {"key": "10.1002/hep.29367-BIB0275|hep29367-cit-0275", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/j.cgh.2010.09.015", "article-title": "A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis", "volume": "9", "author": "Alkhouri", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0276|hep29367-cit-0276", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1053/j.gastro.2008.09.013", "article-title": "Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease", "volume": "136", "author": "Nobili", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0277|hep29367-cit-0277", "doi-asserted-by": "crossref", "first-page": "2121", "DOI": "10.1016/j.cgh.2014.05.010", "article-title": "Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease", "volume": "12", "author": "Vuppalanchi", "year": "2014", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.29367-BIB0278|hep29367-cit-0278", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1002/hep.23133", "article-title": "Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study", "volume": "50", "author": "Carter-Kent", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0279|hep29367-cit-0279", "author": "Africa", "year": "2017", "article-title": "In children with nonalcoholic fatty liver disease, zone 1 steatosis is associated with advanced fibrosis", "journal-title": "Clin Gastroenterol Hepatol", "DOI": "10.1016/j.cgh.2017.02.030", "doi-asserted-by": "publisher"}, {"key": "10.1002/hep.29367-BIB0280|hep29367-cit-0280", "doi-asserted-by": "crossref", "first-page": "1553", "DOI": "10.1111/j.1365-2036.2006.03161.x", "article-title": "Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease", "volume": "24", "author": "Nobili", "year": "2006", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.29367-BIB0281|hep29367-cit-0281", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1002/hep.22336", "article-title": "Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial", "volume": "48", "author": "Nobili", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1002/hep.29367-BIB0282|hep29367-cit-0282", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1038/ijo.2015.175", "article-title": "Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment", "volume": "40", "author": "Koot", "year": "2016", "journal-title": "Int J Obes (Lond)"}, {"key": "10.1002/hep.29367-BIB0283|hep29367-cit-0283", "first-page": "236", "article-title": "Management of child and adolescent obesity: summary and recommendations based on reports from pediatricians, pediatric nurse practitioners, and registered dietitians", "volume": "110", "author": "Barlow", "year": "2002", "journal-title": "Pediatrics"}, {"key": "10.1002/hep.29367-BIB0284|hep29367-cit-0284", "doi-asserted-by": "crossref", "first-page": "1141", "DOI": "10.1053/j.gastro.2016.08.027", "article-title": "In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores", "volume": "151", "author": "Schwimmer", "year": "2016", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.29367-BIB0285|hep29367-cit-0285", "doi-asserted-by": "crossref", "first-page": "1358", "DOI": "10.1016/j.jpeds.2015.01.056", "article-title": "Omega-3 Fatty acids therapy in children with nonalcoholic fatty liver disease: a randomized controlled trial", "volume": "166", "author": "Janczyk", "year": "2015", "journal-title": "J Pediatr"}, {"key": "10.1002/hep.29367-BIB0286|hep29367-cit-0286", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1016/j.numecd.2015.04.003", "article-title": "A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease", "volume": "25", "author": "Pacifico", "year": "2015", "journal-title": "Nutr Metab Cardiovasc Dis"}, {"key": "10.1002/hep.29367-BIB0287|hep29367-cit-0287", "doi-asserted-by": "crossref", "first-page": "2735", "DOI": "10.1161/CIRCULATIONAHA.105.169404", "article-title": "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement", "volume": "112", "author": "Grundy", "year": "2005", "journal-title": "Circulation"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.29367", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29367/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T13:15:49Z", "timestamp": 1569849349000}, "score": 65.77328, "subtitle": ["Hepatology, Vol. XX, No. X, 2017"], "issued": {"date-parts": [[2017, 9, 29]]}, "references-count": 287, "journal-issue": {"published-print": {"date-parts": [[2018, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/hep.29367", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T19:23:14Z", "timestamp": 1576696994963}, "reference-count": 148, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2555, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1002/hep.22603", "type": "journal-article", "created": {"date-parts": [[2008, 9, 2]], "date-time": "2008-09-02T15:31:06Z", "timestamp": 1220369466000}, "page": "306-317", "source": "Crossref", "is-referenced-by-count": 331, "title": ["Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management"], "prefix": "10.1002", "volume": "49", "author": [{"given": "Raj", "family": "Vuppalanchi", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2008, 9, 2]]}, "reference": [{"key": "10.1002/hep.22603-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "1221", "DOI": "10.1056/NEJMra011775", "article-title": "Nonalcoholic fatty liver disease", "volume": "346", "author": "Angulo", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "960", "DOI": "10.1111/j.1572-0241.2003.07486.x", "article-title": "The prevalence and etiology of elevated aminotransferase levels in the United States", "volume": "98", "author": "Clark", "year": "2003", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "1682", "DOI": "10.1053/j.gastro.2008.02.077", "article-title": "Diagnosis and therapy of nonalcoholic steatohepatitis", "volume": "134", "author": "Torres", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1814", "DOI": "10.1053/j.gastro.2007.08.077", "article-title": "Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004", "volume": "133", "author": "Fraser", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1048", "DOI": "10.1016/S1542-3565(04)00440-9", "article-title": "Nonalcoholic fatty liver disease: a review of current understanding and future impact", "volume": "2", "author": "Charlton", "year": "2004", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1016/S0016-5085(99)70506-8", "article-title": "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", "volume": "116", "author": "Matteoni", "year": "1999", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "2022", "DOI": "10.1111/j.1572-0241.1998.00587.x", "article-title": "Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology", "volume": "93", "author": "McCullough", "year": "1998", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB8|cit8", "first-page": "26", "article-title": "Risk of fatty infiltration or cirrhosis of the liver in relation to ethanol consumption: a case-control study", "volume": "9", "author": "Coates", "year": "1986", "journal-title": "Clin Invest Med"}, {"key": "10.1002/hep.22603-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1260", "DOI": "10.1016/S1542-3565(05)00743-3", "article-title": "Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population", "volume": "3", "author": "Ruhl", "year": "2005", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1947", "DOI": "10.1002/hep.22292", "article-title": "Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease", "volume": "47", "author": "Dunn", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1111/j.1530-0277.2002.tb02542.x", "article-title": "CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project", "volume": "26", "author": "Conigrave", "year": "2002", "journal-title": "Alcohol Clin Exp Res"}, {"key": "10.1002/hep.22603-BIB12|cit12", "first-page": "1769", "article-title": "Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase", "volume": "47", "author": "Anton", "year": "2001", "journal-title": "Clin Chem"}, {"key": "10.1002/hep.22603-BIB13|cit13", "first-page": "455", "article-title": "An overview of serum mitochondrial aspartate aminotransferase (mAST) activity as a marker of chronic alcohol abuse", "volume": "1", "author": "Nalpas", "year": "1991", "journal-title": "Alcohol Alcohol Suppl"}, {"key": "10.1002/hep.22603-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1053/j.gastro.2006.08.020", "article-title": "Utility of a new model to diagnose an alcohol basis for steatohepatitis", "volume": "131", "author": "Dunn", "year": "2006", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1097/01.mcg.0000139072.38580.a0", "article-title": "Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis", "volume": "38", "author": "Cotler", "year": "2004", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.22603-BIB16|cit16", "first-page": "261", "article-title": "A prospective study on the prevalence and clinical significance of autoantibodies in patients with suspected nonalcoholic fatty liver disease", "volume": "11", "author": "Cho", "year": "2005", "journal-title": "Korean J Hepatol"}, {"key": "10.1002/hep.22603-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1130", "DOI": "10.1007/s00535-005-1711-z", "article-title": "Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?", "volume": "40", "author": "Yatsuji", "year": "2005", "journal-title": "J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "2173", "DOI": "10.1023/B:DDAS.0000004522.36120.08", "article-title": "Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates", "volume": "48", "author": "Loria", "year": "2003", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.22603-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "923", "DOI": "10.1111/j.1872-034X.2007.00150.x", "article-title": "Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis", "volume": "37", "author": "Niwa", "year": "2007", "journal-title": "Hepatol Res"}, {"key": "10.1002/hep.22603-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1316", "DOI": "10.1111/j.1572-0241.2004.30444.x", "article-title": "The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease", "volume": "99", "author": "Adams", "year": "2004", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1016/0016-5085(94)90235-6", "article-title": "Nonalcoholic steatohepatitis: an expanded clinical entity", "volume": "107", "author": "Bacon", "year": "1994", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "2448", "DOI": "10.1111/j.1572-0241.2001.04052.x", "article-title": "Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis", "volume": "96", "author": "Fargion", "year": "2001", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "3905", "DOI": "10.3748/wjg.v11.i25.3905", "article-title": "Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan", "volume": "11", "author": "Lin", "year": "2005", "journal-title": "World J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1053/jhep.2002.33892", "article-title": "HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity", "volume": "36", "author": "Chitturi", "year": "2002", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1002/hep.510300604", "article-title": "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", "volume": "30", "author": "Angulo", "year": "1999", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.2337/diacare.23.1.57", "article-title": "Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity", "volume": "23", "author": "Bonora", "year": "2000", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.22603-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "E15", "DOI": "10.1152/ajpendo.00645.2007", "article-title": "Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage", "volume": "294", "author": "Muniyappa", "year": "2008", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "10.1002/hep.22603-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.2337/diabetes.54.2.333", "article-title": "Identification of individuals with insulin resistance using routine clinical measurements", "volume": "54", "author": "Stern", "year": "2005", "journal-title": "Diabetes"}, {"key": "10.1002/hep.22603-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1007/s00535-007-2060-x", "article-title": "High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH", "volume": "42", "author": "Yoneda", "year": "2007", "journal-title": "J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "1394", "DOI": "10.1038/oby.2008.64", "article-title": "NASH predicts plasma inflammatory biomarkers independently of visceral fat in men", "volume": "16", "author": "Targher", "year": "2008", "journal-title": "Obesity (Silver Spring)"}, {"key": "10.1002/hep.22603-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "2338", "DOI": "10.1007/s10620-005-3058-y", "article-title": "Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease", "volume": "50", "author": "Singh", "year": "2005", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.22603-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "918", "DOI": "10.1097/01.mcg.0000225692.62121.55", "article-title": "Liver enzymes and histology in obese patients with obstructive sleep apnea", "volume": "41", "author": "Kallwitz", "year": "2007", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.22603-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1002/hep.20140", "article-title": "Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction", "volume": "39", "author": "Adams", "year": "2004", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1097/00004836-200310000-00014", "article-title": "Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?", "volume": "37", "author": "Liangpunsakul", "year": "2003", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.22603-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "412", "DOI": "10.1016/j.jhep.2007.04.012", "article-title": "Nonalcoholic fatty liver disease in women with polycystic ovary syndrome", "volume": "47", "author": "Cerda", "year": "2007", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.22603-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "1741", "DOI": "10.1210/jc.2005-2774", "article-title": "Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome", "volume": "91", "author": "Setji", "year": "2006", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/hep.22603-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1016/j.cgh.2006.10.010", "article-title": "Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome", "volume": "5", "author": "Gambarin-Gelwan", "year": "2007", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1136/gut.2007.139303", "article-title": "Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance", "volume": "57", "author": "Newton", "year": "2008", "journal-title": "Gut"}, {"key": "10.1002/hep.22603-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1378/chest.07-0773", "article-title": "Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea", "volume": "133", "author": "Kheirandish-Gozal", "year": "2008", "journal-title": "Chest"}, {"key": "10.1002/hep.22603-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "1290", "DOI": "10.1002/hep.20725", "article-title": "Chronic liver injury during obstructive sleep apnea", "volume": "41", "author": "Tanne", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1016/j.hepres.2005.09.006", "article-title": "Pathology of nonalcoholic steatohepatitis", "volume": "33", "author": "Brunt", "year": "2005", "journal-title": "Hepatol Res"}, {"issue": "Suppl 1", "key": "10.1002/hep.22603-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "S104", "DOI": "10.1016/j.jhep.2008.01.009", "article-title": "Non-alcoholic fatty liver disease: the mist gradually clears", "volume": "48", "author": "de Alwis", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.22603-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "A754", "DOI": "10.1016/S0016-5085(08)63522-2", "article-title": "Over twenty five years of follow up for a Non-Alcoholic Fatty Liver Disease Cohort", "volume": "134", "author": "Rafiq", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.1053/j.gastro.2005.03.084", "article-title": "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", "volume": "128", "author": "Ratziu", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "874", "DOI": "10.1002/hep.21346", "article-title": "Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease", "volume": "44", "author": "Merriman", "year": "2006", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB46|cit46", "first-page": "A809", "article-title": "Increased diagnostic yield from liver biopsy in suspected NAFLD using multiple cores and mutiple readings", "volume": "132", "author": "Vuppalanchi", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1002/hep.20701", "article-title": "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", "volume": "41", "author": "Kleiner", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "1725", "DOI": "10.1007/s10620-005-9065-1", "article-title": "Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitis", "volume": "51", "author": "Alazmi", "year": "2006", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.22603-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "2247", "DOI": "10.1111/j.1572-0241.2006.00719.x", "article-title": "Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD", "volume": "101", "author": "Kang", "year": "2006", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "1377", "DOI": "10.1053/j.gastro.2007.08.045", "article-title": "Noninvasive markers of advanced histology in nonalcoholic fatty liver disease: are we there yet?", "volume": "133", "author": "Wilson", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/hep.21223", "article-title": "In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease", "volume": "44", "author": "Wieckowska", "year": "2006", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "567", "DOI": "10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J", "article-title": "Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis", "volume": "187", "author": "Leers", "year": "1999", "journal-title": "J Pathol"}, {"key": "10.1002/hep.22603-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.3748/wjg.v13.i6.837", "article-title": "Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis", "volume": "13", "author": "Yilmaz", "year": "2007", "journal-title": "World J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1016/S0016-5085(03)00907-7", "article-title": "Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis", "volume": "125", "author": "Feldstein", "year": "2003", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "484", "DOI": "10.1002/hep.22063", "article-title": "Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease", "volume": "47", "author": "Charlton", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1002/hep.21496", "article-title": "The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD", "volume": "45", "author": "Angulo", "year": "2007", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1002/hep.21984", "article-title": "Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers", "volume": "47", "author": "Guha", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "1441", "DOI": "10.1136/gut.2007.146019", "article-title": "Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease", "volume": "57", "author": "Harrison", "year": "2008", "journal-title": "Gut"}, {"key": "10.1002/hep.22603-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "1704", "DOI": "10.1053/j.gastro.2004.08.052", "article-title": "Serum markers detect the presence of liver fibrosis: a cohort study", "volume": "127", "author": "Rosenberg", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.1186/1471-230X-6-6", "article-title": "Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease", "volume": "6", "author": "Ratziu", "year": "2006", "journal-title": "BMC Gastroenterol"}, {"key": "10.1002/hep.22603-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/j.dld.2007.10.019", "article-title": "Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)", "volume": "40", "author": "Yoneda", "year": "2008", "journal-title": "Dig Liver Dis"}, {"key": "10.1002/hep.22603-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "1027", "DOI": "10.1016/j.cgh.2008.02.038", "article-title": "Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases", "volume": "6", "author": "Wong", "year": "2008", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1002/hep.22140", "article-title": "The future is around the corner: noninvasive diagnosis of progressive nonalcoholic steatohepatitis", "volume": "47", "author": "Baranova", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "1158", "DOI": "10.1002/hep.22137", "article-title": "Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease", "volume": "47", "author": "Krasnoff", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "746", "DOI": "10.1002/hep.22009", "article-title": "Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach", "volume": "47", "author": "Bellentani", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB66|cit66", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1111/j.1572-0241.2005.41334.x", "article-title": "One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study", "volume": "100", "author": "Huang", "year": "2005", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1093/ajcn/86.2.285", "article-title": "Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease", "volume": "86", "author": "Zivkovic", "year": "2007", "journal-title": "Am J Clin Nutr"}, {"key": "10.1002/hep.22603-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1016/j.jhep.2008.02.011", "article-title": "Fructose consumption as a risk factor for non-alcoholic fatty liver disease", "volume": "48", "author": "Ouyang", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.22603-BIB69|cit69", "first-page": "A809", "article-title": "Orlistat (Xenical) in the treatment of overweight patients with nonalcoholic steatohepatitis (NASH): a multi-centered, randomized, prospective trial", "volume": "132", "author": "Harrison", "year": "2007", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1016/j.physbeh.2007.11.012", "article-title": "Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome", "volume": "93", "author": "Vemuri", "year": "2008", "journal-title": "Physiol Behav"}, {"key": "10.1002/hep.22603-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "1389", "DOI": "10.1016/S0140-6736(05)66374-X", "article-title": "Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study", "volume": "365", "author": "Van Gaal", "year": "2005", "journal-title": "Lancet"}, {"key": "10.1002/hep.22603-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.1001/jama.295.7.761", "article-title": "Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial", "volume": "295", "author": "Pi-Sunyer", "year": "2006", "journal-title": "JAMA"}, {"key": "10.1002/hep.22603-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1038/nm1421", "article-title": "CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis", "volume": "12", "author": "Teixeira-Clerc", "year": "2006", "journal-title": "Nat Med"}, {"key": "10.1002/hep.22603-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1002/hep.21641", "article-title": "Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats", "volume": "46", "author": "Gary-Bobo", "year": "2007", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1016/S1072-7515(01)00894-8", "article-title": "Liver transplantation after jejunoileal bypass for morbid obesity", "volume": "185", "author": "Lowell", "year": "1997", "journal-title": "J Am Coll Surg"}, {"key": "10.1002/hep.22603-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1381/096089294765558872", "article-title": "Long-term follow-up of jejunoileal bypass patients with preoperative cirrhosis of the liver", "volume": "4", "author": "Wills", "year": "1994", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.22603-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "2493", "DOI": "10.1023/A:1026698602714", "article-title": "Long-term consequences after jejunoileal bypass for morbid obesity", "volume": "43", "author": "Hocking", "year": "1998", "journal-title": "Dig Dis Sci"}, {"key": "10.1002/hep.22603-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1007/s11695-007-9214-z", "article-title": "The comparative effects of bariatric surgery on weight and type 2 diabetes", "volume": "17", "author": "Levy", "year": "2007", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.22603-BIB79|cit79", "author": "Sears", "year": "2008", "article-title": "Evaluation of gastric bypass patients 1 year after surgery: changes in quality of life and obesity-related conditions", "journal-title": "Obes Surg", "DOI": "10.1007/s11695-008-9604-x", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.22603-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "2683", "DOI": "10.1056/NEJMoa035622", "article-title": "Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery", "volume": "351", "author": "Sjostrom", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1067/j.cpsurg.2007.12.003", "article-title": "Surgical management of morbid obesity", "volume": "45", "author": "Tessier", "year": "2008", "journal-title": "Curr Probl Surg"}, {"key": "10.1002/hep.22603-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "1442", "DOI": "10.1007/s11695-008-9421-2", "article-title": "Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results", "volume": "17", "author": "Braghetto", "year": "2007", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.22603-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1111/j.1440-1746.2007.04833.x", "article-title": "Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years", "volume": "22", "author": "Furuya", "year": "2007", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB84|cit84", "author": "Mummadi", "year": "2008", "article-title": "Effect of bariatric surgery on nonalcoholic fatty liver disease (NAFLD): systemic review and meta-analysis", "journal-title": "Clin Gastroenterol Hepatol", "DOI": "10.1016/j.cgh.2008.08.012", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.22603-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1381/096089204772787284", "article-title": "Results of laparoscopic gastric bypass in patients with cirrhosis", "volume": "14", "author": "Dallal", "year": "2004", "journal-title": "Obes Surg"}, {"key": "10.1002/hep.22603-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1016/j.surg.2003.10.003", "article-title": "Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis", "volume": "135", "author": "Kral", "year": "2004", "journal-title": "Surgery"}, {"key": "10.1002/hep.22603-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.7326/0003-4819-137-1-200207020-00009", "article-title": "Metformin: an update", "volume": "137", "author": "Kirpichnikov", "year": "2002", "journal-title": "Ann Intern Med"}, {"key": "10.1002/hep.22603-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1161/01.HYP.0000221429.94591.72", "article-title": "Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells", "volume": "47", "author": "Hattori", "year": "2006", "journal-title": "Hypertension"}, {"key": "10.1002/hep.22603-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1038/79697", "article-title": "Metformin reverses fatty liver disease in obese, leptin-deficient mice", "volume": "6", "author": "Lin", "year": "2000", "journal-title": "Nat Med"}, {"key": "10.1002/hep.22603-BIB90|cit90", "author": "Angelico", "year": "2007", "article-title": "Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis", "journal-title": "Cochrane Database Syst Rev", "DOI": "10.1002/14651858.CD005166.pub2", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.22603-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1056/NEJMoa012512", "article-title": "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", "volume": "346", "author": "Knowler", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB92|cit92", "first-page": "271", "article-title": "Mechanisms of action of thiazolidinediones", "volume": "27", "author": "Girard", "year": "2001", "journal-title": "Diabetes Metab"}, {"key": "10.1002/hep.22603-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "1106", "DOI": "10.1056/NEJMra041001", "article-title": "Thiazolidinediones", "volume": "351", "author": "Yki-Jarvinen", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1002/hep.20598", "article-title": "Insight into hepatotoxicity: the troglitazone experience", "volume": "41", "author": "Watkins", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.2165/00002018-200124120-00002", "article-title": "Hepatotoxicity with thiazolidinediones: is it a class effect?", "volume": "24", "author": "Scheen", "year": "2001", "journal-title": "Drug Saf"}, {"key": "10.1002/hep.22603-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1111/j.1463-1326.2007.00755.x", "article-title": "The effect of thiazolidinediones on adiponectin serum level: a meta-analysis", "volume": "10", "author": "Riera-Guardia", "year": "2008", "journal-title": "Diabetes Obes Metab"}, {"key": "10.1002/hep.22603-BIB97|cit97", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.1572-0241.2001.03553.x", "article-title": "A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis", "volume": "96", "author": "Caldwell", "year": "2001", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1053/jhep.2003.50420", "article-title": "Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone", "volume": "38", "author": "Neuschwander-Tetri", "year": "2003", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1002/hep.20012", "article-title": "A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis", "volume": "39", "author": "Promrat", "year": "2004", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1053/S1542-3565(03)00198-8", "article-title": "Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity", "volume": "1", "author": "Shadid", "year": "2003", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB101|cit101", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1016/S1542-3565(04)00457-4", "article-title": "A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis", "volume": "2", "author": "Sanyal", "year": "2004", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1056/NEJMoa060326", "article-title": "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", "volume": "355", "author": "Belfort", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB103|cit103", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1053/j.gastro.2008.03.078", "article-title": "Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial", "volume": "135", "author": "Ratziu", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB104|cit104", "author": "Aithal", "year": "2008", "article-title": "Randomized, placebo controlled trial of pioglitazone in non-diabetic subjects with nonalcoholic steatohepatitis (NASH)", "journal-title": "Gastroenterology", "DOI": "10.1053/j.gastro.2008.06.047", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.22603-BIB105|cit105", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1002/hep.21661", "article-title": "The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis", "volume": "46", "author": "Lutchman", "year": "2007", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB106|cit106", "doi-asserted-by": "crossref", "first-page": "2457", "DOI": "10.1056/NEJMoa072761", "article-title": "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes", "volume": "356", "author": "Nissen", "year": "2007", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.22603-BIB107|cit107", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1002/hep.21006", "article-title": "Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice", "volume": "43", "author": "Ding", "year": "2006", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1089/dia.2005.7.467", "article-title": "Exenatide improves glycemic control and reduces body weight in subjects with type 2 diabetes: a dose-ranging study", "volume": "7", "author": "Poon", "year": "2005", "journal-title": "Diabetes Technol Ther"}, {"key": "10.1002/hep.22603-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1002/hep.22105", "article-title": "Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: another piece of the puzzle", "volume": "47", "author": "Bugianesi", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1002/hep.21327", "article-title": "Long-term follow-up of patients with NAFLD and elevated liver enzymes", "volume": "44", "author": "Ekstedt", "year": "2006", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "684", "DOI": "10.1016/j.numecd.2007.01.007", "article-title": "Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question", "volume": "17", "author": "Loria", "year": "2007", "journal-title": "Nutr Metab Cardiovasc Dis"}, {"key": "10.1002/hep.22603-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1464-5491.2007.02025.x", "article-title": "Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens", "volume": "24", "author": "Targher", "year": "2007", "journal-title": "Diabet Med"}, {"key": "10.1002/hep.22603-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "S5", "DOI": "10.1016/S0168-8278(08)60008-2", "article-title": "Non-alcoholic fatty liver disease (NAFLD) is associated with higher overall mortality and liver related mortality", "volume": "48", "author": "Ong", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.22603-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1053/jhep.2003.50161", "article-title": "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", "volume": "37", "author": "Marchesini", "year": "2003", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1016/j.cld.2004.04.004", "article-title": "The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease", "volume": "8", "author": "McCullough", "year": "2004", "journal-title": "Clin Liver Dis"}, {"key": "10.1002/hep.22603-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "1286", "DOI": "10.1053/jhep.2003.50229", "article-title": "Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values", "volume": "37", "author": "Mofrad", "year": "2003", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1002/hep.20781", "article-title": "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease", "volume": "42", "author": "Villanova", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB119|cit119", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1111/j.1572-0241.2004.30159.x", "article-title": "Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis", "volume": "99", "author": "Chalasani", "year": "2004", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1203/PDR.0b013e318165b8e7", "article-title": "Nonalcoholic fatty liver disease and carotid atherosclerosis in children", "volume": "63", "author": "Pacifico", "year": "2008", "journal-title": "Pediatr Res"}, {"key": "10.1002/hep.22603-BIB121|cit121", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/j.amjmed.2007.08.041", "article-title": "Carotid artery intima-media thickness in nonalcoholic fatty liver disease", "volume": "121", "author": "Fracanzani", "year": "2008", "journal-title": "Am J Med"}, {"key": "10.1002/hep.22603-BIB122|cit122", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.2337/dc06-0135", "article-title": "Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease", "volume": "29", "author": "Targher", "year": "2006", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.22603-BIB123|cit123", "doi-asserted-by": "crossref", "first-page": "618", "DOI": "10.1253/circj.72.618", "article-title": "Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT)", "volume": "72", "author": "Akabame", "year": "2008", "journal-title": "Circ J"}, {"key": "10.1002/hep.22603-BIB124|cit124", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1002/hep.21983", "article-title": "Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver", "volume": "47", "author": "Perseghin", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB125|cit125", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1111/j.1464-5491.2006.01817.x", "article-title": "Increased prevalence of cardiovascular disease in type 2 diabetic patients with non-alcoholic fatty liver disease", "volume": "23", "author": "Targher", "year": "2006", "journal-title": "Diabet Med"}, {"key": "10.1002/hep.22603-BIB126|cit126", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1053/j.gastro.2004.02.015", "article-title": "Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity", "volume": "126", "author": "Chalasani", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.22603-BIB127|cit127", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1002/hep.20671", "article-title": "Statins and hepatotoxicity: focus on patients with fatty liver", "volume": "41", "author": "Chalasani", "year": "2005", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB128|cit128", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1097/00000441-200502000-00002", "article-title": "Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes", "volume": "329", "author": "Vuppalanchi", "year": "2005", "journal-title": "Am J Med Sci"}, {"key": "10.1002/hep.22603-BIB129|cit129", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1002/hep.21848", "article-title": "Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial", "volume": "46", "author": "Lewis", "year": "2007", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB130|cit130", "first-page": "1459", "article-title": "Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease", "volume": "21", "author": "Kaneda", "year": "2006", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/hep.22603-BIB131|cit131", "doi-asserted-by": "crossref", "first-page": "1330", "DOI": "10.1136/gut.2007.126417", "article-title": "Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD)", "volume": "56", "author": "Yoneda", "year": "2007", "journal-title": "Gut"}, {"key": "10.1002/hep.22603-BIB132|cit132", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.1002/hep.21972", "article-title": "Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications", "volume": "47", "author": "Talwalkar", "year": "2008", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB133|cit133", "doi-asserted-by": "crossref", "first-page": "E462", "DOI": "10.1152/ajpendo.00064.2004", "article-title": "Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population", "volume": "288", "author": "Szczepaniak", "year": "2005", "journal-title": "Am J Physiol Endocrinol Metab"}, {"key": "10.1002/hep.22603-BIB134|cit134", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1097/01.rli.0000258058.44876.a5", "article-title": "Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging", "volume": "42", "author": "Tsuda", "year": "2007", "journal-title": "Invest Radiol"}, {"key": "10.1002/hep.22603-BIB135|cit135", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1042/CS20050346", "article-title": "Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis", "volume": "111", "author": "Portincasa", "year": "2006", "journal-title": "Clin Sci (Lond)"}, {"key": "10.1002/hep.22603-BIB136|cit136", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1080/13547500500421070", "article-title": "Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations", "volume": "11", "author": "Solga", "year": "2006", "journal-title": "Biomarkers"}, {"key": "10.1002/hep.22603-BIB137|cit137", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1186/1471-230X-5-35", "article-title": "Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis", "volume": "5", "author": "Horoz", "year": "2005", "journal-title": "BMC Gastroenterol"}, {"key": "10.1002/hep.22603-BIB138|cit138", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1002/hep.20280", "article-title": "Beyond insulin resistance in NASH: TNF-alpha or adiponectin?", "volume": "40", "author": "Hui", "year": "2004", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB139|cit139", "doi-asserted-by": "crossref", "first-page": "2438", "DOI": "10.1111/j.1572-0241.2005.00297.x", "article-title": "Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis", "volume": "100", "author": "Musso", "year": "2005", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB140|cit140", "doi-asserted-by": "crossref", "first-page": "1372", "DOI": "10.1111/j.1572-0241.2007.01774.x", "article-title": "Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis", "volume": "103", "author": "Wieckowska", "year": "2008", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB141|cit141", "doi-asserted-by": "crossref", "first-page": "1167", "DOI": "10.1016/j.jhep.2006.02.011", "article-title": "Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2", "volume": "44", "author": "Haukeland", "year": "2006", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.22603-BIB142|cit142", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1016/S0140-6736(01)06042-1", "article-title": "Metformin in non-alcoholic steatohepatitis", "volume": "358", "author": "Marchesini", "year": "2001", "journal-title": "Lancet"}, {"key": "10.1002/hep.22603-BIB143|cit143", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1111/j.1365-2036.2004.02025.x", "article-title": "Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial", "volume": "20", "author": "Nair", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.22603-BIB144|cit144", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1111/j.1365-2036.2004.01888.x", "article-title": "Metformin in the treatment of patients with non-alcoholic steatohepatitis", "volume": "19", "author": "Uygun", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.22603-BIB145|cit145", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1111/j.1572-0241.2005.41583.x", "article-title": "A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease", "volume": "100", "author": "Bugianesi", "year": "2005", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.22603-BIB146|cit146", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1111/j.1365-2036.2005.02420.x", "article-title": "A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis", "volume": "21", "author": "Schwimmer", "year": "2005", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.22603-BIB147|cit147", "first-page": "260A", "article-title": "Pilot study of metformin in patients with nonalcoholic steatohepatitis", "volume": "44", "author": "Loomba", "year": "2006", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.22603-BIB148|cit148", "doi-asserted-by": "crossref", "first-page": "1168", "DOI": "10.1016/j.clinthera.2008.06.012", "article-title": "Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study", "volume": "30", "author": "Nobili", "year": "2008", "journal-title": "Clin Ther"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.22603", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/hep.22603", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 13]], "date-time": "2019-05-13T19:34:04Z", "timestamp": 1557776044000}, "score": 61.883564, "issued": {"date-parts": [[2008, 9, 2]]}, "references-count": 148, "journal-issue": {"published-print": {"date-parts": [[2009, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/hep.22603", "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}], "subject": ["Hepatology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T05:33:26Z", "timestamp": 1574314406024}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 9, 1]], "date-time": "2009-09-01T00:00:00Z", "timestamp": 1251763200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2009, 9]]}, "DOI": "10.1053/j.gastro.2009.07.032", "type": "journal-article", "created": {"date-parts": [[2009, 7, 27]], "date-time": "2009-07-27T08:08:56Z", "timestamp": 1248682136000}, "page": "772-775", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Nonalcoholic Fatty Liver Disease Liver Fat Score and Fat Equation to Predict and Quantitate Hepatic Steatosis: Promising But Not Prime Time!"], "prefix": "10.1053", "volume": "137", "author": [{"given": "Naga", "family": "Chalasani", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508509011883?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508509011883?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T18:09:43Z", "timestamp": 1558462183000}, "score": 61.830177, "issued": {"date-parts": [[2009, 9]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2009, 9]]}, "issue": "3"}, "alternative-id": ["S0016508509011883"], "URL": "http://dx.doi.org/10.1053/j.gastro.2009.07.032", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T08:13:52Z", "timestamp": 1574324032628}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 10, 1]], "date-time": "2007-10-01T00:00:00Z", "timestamp": 1191196800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2007, 10]]}, "DOI": "10.1053/j.gastro.2007.08.045", "type": "journal-article", "created": {"date-parts": [[2007, 10, 3]], "date-time": "2007-10-03T11:12:27Z", "timestamp": 1191409947000}, "page": "1377-1378", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Noninvasive Markers of Advanced Histology in Nonalcoholic Fatty Liver Disease: Are We There yet?"], "prefix": "10.1053", "volume": "133", "author": [{"given": "Spencer", "family": "Wilson", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508507015685?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508507015685?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 3]], "date-time": "2019-01-03T18:26:42Z", "timestamp": 1546540002000}, "score": 59.599884, "issued": {"date-parts": [[2007, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 10]]}, "issue": "4"}, "alternative-id": ["S0016508507015685"], "URL": "http://dx.doi.org/10.1053/j.gastro.2007.08.045", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T11:27:51Z", "timestamp": 1574508471816}, "reference-count": 9, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1065, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2012, 10]]}, "DOI": "10.1002/hep.26031", "type": "journal-article", "created": {"date-parts": [[2012, 10, 5]], "date-time": "2012-10-05T02:36:16Z", "timestamp": 1349404576000}, "page": "1580-1584", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition?"], "prefix": "10.1002", "volume": "56", "author": [{"given": "Julia", "family": "Wattacheril", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 10, 4]]}, "reference": [{"key": "10.1002/hep.26031-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1002/hep.25762", "article-title": "The diagnosis and management of nonalcoholic fatty liver disease", "volume": "55", "author": "Chalasani", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1002/hep.26031-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.3109/07853890.2010.518623", "article-title": "Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", "volume": "43", "author": "Musso", "year": "2011", "journal-title": "Ann Med"}, {"key": "10.1002/hep.26031-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "d6891", "DOI": "10.1136/bmj.d6891", "article-title": "Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study", "volume": "343", "author": "Lazo", "year": "2011", "journal-title": "BMJ"}, {"key": "10.1002/hep.26031-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1053/j.gastro.2011.06.061", "article-title": "Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States", "volume": "141", "author": "Charlton", "year": "2011", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.26031-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease; a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.26031-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2263", "DOI": "10.1111/j.1572-0241.2008.02034.x", "article-title": "Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study", "volume": "103", "author": "Dunn", "year": "2008", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.26031-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1016/j.jhep.2008.06.018", "article-title": "Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease", "volume": "48", "author": "Ong", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.26031-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1053/j.gastro.2008.10.052", "article-title": "Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population", "volume": "136", "author": "Ruhl", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.26031-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/j.cgh.2011.12.039", "article-title": "Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US", "volume": "10", "author": "Stepanova", "year": "2012", "journal-title": "Clin Gastroenterol Hepatol"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.26031", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/hep.26031", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 2]], "date-time": "2018-08-02T00:28:32Z", "timestamp": 1533169712000}, "score": 59.599884, "issued": {"date-parts": [[2012, 10]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2012, 10]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/hep.26031", "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T15:48:46Z", "timestamp": 1575388126545}, "reference-count": 74, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2013, 11, 2]], "date-time": "2013-11-02T00:00:00Z", "timestamp": 1383350400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatol Int"], "published-print": {"date-parts": [[2013, 12]]}, "DOI": "10.1007/s12072-013-9480-x", "type": "journal-article", "created": {"date-parts": [[2013, 11, 1]], "date-time": "2013-11-01T08:37:06Z", "timestamp": 1383295026000}, "page": "755-764", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)"], "prefix": "10.1007", "volume": "7", "author": [{"given": "Ajay", "family": "Duseja", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 11, 2]]}, "reference": [{"key": "9480_CR1", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1136/gutjnl-2011-300342", "volume": "61", "author": "VW Wong", "year": "2012", "unstructured": "Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 2012;61:409\u2013415", "journal-title": "Gut"}, {"key": "9480_CR2", "doi-asserted-by": "crossref", "first-page": "6419", "DOI": "10.3748/wjg.13.6419", "volume": "13", "author": "YJ Zhou", "year": "2007", "unstructured": "Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007;13:6419\u20136424", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR3", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S1665-2681(19)31922-2", "volume": "6", "author": "D Amarapurkar", "year": "2007", "unstructured": "Amarapurkar D, Kamani P, Patel N, Gupte P, Kumar P, Agal S, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol 2007;6:161\u2013163", "journal-title": "Ann Hepatol"}, {"issue": "2", "key": "9480_CR4", "first-page": "76", "volume": "25", "author": "SP Singh", "year": "2004", "unstructured": "Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004;25(2):76\u201379", "journal-title": "Trop Gastroenterol"}, {"key": "9480_CR5", "doi-asserted-by": "crossref", "first-page": "84", "DOI": "10.1016/j.diabres.2008.11.039", "volume": "84", "author": "V Mohan", "year": "2009", "unstructured": "Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009;84:84\u201391", "journal-title": "Diabetes Res Clin Pract"}, {"key": "9480_CR6", "doi-asserted-by": "crossref", "first-page": "1593", "DOI": "10.1002/hep.23567", "volume": "51", "author": "K Das", "year": "2010", "unstructured": "Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010;51:1593\u20131602", "journal-title": "Hepatology"}, {"key": "9480_CR7", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1097/01.tp.0000250671.06456.3f", "volume": "83", "author": "K Yamamoto", "year": "2007", "unstructured": "Yamamoto K, Takada Y, Fujimoto Y, Haga H, Oike F, Kobayashi N, et al. Nonalcoholic steatohepatitis in donors for living donor liver transplantation. Transplantation 2007;83:257\u2013262", "journal-title": "Transplantation"}, {"key": "9480_CR8", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.jhep.2007.02.007", "volume": "47", "author": "JY Lee", "year": "2007", "unstructured": "Lee JY, Kim KM, Lee SG, Yu E, Lim YS, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239\u2013244", "journal-title": "J Hepatol"}, {"key": "9480_CR9", "doi-asserted-by": "crossref", "first-page": "2867", "DOI": "10.3748/wjg.14.2867", "volume": "14", "author": "R Jamali", "year": "2008", "unstructured": "Jamali R, Khonsari M, Merat S, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol 2008;14:2867\u20132871", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR10", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1111/j.1440-1746.2006.04615.x", "volume": "22", "author": "CH Chen", "year": "2007", "unstructured": "Chen CH, Huang MH, Yang JC, et al. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. J Gastroenterol Hepatol 2007;22:1482\u20131489", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR11", "doi-asserted-by": "crossref", "first-page": "1291", "DOI": "10.1111/j.1440-1746.2004.03446.x", "volume": "19", "author": "K Madan", "year": "2004", "unstructured": "Madan K, Batra Y, Panda SK, Dattagupta S, Hazari S, Jha JK, et al. Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: implications in diagnostic approach. J Gastroenterol Hepatol 2004;19:1291\u20131299", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR12", "first-page": "130", "volume": "25", "author": "DN Amarapurkar", "year": "2004", "unstructured": "Amarapurkar DN, Patel ND. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferases values. Trop Gastroenterol 2004;25:130\u2013134", "journal-title": "Trop Gastroenterol"}, {"key": "9480_CR13", "first-page": "2005", "volume": "50", "author": "H Sakugawa", "year": "2003", "unstructured": "Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Yamashiro T, Maeshiro T, et al. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan. Hepatogastroenterology 2003;50:2005\u20132008", "journal-title": "Hepatogastroenterology"}, {"key": "9480_CR14", "first-page": "3", "volume": "23", "author": "D Amrapurkar", "year": "2002", "unstructured": "Amrapurkar D, Das HS. Chronic liver disease in diabetes mellitus. Trop Gastroenterol 2002;23:3\u20135", "journal-title": "Trop Gastroenterol"}, {"key": "9480_CR15", "doi-asserted-by": "crossref", "first-page": "2248", "DOI": "10.1002/hep.23838", "volume": "52", "author": "A Duseja", "year": "2010", "unstructured": "Duseja A, Sharma B, Kumar A, Kapil S, Das A, Dhiman RK, et al. Nonalcoholic fatty liver in a developing country is responsible for significant liver disease. Hepatology 2010;52:2248\u20132249", "journal-title": "Hepatology"}, {"key": "9480_CR16", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/j.humpath.2009.06.021", "volume": "41", "author": "NC Nayak", "year": "2010", "unstructured": "Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol 2010;41:425\u2013430", "journal-title": "Hum Pathol"}, {"key": "9480_CR17", "doi-asserted-by": "crossref", "first-page": "967", "DOI": "10.1007/s00535-008-2264-8", "volume": "43", "author": "H Abe", "year": "2008", "unstructured": "Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008;43:967\u2013974", "journal-title": "J Gastroenterol"}, {"key": "9480_CR18", "first-page": "45", "volume": "45", "author": "KC Oh", "year": "2005", "unstructured": "Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, et al. Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea? Korean J Gastroenterol 2005;45:45\u201351", "journal-title": "Korean J Gastroenterol"}, {"key": "9480_CR19", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.3904/kjim.2012.27.1.47", "volume": "27", "author": "HY Song", "year": "2012", "unstructured": "Song HY, Lee HK, Lee JS, Kim JY, Yim YH, Song TJ, et al. Risk factors of cryptogenic hepatocellular carcinoma in patients with low body mass index or without metabolic syndrome. Korean J Intern Med 2012;27:47\u201352", "journal-title": "Korean J Intern Med"}, {"key": "9480_CR20", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1111/jgh.12116", "volume": "28", "author": "J Alexander", "year": "2013", "unstructured": "Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol 2013;28:848\u2013854", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR21", "doi-asserted-by": "crossref", "first-page": "1436", "DOI": "10.3748/wjg.v16.i12.1436", "volume": "16", "author": "Y Takuma", "year": "2010", "unstructured": "Takuma Y, Nouso K. Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World J Gastroenterol 2010;16:1436\u20131441", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR22", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1016/j.jhep.2005.02.042", "volume": "43", "author": "JG Fan", "year": "2005", "unstructured": "Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005;43:508\u2013514", "journal-title": "J Hepatol"}, {"key": "9480_CR23", "doi-asserted-by": "crossref", "first-page": "3400", "DOI": "10.3748/wjg.v12.i21.3400", "volume": "12", "author": "K Madan", "year": "2006", "unstructured": "Madan K, Batra Y, Gupta SD, Chander B, Rajan KD, Tewatia MS, et al. Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. World J Gastroenterol 2006;12:3400\u20133405", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR24", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.4254/wjh.v4.i7.209", "volume": "4", "author": "G Bhat", "year": "2012", "unstructured": "Bhat G, Baba CS, Pandey A, Kumari N, Choudhuri G. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J Hepatol 2012;4:209\u2013217", "journal-title": "World J Hepatol"}, {"key": "9480_CR25", "doi-asserted-by": "crossref", "first-page": "2368", "DOI": "10.1007/s10620-006-9136-y", "volume": "52", "author": "A Duseja", "year": "2007", "unstructured": "Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci 2007;52:2368\u20132374", "journal-title": "Dig Dis Sci"}, {"issue": "1 Pt 1", "key": "9480_CR26", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1111/j.1440-1746.2005.04086.x", "volume": "21", "author": "SH Park", "year": "2006", "unstructured": "Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21(1 Pt 1):138\u2013143", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR27", "doi-asserted-by": "crossref", "first-page": "372", "DOI": "10.1002/hep.20554", "volume": "41", "author": "SR Weston", "year": "2005", "unstructured": "Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005;41:372\u2013379", "journal-title": "Hepatology"}, {"key": "9480_CR28", "doi-asserted-by": "crossref", "first-page": "1106", "DOI": "10.3748/wjg.v9.i5.1106", "volume": "9", "author": "L Shen", "year": "2003", "unstructured": "Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, et al. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003;9:1106\u20131110", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR29", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.3748/wjg.v13.i4.649", "volume": "13", "author": "A Duseja", "year": "2007", "unstructured": "Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, et al. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol 2007;13:649\u2013650", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR30", "doi-asserted-by": "crossref", "first-page": "954", "DOI": "10.1007/s00535-003-1178-8", "volume": "38", "author": "S Kojima", "year": "2003", "unstructured": "Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12\u00a0years: analysis of clinical background. J Gastroenterol 2003;38:954\u2013961", "journal-title": "J Gastroenterol"}, {"key": "9480_CR31", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1056/NEJMoa0907295", "volume": "362", "author": "KF Petersen", "year": "2010", "unstructured": "Petersen KF, Dufour S, Hariri A, et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010;362:1082\u20131089", "journal-title": "N Engl J Med"}, {"key": "9480_CR32", "doi-asserted-by": "crossref", "first-page": "18273", "DOI": "10.1073/pnas.0608537103", "volume": "103", "author": "KF Petersen", "year": "2006", "unstructured": "Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci 2006;103:18273\u201318277", "journal-title": "Proc Natl Acad Sci"}, {"key": "9480_CR33", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1053/jhep.2002.33892", "volume": "36", "author": "S Chitturi", "year": "2002", "unstructured": "Chitturi S, Weltman M, Farrell GC, et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002;36:142\u2013149", "journal-title": "Hepatology"}, {"key": "9480_CR34", "doi-asserted-by": "crossref", "first-page": "654", "DOI": "10.1007/s00535-003-1361-y", "volume": "39", "author": "N Yamauchi", "year": "2004", "unstructured": "Yamauchi N, Itoh Y, Tanaka Y, et al. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE mutation in Japanese patients with nonalcoholic steatohepatitis. J Gastroenterol 2004;39:654\u2013660", "journal-title": "J Gastroenterol"}, {"key": "9480_CR35", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.3748/wjg.v11.i3.393", "volume": "21", "author": "A Duseja", "year": "2005", "unstructured": "Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol 2005;21:393\u2013395", "journal-title": "World J Gastroenterol"}, {"key": "9480_CR36", "doi-asserted-by": "crossref", "first-page": "1730", "DOI": "10.1007/s10620-005-9041-9", "volume": "51", "author": "A Duseja", "year": "2006", "unstructured": "Duseja A, Das R, Das A, Dhiman RK, Chawla Y, Garewal G. Serum iron and hepatic ironoverload in patients with nonalcoholic steatohepatitis. Dig Dis Sci 2006;51:1730\u20131731", "journal-title": "Dig Dis Sci"}, {"key": "9480_CR37", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1002/hep.24072", "volume": "53", "author": "J Kozlitina", "year": "2011", "unstructured": "Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 2011;53:467\u2013474", "journal-title": "Hepatology"}, {"key": "9480_CR38", "doi-asserted-by": "crossref", "first-page": "1409", "DOI": "10.1016/j.jhep.2011.03.035", "volume": "55", "author": "L Valenti", "year": "2011", "unstructured": "Valenti L, Nobili V, Al-Serri A, et al. The APOC3 T\u2013455C and C\u2013482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148\u00a0M genotype in patients with nonalcoholic fatty liver. J Hepatol 2011;55:1409\u20131414", "journal-title": "J Hepatol"}, {"key": "9480_CR39", "doi-asserted-by": "crossref", "first-page": "848", "DOI": "10.1111/j.1440-1746.2012.07103.x", "volume": "27", "author": "A Duseja", "year": "2012", "unstructured": "Duseja A, Aggarwal R. APOC3 and PNPLA3 in non-alcoholic fatty liver disease: need to clear the air. J Gastroenterol Hepatol 2012;27:848\u2013851", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "6", "key": "9480_CR40", "doi-asserted-by": "crossref", "first-page": "716", "DOI": "10.1038/ng.156", "volume": "40", "author": "JC Chambers", "year": "2008", "unstructured": "Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008;40(6):716\u2013718", "journal-title": "Nat Genet"}, {"key": "9480_CR41", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1002/hep.24659", "volume": "55", "author": "Y Li", "year": "2012", "unstructured": "Li Y, Xing C, Cohen JC, Hobbs HH. Genetic variant in PNPLA3 is associated with nonalcoholic fatty liver disease in China. Hepatology 2012;55:327\u2013328", "journal-title": "Hepatology"}, {"key": "9480_CR42", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1016/j.jpeds.2010.11.016", "volume": "158", "author": "YC Lin", "year": "2011", "unstructured": "Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr 2011;158:740\u2013744", "journal-title": "J Pediatr"}, {"key": "9480_CR43", "doi-asserted-by": "crossref", "first-page": "e38322", "DOI": "10.1371/journal.pone.0038322", "volume": "7", "author": "T Kawaguchi", "year": "2012", "unstructured": "Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One 2012;7:e38322", "journal-title": "PLoS One"}, {"key": "9480_CR44", "doi-asserted-by": "crossref", "first-page": "788", "DOI": "10.1111/j.1440-1746.2007.05042.x", "volume": "22", "author": "DN Amarapurkar", "year": "2007", "unstructured": "Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liverdisease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007;22:788\u2013793", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "Suppl", "key": "9480_CR45", "first-page": "A402", "volume": "19", "author": "A Duseja", "year": "2004", "unstructured": "Duseja A, Bhansali A, Bhadada S, Jain P, Dhiman RK, Chawla Y. Nonalcoholic fatty liver disease in patients with recent onset type 2 diabetes mellitus [abstract]. J Gastroenterol Hepatol 2004;19(Suppl):A402", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR46", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1111/j.1440-1746.2004.03312.x", "volume": "19", "author": "P Gupte", "year": "2004", "unstructured": "Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, et al. Hafeezunnisa. Non alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004;19:854\u2013858", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR47", "doi-asserted-by": "crossref", "first-page": "663", "DOI": "10.1111/j.1440-1746.2007.04892.x", "volume": "22", "author": "JG Fan", "year": "2007", "unstructured": "Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol 2007;22:663\u2013668", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR48", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/j.atherosclerosis.2008.07.024", "volume": "203", "author": "KC Sung", "year": "2009", "unstructured": "Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2009;203:581\u2013586", "journal-title": "Atherosclerosis"}, {"key": "9480_CR49", "doi-asserted-by": "crossref", "first-page": "2940", "DOI": "10.2337/dc07-0792", "volume": "30", "author": "M Shibata", "year": "2007", "unstructured": "Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007;30:2940\u20132944", "journal-title": "Diabetes Care"}, {"key": "9480_CR50", "doi-asserted-by": "crossref", "first-page": "1086", "DOI": "10.1111/j.1440-1746.2006.04781.x", "volume": "22", "author": "JG Fan", "year": "2007", "unstructured": "Fan JG, Li F, Cai XB, Peng YD, Ao QH, Gao Y. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J Gastroenterol Hepatol 2007;22:1086\u20131091", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "47", "key": "9480_CR51", "first-page": "586", "volume": "2012", "author": "Y Eguchi", "year": "2009", "unstructured": "Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, et al. JSG-NAFLD. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2009;2012(47):586\u2013595", "journal-title": "J Gastroenterol"}, {"key": "9480_CR52", "doi-asserted-by": "crossref", "first-page": "1457", "DOI": "10.1007/s11695-008-9423-0", "volume": "17", "author": "HL Huang", "year": "2007", "unstructured": "Huang HL, Lin WY, Lee LT, Wang HH, Lee WJ, Huang KC. Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects. Obes Surg 2007;17:1457\u20131463", "journal-title": "Obes Surg"}, {"key": "9480_CR53", "first-page": "311", "volume": "48", "author": "DN Amarapurkar", "year": "2000", "unstructured": "Amarapurkar DN, Amarapurkar AD. Nonalcoholic steatohepatitis: clinicopathological profile. J Assoc Physicians India 2000;48:311\u2013313", "journal-title": "J Assoc Physicians India"}, {"key": "9480_CR54", "first-page": "183", "volume": "20", "author": "SR Agarwal", "year": "2001", "unstructured": "Agarwal SR, Malhotra V, Sakhuja P, Sarin SK. Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol 2001;20:183\u2013186", "journal-title": "Indian J Gastroenterol"}, {"key": "9480_CR55", "first-page": "12", "volume": "23", "author": "A Duseja", "year": "2004", "unstructured": "Duseja A, Murlidharan R, Bhansali A, Sharma S, Das A, Das R, et al. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis\u2014a preliminary report. Indian J Gastroenterol 2004;23:12\u201315", "journal-title": "Indian J Gastroenterol"}, {"key": "9480_CR56", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1046/j.1467-789X.2002.00069.x", "volume": "3", "author": "M Deurenberg-Yap", "year": "2002", "unstructured": "Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev 2002;3:209\u2013215", "journal-title": "Obes Rev"}, {"key": "9480_CR57", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1038/sj.ijo.0801043", "volume": "23", "author": "GT Ko", "year": "1999", "unstructured": "Ko GT, Chan JC, Cockram CS, Woo J. Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999;23:1136\u20131142", "journal-title": "Int J Obes Relat Metab Disord"}, {"key": "9480_CR58", "doi-asserted-by": "crossref", "first-page": "277", "DOI": "10.1089/1540419031361390", "volume": "1", "author": "A Misra", "year": "2003", "unstructured": "Misra A, Misra R. Asian Indians and insulin resistance syndrome: global perspective. Metab Syndr Relat Disord 2003;1:277\u2013283", "journal-title": "Metab Syndr Relat Disord"}, {"key": "9480_CR59", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1038/sj.ijo.0801157", "volume": "24", "author": "SD Hsieh", "year": "2000", "unstructured": "Hsieh SD, Yoshinaga H, Muto T, Sakurai Y, Kosaka K. Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord 2000;24:358\u2013362", "journal-title": "Int J Obes Relat Metab Disord"}, {"key": "9480_CR60", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1016/S1665-2681(19)31461-9", "volume": "11", "author": "NS Choudhary", "year": "2012", "unstructured": "Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD). Ann Hepatol 2012;11:478\u2013486", "journal-title": "Ann Hepatol"}, {"key": "9480_CR61", "first-page": "46", "volume": "40", "author": "JM Hui", "year": "2004", "unstructured": "Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004;40:46\u201354", "journal-title": "Hepatology"}, {"key": "9480_CR62", "doi-asserted-by": "crossref", "first-page": "1825", "DOI": "10.1111/j.1440-1746.2005.04058.x", "volume": "20", "author": "JG Fan", "year": "2005", "unstructured": "Fan JG, Zhu J, Li XJ, Chen L, Lu YS, Li L, et al. Fatty liver and the metabolic syndrome among Shanghai adults. J Gastroenterol Hepatol 2005;20:1825\u20131832", "journal-title": "J Gastroenterol Hepatol"}, {"key": "9480_CR63", "first-page": "125", "volume": "25", "author": "DN Amarapurkar", "year": "2004", "unstructured": "Amarapurkar DN, Patel ND. Prevalence of metabolic syndrome in non-diabetic and non-cirrhotic patients with non-alcoholic steatohepatitis. Trop Gastroenterol 2004;25:125\u2013129", "journal-title": "Trop Gastroenterol"}, {"key": "9480_CR64", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.7326/0003-4819-143-10-200511150-00009", "volume": "143", "author": "M Hamaguchi", "year": "2005", "unstructured": "Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, et al. The metabolic syndrome as a predictor of non-alcoholic fatty liver disease. Ann Intern Med 2005;143:722\u2013728", "journal-title": "Ann Intern Med"}, {"key": "9480_CR65", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/hep.20543", "volume": "41", "author": "A Suzuki", "year": "2005", "unstructured": "Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, Okada T, et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 2005;41:64\u201371", "journal-title": "Hepatology"}, {"key": "9480_CR66", "doi-asserted-by": "crossref", "first-page": "960", "DOI": "10.1111/j.1572-0241.2003.07486.x", "volume": "98", "author": "JM Clark", "year": "2003", "unstructured": "Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960\u2013967", "journal-title": "Am J Gastroenterol"}, {"key": "9480_CR67", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1111/j.1572-0241.2005.00341.x", "volume": "101", "author": "GN Ioannou", "year": "2006", "unstructured": "Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999\u20132002. Am J Gastroenterol 2006;101:76\u201382", "journal-title": "Am J Gastroenterol"}, {"key": "9480_CR68", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1002/hep.20466", "volume": "40", "author": "JD Browning", "year": "2004", "unstructured": "Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387", "journal-title": "Hepatology"}, {"key": "9480_CR69", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1053/j.gastro.2010.09.038", "volume": "140", "author": "CD Williams", "year": "2011", "unstructured": "Williams CD, Stenger J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140:124\u2013131", "journal-title": "Gastroenterology"}, {"key": "9480_CR70", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1002/hep.21827", "volume": "46", "author": "G Bedogni", "year": "2007", "unstructured": "Bedogni G, Miglioli L, Masutti F, Castiglione A, Croce LS, Tiribelli C, et al. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 2007;46:1387\u2013191", "journal-title": "Hepatology"}, {"key": "9480_CR71", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1097/MEG.0b013e32832fcdf0", "volume": "22", "author": "L Caballeria", "year": "2010", "unstructured": "Caballeria L, Pera G, Antonia Auladell M, Toran P, Munoz L, Mirandac L, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol 2010;22:24\u201332", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "9480_CR72", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.jhep.2011.03.020", "volume": "56", "author": "MJ Armstrong", "year": "2012", "unstructured": "Armstrong MJ, Houlihan DD, Bentham L, Shaw JC, Cramb R, Olliff S, et al. Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort. J Hepatol 2012;56:234\u2013240", "journal-title": "J Hepatol"}, {"key": "9480_CR73", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.7861/clinmedicine.7-2-119", "volume": "7", "author": "S Whalley", "year": "2007", "unstructured": "Whalley S, Puvanachandra P, Desai A, Kennedy H. Hepatology outpatient service provision in secondary care. Clin Med 2007;7:119\u2013124", "journal-title": "Clin Med"}, {"key": "9480_CR74", "doi-asserted-by": "crossref", "first-page": "932", "DOI": "10.1136/bmj.38391.663287.E0", "volume": "330", "author": "S Bruno", "year": "2005", "unstructured": "Bruno S, Maisonnneuve P, Castellana P, Rotmensz N, Rossi S, Maggioni M, et al. Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 2005;330:932\u2013938", "journal-title": "BMJ"}], "container-title": ["Hepatology International"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12072-013-9480-x.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s12072-013-9480-x/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12072-013-9480-x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 31]], "date-time": "2019-07-31T22:01:51Z", "timestamp": 1564610511000}, "score": 59.599884, "issued": {"date-parts": [[2013, 11, 2]]}, "references-count": 74, "journal-issue": {"published-print": {"date-parts": [[2013, 12]]}, "issue": "S2"}, "alternative-id": ["9480"], "URL": "http://dx.doi.org/10.1007/s12072-013-9480-x", "relation": {"cites": []}, "ISSN": ["1936-0533", "1936-0541"], "issn-type": [{"value": "1936-0533", "type": "print"}, {"value": "1936-0541", "type": "electronic"}], "subject": ["Hepatology"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T20:06:12Z", "timestamp": 1575144372158}, "reference-count": 51, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 8, 1]], "date-time": "2004-08-01T00:00:00Z", "timestamp": 1091318400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinics in Liver Disease"], "published-print": {"date-parts": [[2004, 8]]}, "DOI": "10.1016/j.cld.2004.04.007", "type": "journal-article", "created": {"date-parts": [[2005, 4, 18]], "date-time": "2005-04-18T17:29:14Z", "timestamp": 1113845354000}, "page": "535-547", "source": "Crossref", "is-referenced-by-count": 37, "title": ["Nonalcoholic fatty liver disease in individuals with severe obesity"], "prefix": "10.1016", "volume": "8", "author": [{"given": "Paul", "family": "Haynes", "sequence": "first", "affiliation": []}, {"given": "Suthat", "family": "Liangpunsakul", "sequence": "additional", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinics in Liver Disease"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1089326104000376?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1089326104000376?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 27]], "date-time": "2019-01-27T03:58:05Z", "timestamp": 1548561485000}, "score": 59.550816, "issued": {"date-parts": [[2004, 8]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2004, 8]]}, "issue": "3"}, "alternative-id": ["S1089326104000376"], "URL": "http://dx.doi.org/10.1016/j.cld.2004.04.007", "ISSN": ["1089-3261"], "issn-type": [{"value": "1089-3261", "type": "print"}], "subject": ["Hepatology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:54:30Z", "timestamp": 1574459670591}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "01", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Semin Liver Dis"], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1055/s-0032-1306423", "type": "journal-article", "created": {"date-parts": [[2012, 3, 14]], "date-time": "2012-03-14T00:07:04Z", "timestamp": 1331683624000}, "page": "022-029", "source": "Crossref", "is-referenced-by-count": 78, "title": ["Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease"], "prefix": "10.1055", "volume": "32", "author": [{"given": "Hemant", "family": "Chatrath", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"}]}, {"given": "Raj", "family": "Vuppalanchi", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana"}]}], "member": "194", "published-online": {"date-parts": [[2012, 3, 13]]}, "container-title": ["Seminars in Liver Disease"], "language": "en", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1306423.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 23]], "date-time": "2017-05-23T00:50:20Z", "timestamp": 1495500620000}, "score": 58.650326, "issued": {"date-parts": [[2012, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 2]]}, "issue": "01"}, "URL": "http://dx.doi.org/10.1055/s-0032-1306423", "ISSN": ["0272-8087", "1098-8971"], "issn-type": [{"value": "0272-8087", "type": "print"}, {"value": "1098-8971", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:06:53Z", "timestamp": 1575176813145}, "reference-count": 148, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 944, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann. N.Y. Acad. Sci."], "published-print": {"date-parts": [[2013, 4]]}, "DOI": "10.1111/nyas.12016", "type": "journal-article", "created": {"date-parts": [[2013, 1, 30]], "date-time": "2013-01-30T22:31:12Z", "timestamp": 1359585072000}, "page": "106-122", "source": "Crossref", "is-referenced-by-count": 128, "title": ["Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals"], "prefix": "10.1111", "volume": "1281", "author": [{"given": "Howard C.", "family": "Masuoka", "sequence": "first", "affiliation": [{"name": "Division of Gastroenterology and Hepatology; Department of Medicine; Indiana University School of Medicine; Indianapolis; Indiana"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Division of Gastroenterology and Hepatology; Department of Medicine; Indiana University School of Medicine; Indianapolis; Indiana"}]}], "member": "311", "published-online": {"date-parts": [[2013, 1, 30]]}, "reference": [{"key": "10.1111/nyas.12016-BIB0001|nyas12016-cit-0001", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0002|nyas12016-cit-0002", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1002/hep.21327", "article-title": "Long-term follow-up of patients with NAFLD and elevated liver enzymes", "volume": "44", "author": "Ekstedt", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0003|nyas12016-cit-0003", "doi-asserted-by": "crossref", "first-page": "802", "DOI": "10.1002/hep.21391", "article-title": "Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious", "volume": "44", "author": "Ratziu", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0004|nyas12016-cit-0004", "doi-asserted-by": "crossref", "first-page": "664", "DOI": "10.1002/hep.510290347", "article-title": "Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease", "volume": "29", "author": "Caldwell", "year": "1999", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0005|nyas12016-cit-0005", "doi-asserted-by": "crossref", "first-page": "1048", "DOI": "10.1016/S1542-3565(04)00440-9", "article-title": "Nonalcoholic fatty liver disease: a review of current understanding and future impact", "volume": "2", "author": "Charlton", "year": "2004", "journal-title": "Clin. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0006|nyas12016-cit-0006", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1053/j.gastro.2011.06.061", "article-title": "Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States", "volume": "141", "author": "Charlton", "year": "2011", "journal-title": "Gastroenterology"}, {"issue": "Suppl 2", "key": "10.1111/nyas.12016-BIB0007|nyas12016-cit-0007", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1111/j.1440-1746.2011.07018.x", "article-title": "Pathophysiology guided treatment of nonalcoholic steatohepatitis", "volume": "27", "author": "Nguyen", "year": "2012", "journal-title": "J. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0008|nyas12016-cit-0008", "first-page": "131", "article-title": "Mechanisms of lipotoxicity in NAFLD and clinical implications", "volume": "53", "author": "Ibrahim", "year": "2011", "journal-title": "J. Pediatr. Gastroenterol. Nutr"}, {"key": "10.1111/nyas.12016-BIB0009|nyas12016-cit-0009", "doi-asserted-by": "crossref", "first-page": "1152", "DOI": "10.1136/gut.2010.218214", "article-title": "Non-alcoholic fatty liver disease: what's new under the microscope?", "volume": "60", "author": "Brunt", "year": "2011", "journal-title": "Gut"}, {"key": "10.1111/nyas.12016-BIB0010|nyas12016-cit-0010", "doi-asserted-by": "crossref", "first-page": "1519", "DOI": "10.1126/science.1204265", "article-title": "Human fatty liver disease: old questions and new insights", "volume": "332", "author": "Cohen", "year": "2011", "journal-title": "Science"}, {"key": "10.1111/nyas.12016-BIB0011|nyas12016-cit-0011", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1055/s-0031-1276643", "article-title": "Genetics of alcoholic and nonalcoholic fatty liver disease", "volume": "31", "author": "Anstee", "year": "2011", "journal-title": "Semin. Liver Dis"}, {"key": "10.1111/nyas.12016-BIB0012|nyas12016-cit-0012", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1007/s00535-012-0527-x", "article-title": "Inflammation and fibrogenesis in steatohepatitis", "volume": "47", "author": "Fujii", "year": "2012", "journal-title": "J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0013|nyas12016-cit-0013", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1053/j.gastro.2012.02.003", "article-title": "Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications", "volume": "142", "author": "Cusi", "year": "2012", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0014|nyas12016-cit-0014", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1097/PAP.0b013e318220f59b", "article-title": "Update on fatty liver disease and steatohepatitis", "volume": "18", "author": "Aly", "year": "2011", "journal-title": "Adv. Anat. Pathol"}, {"key": "10.1111/nyas.12016-BIB0015|nyas12016-cit-0015", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1002/hep.25762", "article-title": "The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association", "volume": "55", "author": "Chalasani", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0016|nyas12016-cit-0016", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/hep.20543", "article-title": "Chronological development of elevated aminotransferases in a nonalcoholic population", "volume": "41", "author": "Suzuki", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0017|nyas12016-cit-0017", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1038/hr.2010.45", "article-title": "Fatty liver incidence and predictive variables", "volume": "33", "author": "Tsuneto", "year": "2010", "journal-title": "Hyper Res"}, {"key": "10.1111/nyas.12016-BIB0018|nyas12016-cit-0018", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.7861/clinmedicine.7-2-119", "article-title": "Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs", "volume": "7", "author": "Whalley", "year": "2007", "journal-title": "Clin Med"}, {"key": "10.1111/nyas.12016-BIB0019|nyas12016-cit-0019", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1111/j.1365-2036.2011.04724.x", "article-title": "Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults", "volume": "34", "author": "Vernon", "year": "2011", "journal-title": "Aliment. Pharm. Ther"}, {"key": "10.1111/nyas.12016-BIB0020|nyas12016-cit-0020", "doi-asserted-by": "crossref", "first-page": "2410", "DOI": "10.1097/00007890-200006150-00034", "article-title": "Selection and outcome of living donors for adult to adult right lobe transplantation", "volume": "69", "author": "Marcos", "year": "2000", "journal-title": "Transplantation"}, {"key": "10.1111/nyas.12016-BIB0021|nyas12016-cit-0021", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1002/hep.20466", "article-title": "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", "volume": "40", "author": "Browning", "year": "2004", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0022|nyas12016-cit-0022", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.jhep.2007.02.007", "article-title": "Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center", "volume": "47", "author": "Lee", "year": "2007", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0023|nyas12016-cit-0023", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1631/jzus.B0720016", "article-title": "Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease", "volume": "9", "author": "Chen", "year": "2008", "journal-title": "J. Zhejiang Univ. Science B"}, {"key": "10.1111/nyas.12016-BIB0024|nyas12016-cit-0024", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S1665-2681(19)31922-2", "article-title": "Prevalence of non-alcoholic fatty liver disease: population based study", "volume": "6", "author": "Amarapurkar", "year": "2007", "journal-title": "Ann. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0025|nyas12016-cit-0025", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1016/S1665-2681(19)31616-3", "article-title": "Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens", "volume": "9", "author": "Gutierrez-Grobe", "year": "2010", "journal-title": "Ann. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0026|nyas12016-cit-0026", "first-page": "411", "article-title": "Fatty metamorphosis of the liver associated with jejunoileal bypass. Report of five cases", "volume": "101", "author": "Piepkorn", "year": "1977", "journal-title": "Arch. Pathol. Lab. Med"}, {"key": "10.1111/nyas.12016-BIB0027|nyas12016-cit-0027", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1093/ajcp/63.3.318", "article-title": "Post-jejunoileal-bypass hepatic disease. Its similarity to alcoholic hepatic disease", "volume": "63", "author": "Peters", "year": "1975", "journal-title": "Am. J. Clin. Pathol"}, {"key": "10.1111/nyas.12016-BIB0028|nyas12016-cit-0028", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1007/s00534-009-0187-2", "article-title": "Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system", "volume": "17", "author": "Kato", "year": "2010", "journal-title": "J. Hepato-biliary-pancreatic sciences"}, {"key": "10.1111/nyas.12016-BIB0029|nyas12016-cit-0029", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.1381/0960892055002347", "article-title": "Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass", "volume": "15", "author": "Boza", "year": "2005", "journal-title": "Obes. Surg"}, {"key": "10.1111/nyas.12016-BIB0030|nyas12016-cit-0030", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1179/acb.2009.084", "article-title": "Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics", "volume": "64", "author": "Haentjens", "year": "2009", "journal-title": "Acta clinica Belgica"}, {"key": "10.1111/nyas.12016-BIB0031|nyas12016-cit-0031", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1001/archsurg.138.11.1240", "article-title": "Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery", "volume": "138", "author": "Beymer", "year": "2003", "journal-title": "Arch. Surg"}, {"key": "10.1111/nyas.12016-BIB0032|nyas12016-cit-0032", "first-page": "236", "article-title": "Endocrine and liver interaction: the role of endocrine pathways in NASH", "volume": "6", "author": "Loria", "year": "2009", "journal-title": "Nat. Revs"}, {"key": "10.1111/nyas.12016-BIB0033|nyas12016-cit-0033", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1210/en.2010-0537", "article-title": "GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism", "volume": "152", "author": "Barclay", "year": "2011", "journal-title": "Endocrinology"}, {"key": "10.1111/nyas.12016-BIB0034|nyas12016-cit-0034", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1097/01.mcg.0000225583.32588.5e", "article-title": "Nonalcoholic fatty liver disease induced by leuprorelin acetate", "volume": "42", "author": "Gabbi", "year": "2008", "journal-title": "J. Clin. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0035|nyas12016-cit-0035", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1111/j.1440-1746.2008.05740.x", "article-title": "An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome", "volume": "24", "author": "Brzozowska", "year": "2009", "journal-title": "J. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0036|nyas12016-cit-0036", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1038/ajg.2011.327", "article-title": "Large-scale long-term follow-up study of Japanese patients with non-alcoholic fatty liver disease for the onset of hepatocellular carcinoma", "volume": "107", "author": "Kawamura", "year": "2012", "journal-title": "Am. J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0037|nyas12016-cit-0037", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1136/gut.2009.205088", "article-title": "Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years", "volume": "59", "author": "Wong", "year": "2010", "journal-title": "Gut"}, {"key": "10.1111/nyas.12016-BIB0038|nyas12016-cit-0038", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1023/A:1005661516165", "article-title": "Fatty infiltration of liver in hyperlipidemic patients", "volume": "45", "author": "Assy", "year": "2000", "journal-title": "Digest. Dis. Sci"}, {"key": "10.1111/nyas.12016-BIB0039|nyas12016-cit-0039", "doi-asserted-by": "crossref", "first-page": "462", "DOI": "10.1007/s00535-006-1790-5", "article-title": "Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease", "volume": "41", "author": "Eguchi", "year": "2006", "journal-title": "J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0040|nyas12016-cit-0040", "doi-asserted-by": "crossref", "first-page": "2735", "DOI": "10.1161/CIRCULATIONAHA.105.169404", "article-title": "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement", "volume": "112", "author": "Grundy", "year": "2005", "journal-title": "Circulation"}, {"key": "10.1111/nyas.12016-BIB0041|nyas12016-cit-0041", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1210/jc.84.5.1513", "article-title": "Liver pathology and the metabolic syndrome X in severe obesity", "volume": "84", "author": "Marceau", "year": "1999", "journal-title": "J. Clin. Endocrinol. Metabol"}, {"key": "10.1111/nyas.12016-BIB0042|nyas12016-cit-0042", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.7326/0003-4819-143-10-200511150-00009", "article-title": "The metabolic syndrome as a predictor of nonalcoholic fatty liver disease", "volume": "143", "author": "Hamaguchi", "year": "2005", "journal-title": "Ann. Int. Med"}, {"key": "10.1111/nyas.12016-BIB0043|nyas12016-cit-0043", "doi-asserted-by": "crossref", "first-page": "3140", "DOI": "10.2337/diabetes.54.11.3140", "article-title": "Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study", "volume": "54", "author": "Hanley", "year": "2005", "journal-title": "Diabetes"}, {"key": "10.1111/nyas.12016-BIB0044|nyas12016-cit-0044", "doi-asserted-by": "crossref", "first-page": "1389", "DOI": "10.1002/hep.25539", "article-title": "Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease", "volume": "55", "author": "Lomonaco", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0045|nyas12016-cit-0045", "doi-asserted-by": "crossref", "first-page": "933", "DOI": "10.1002/hep.25739", "article-title": "Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism", "volume": "56", "author": "Musso", "year": "2012", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0046|nyas12016-cit-0046", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1016/j.jhep.2010.04.030", "article-title": "Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes", "volume": "53", "author": "Targher", "year": "2010", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0047|nyas12016-cit-0047", "first-page": "454", "article-title": "Hepatic steatosis in type 1 diabetes", "volume": "8", "author": "Regnell", "year": "2011", "journal-title": "RDS"}, {"key": "10.1111/nyas.12016-BIB0048|nyas12016-cit-0048", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.2337/dc10-1991", "article-title": "Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study", "volume": "34", "author": "Bae", "year": "2011", "journal-title": "Diabetes Care"}, {"key": "10.1111/nyas.12016-BIB0049|nyas12016-cit-0049", "doi-asserted-by": "crossref", "first-page": "371", "DOI": "10.1016/j.jhep.2009.03.019", "article-title": "Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis", "volume": "51", "author": "Argo", "year": "2009", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0050|nyas12016-cit-0050", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.3109/07853890.2010.518623", "article-title": "Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", "volume": "43", "author": "Musso", "year": "2011", "journal-title": "Ann. Med"}, {"key": "10.1111/nyas.12016-BIB0051|nyas12016-cit-0051", "doi-asserted-by": "crossref", "first-page": "1208", "DOI": "10.1002/hep.24491", "article-title": "The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study", "volume": "54", "author": "Bhala", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0052|nyas12016-cit-0052", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1002/hep.510300604", "article-title": "Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis", "volume": "30", "author": "Angulo", "year": "1999", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0053|nyas12016-cit-0053", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1097/00004836-200608000-00015", "article-title": "Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase", "volume": "40", "author": "Pantsari", "year": "2006", "journal-title": "J. Clin Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0054|nyas12016-cit-0054", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.jhep.2011.03.020", "article-title": "Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort", "volume": "56", "author": "Armstrong", "year": "2012", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0055|nyas12016-cit-0055", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/j.jhep.2004.09.012", "article-title": "The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies", "volume": "42", "author": "Adams", "year": "2005", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0056|nyas12016-cit-0056", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1002/hep.22603", "article-title": "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management", "volume": "49", "author": "Vuppalanchi", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0057|nyas12016-cit-0057", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1007/s12072-011-9277-8", "article-title": "Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network", "volume": "6", "author": "Vuppalanchi", "year": "2011", "journal-title": "Hepatol. Int"}, {"key": "10.1111/nyas.12016-BIB0058|nyas12016-cit-0058", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1002/hep.21496", "article-title": "The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD", "volume": "45", "author": "Angulo", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0059|nyas12016-cit-0059", "doi-asserted-by": "crossref", "first-page": "1704", "DOI": "10.1053/j.gastro.2004.08.052", "article-title": "Serum markers detect the presence of liver fibrosis: a cohort study", "volume": "127", "author": "Rosenberg", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0060|nyas12016-cit-0060", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1002/hep.21984", "article-title": "Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers", "volume": "47", "author": "Guha", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0061|nyas12016-cit-0061", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/hep.21223", "article-title": "In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease", "volume": "44", "author": "Wieckowska", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0062|nyas12016-cit-0062", "doi-asserted-by": "crossref", "first-page": "184", "DOI": "10.1259/0007-1285-52-615-184", "article-title": "Ultrasound in the detection of chronic liver disease (the \u201cbright liver\u201d)", "volume": "52", "author": "Joseph", "year": "1979", "journal-title": "British J. Radiol"}, {"key": "10.1111/nyas.12016-BIB0063|nyas12016-cit-0063", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/S0009-9260(05)80350-2", "article-title": "Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease", "volume": "43", "author": "Joseph", "year": "1991", "journal-title": "Clin. Radiol"}, {"key": "10.1111/nyas.12016-BIB0064|nyas12016-cit-0064", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1016/j.dld.2006.03.021", "article-title": "The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis", "volume": "38", "author": "Palmentieri", "year": "2006", "journal-title": "Digest. Liver Dis"}, {"key": "10.1111/nyas.12016-BIB0065|nyas12016-cit-0065", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.2214/ajr.171.3.9725292", "article-title": "Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT", "volume": "171", "author": "Jacobs", "year": "1998", "journal-title": "AJR"}, {"key": "10.1111/nyas.12016-BIB0066|nyas12016-cit-0066", "doi-asserted-by": "crossref", "first-page": "1465", "DOI": "10.1148/radiographics.18.6.9821195", "article-title": "Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance", "volume": "18", "author": "Outwater", "year": "1998", "journal-title": "Radiographics"}, {"key": "10.1111/nyas.12016-BIB0067|nyas12016-cit-0067", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1148/radiol.2393042218", "article-title": "Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings", "volume": "240", "author": "Kim", "year": "2006", "journal-title": "Radiology"}, {"key": "10.1111/nyas.12016-BIB0068|nyas12016-cit-0068", "doi-asserted-by": "crossref", "first-page": "E462", "DOI": "10.1152/ajpendo.00064.2004", "article-title": "Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population", "volume": "288", "author": "Szczepaniak", "year": "2005", "journal-title": "Am. J. Physiol. Endocrinol. Metab"}, {"key": "10.1111/nyas.12016-BIB0069|nyas12016-cit-0069", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.2214/AJR.11.6729", "article-title": "MRI steatosis grading: development and initial validation of a color mapping system", "volume": "198", "author": "Qayyum", "year": "2012", "journal-title": "AJR"}, {"key": "10.1111/nyas.12016-BIB0070|nyas12016-cit-0070", "doi-asserted-by": "crossref", "first-page": "415", "DOI": "10.1111/j.1440-1746.2010.06614.x", "article-title": "Education and imaging: hepatobiliary and pancreatic: focal steatohepatitis mimicking a metastasis", "volume": "26", "author": "Choi", "year": "2011", "journal-title": "J. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0071|nyas12016-cit-0071", "doi-asserted-by": "crossref", "first-page": "e10", "DOI": "10.1053/j.gastro.2009.09.072", "article-title": "Evaluation of a focal lesion in the liver. answer to the clinical challenges and images in GI question: image 3: Focal fatty infiltration", "volume": "139", "author": "Tharayil", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0072|nyas12016-cit-0072", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1067/j.cpradiol.2009.05.001", "article-title": "Gamut of focal fatty lesions in the liver: imaging manifestations with emphasis on magnetic resonance imaging", "volume": "39", "author": "Fasih", "year": "2010", "journal-title": "Curr. Prob. Diag. Radiol"}, {"key": "10.1111/nyas.12016-BIB0073|nyas12016-cit-0073", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/j.ejrad.2006.11.005", "article-title": "Imaging of hepatic steatosis and fatty sparing", "volume": "61", "author": "Karcaaltincaba", "year": "2007", "journal-title": "Eur. J. Radiol"}, {"key": "10.1111/nyas.12016-BIB0074|nyas12016-cit-0074", "doi-asserted-by": "crossref", "first-page": "1637", "DOI": "10.1148/rg.266065004", "article-title": "Fatty liver: imaging patterns and pitfalls", "volume": "26", "author": "Hamer", "year": "2006", "journal-title": "Radiographics"}, {"key": "10.1111/nyas.12016-BIB0075|nyas12016-cit-0075", "doi-asserted-by": "crossref", "first-page": "454", "DOI": "10.1002/hep.23312", "article-title": "Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease", "volume": "51", "author": "Wong", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0076|nyas12016-cit-0076", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1002/hep.20701", "article-title": "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", "volume": "41", "author": "Kleiner", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0077|nyas12016-cit-0077", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1055/s-2004-823098", "article-title": "Nonalcoholic steatohepatitis", "volume": "24", "author": "Brunt", "year": "2004", "journal-title": "Semin. liver Dis"}, {"key": "10.1111/nyas.12016-BIB0078|nyas12016-cit-0078", "first-page": "434", "article-title": "Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease", "volume": "55", "author": "Ludwig", "year": "1980", "journal-title": "Mayo Clin. Proc"}, {"key": "10.1111/nyas.12016-BIB0079|nyas12016-cit-0079", "doi-asserted-by": "crossref", "first-page": "2467", "DOI": "10.1111/j.1572-0241.1999.01377.x", "article-title": "Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions", "volume": "94", "author": "Brunt", "year": "1999", "journal-title": "Am. J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0080|nyas12016-cit-0080", "doi-asserted-by": "crossref", "first-page": "810", "DOI": "10.1002/hep.24127", "article-title": "Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings", "volume": "53", "author": "Brunt", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0081|nyas12016-cit-0081", "doi-asserted-by": "crossref", "first-page": "1898", "DOI": "10.1053/j.gastro.2005.03.084", "article-title": "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", "volume": "128", "author": "Ratziu", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0082|nyas12016-cit-0082", "doi-asserted-by": "crossref", "first-page": "874", "DOI": "10.1002/hep.21346", "article-title": "Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease", "volume": "44", "author": "Merriman", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0083|nyas12016-cit-0083", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1586/egh.11.6", "article-title": "Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications", "volume": "5", "author": "Alkhouri", "year": "2011", "journal-title": "Expert Rev. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0084|nyas12016-cit-0084", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.1055/s-0030-1267539", "article-title": "Novel insights into the pathophysiology of nonalcoholic fatty liver disease", "volume": "30", "author": "Feldstein", "year": "2010", "journal-title": "Semin. liver Dis"}, {"key": "10.1111/nyas.12016-BIB0085|nyas12016-cit-0085", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1016/S0016-5085(98)70599-2", "article-title": "Steatohepatitis: a tale of two \u201chits\u201d?", "volume": "114", "author": "Day", "year": "1998", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0086|nyas12016-cit-0086", "first-page": "2775", "article-title": "Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model", "volume": "6:e2", "author": "Gorden", "year": "2011", "journal-title": "PloS one"}, {"key": "10.1111/nyas.12016-BIB0087|nyas12016-cit-0087", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.2337/db08-1074", "article-title": "Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver", "volume": "58", "author": "Kotronen", "year": "2009", "journal-title": "Diabetes"}, {"key": "10.1111/nyas.12016-BIB0088|nyas12016-cit-0088", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1016/j.freeradbiomed.2011.10.003", "article-title": "Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis", "volume": "52", "author": "Rolo", "year": "2012", "journal-title": "Free Rad. Biol. Med"}, {"key": "10.1111/nyas.12016-BIB0089|nyas12016-cit-0089", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1089/met.2010.0140", "article-title": "Oxidative stress is activated by free fatty acids in cultured human hepatocytes", "volume": "9", "author": "Soardo", "year": "2011", "journal-title": "Metab. Synd. related Disord"}, {"key": "10.1111/nyas.12016-BIB0090|nyas12016-cit-0090", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.1055/s-0028-1091980", "article-title": "Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease", "volume": "28", "author": "Malhi", "year": "2008", "journal-title": "Semin. liver Dis"}, {"key": "10.1111/nyas.12016-BIB0091|nyas12016-cit-0091", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1586/egh.11.4", "article-title": "Autophagy in nonalcoholic steatohepatitis", "volume": "5", "author": "Amir", "year": "2011", "journal-title": "Exp. Rev. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0092|nyas12016-cit-0092", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1016/j.clinbiochem.2012.03.024", "article-title": "Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation", "volume": "45", "author": "Grattagliano", "year": "2012", "journal-title": "Clin. Biochem"}, {"key": "10.1111/nyas.12016-BIB0093|nyas12016-cit-0093", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.3748/wjg.14.487", "article-title": "Natural killer T cells and non-alcoholic fatty liver disease: fat chews on the immune system", "volume": "14", "author": "Kremer", "year": "2008", "journal-title": "WJG"}, {"key": "10.1111/nyas.12016-BIB0094|nyas12016-cit-0094", "doi-asserted-by": "crossref", "first-page": "4652", "DOI": "10.3748/wjg.v16.i37.4652", "article-title": "Roles of liver innate immune cells in nonalcoholic fatty liver disease", "volume": "16", "author": "Zhan", "year": "2010", "journal-title": "WJG"}, {"key": "10.1111/nyas.12016-BIB0095|nyas12016-cit-0095", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.3748/wjg.v18.i8.727", "article-title": "Role of cytokines and chemokines in non-alcoholic fatty liver disease", "volume": "18", "author": "Braunersreuther", "year": "2012", "journal-title": "WJG"}, {"key": "10.1111/nyas.12016-BIB0096|nyas12016-cit-0096", "doi-asserted-by": "crossref", "first-page": "622", "DOI": "10.1111/j.1440-1746.2012.07084.x", "article-title": "Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis?", "volume": "27", "author": "Ono", "year": "2012", "journal-title": "J. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0097|nyas12016-cit-0097", "doi-asserted-by": "crossref", "first-page": "1408", "DOI": "10.1016/0016-5085(90)91169-7", "article-title": "Effect of weight reduction on hepatic abnormalities in overweight patients", "volume": "99", "author": "Palmer", "year": "1990", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0098|nyas12016-cit-0098", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.3346/jkms.1995.10.6.414", "article-title": "Effect of weight control on hepatic abnormalities in obese patients with fatty liver", "volume": "10", "author": "Park", "year": "1995", "journal-title": "J. Kor. Med. Sci"}, {"key": "10.1111/nyas.12016-BIB0099|nyas12016-cit-0099", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0168-8278(97)80287-5", "article-title": "Therapeutic effects of restricted diet and exercise in obese patients with fatty liver", "volume": "27", "author": "Ueno", "year": "1997", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0100|nyas12016-cit-0100", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1002/hep.22575", "article-title": "Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial", "volume": "49", "author": "Harrison", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0101|nyas12016-cit-0101", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1002/hep.23276", "article-title": "Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis", "volume": "51", "author": "Promrat", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0102|nyas12016-cit-0102", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1016/0168-8278(91)90942-5", "article-title": "Hepatic effects of dietary weight loss in morbidly obese subjects", "volume": "12", "author": "Andersen", "year": "1991", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0103|nyas12016-cit-0103", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1053/j.gastro.2009.04.052", "article-title": "Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease", "volume": "137", "author": "Mathurin", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0104|nyas12016-cit-0104", "doi-asserted-by": "crossref", "first-page": "1396", "DOI": "10.1016/j.cgh.2008.08.012", "article-title": "Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis", "volume": "6", "author": "Mummadi", "year": "2008", "journal-title": "Clin. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0105|nyas12016-cit-0105", "author": "Chavez-Tapia", "first-page": "CD007340", "year": "2010", "article-title": "Bariatric surgery for non-alcoholic steatohepatitis in obese patients", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1111/nyas.12016-BIB0106|nyas12016-cit-0106", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1186/1423-0127-19-26", "article-title": "Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress", "volume": "19", "author": "Rezazadeh", "year": "2012", "journal-title": "J. Biomed. Sci"}, {"key": "10.1111/nyas.12016-BIB0107|nyas12016-cit-0107", "doi-asserted-by": "crossref", "first-page": "815", "DOI": "10.1016/j.clinbiochem.2010.04.003", "article-title": "Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes", "volume": "43", "author": "Narasimhan", "year": "2010", "journal-title": "Clin. Biochem"}, {"key": "10.1111/nyas.12016-BIB0108|nyas12016-cit-0108", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1056/NEJMoa0907929", "article-title": "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis", "volume": "362", "author": "Sanyal", "year": "2010", "journal-title": "N. Engl. J. Med"}, {"key": "10.1111/nyas.12016-BIB0109|nyas12016-cit-0109", "doi-asserted-by": "crossref", "first-page": "1549", "DOI": "10.1001/jama.2011.1437", "article-title": "Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)", "volume": "306", "author": "Klein", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1111/nyas.12016-BIB0110|nyas12016-cit-0110", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.7326/0003-4819-142-1-200501040-00110", "article-title": "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality", "volume": "142", "author": "Miller", "year": "2005", "journal-title": "Ann. Int. Med"}, {"key": "10.1111/nyas.12016-BIB0111|nyas12016-cit-0111", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1001/jama.297.8.842", "article-title": "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis", "volume": "297", "author": "Bjelakovic", "year": "2007", "journal-title": "JAMA"}, {"key": "10.1111/nyas.12016-BIB0112|nyas12016-cit-0112", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1177/1740774508101279", "article-title": "Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality", "volume": "6", "author": "Berry", "year": "2009", "journal-title": "Clin. Trials"}, {"issue": "Suppl", "key": "10.1111/nyas.12016-BIB0113|nyas12016-cit-0113", "first-page": "OL1111", "article-title": "The questionable association of vitamin E supplementation and mortality-inconsistent results of different meta-analytic approaches", "volume": "55", "author": "Gerss", "year": "2009", "journal-title": "Cell. Mol. Biol. (Noisy-le-grand)"}, {"key": "10.1111/nyas.12016-BIB0114|nyas12016-cit-0114", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/j.atherosclerosis.2008.12.019", "article-title": "Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: does the underlying health status play a role?", "volume": "205", "author": "Dietrich", "year": "2009", "journal-title": "Atherosclerosis"}, {"key": "10.1111/nyas.12016-BIB0115|nyas12016-cit-0115", "doi-asserted-by": "crossref", "first-page": "158", "DOI": "10.2174/1874609811104020158", "article-title": "Vitamin E and all-cause mortality: a meta-analysis", "volume": "4", "author": "Abner", "year": "2011", "journal-title": "Curr. Ag. Sci"}, {"key": "10.1111/nyas.12016-BIB0116|nyas12016-cit-0116", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1111/j.1572-0241.2005.41583.x", "article-title": "A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease", "volume": "100", "author": "Bugianesi", "year": "2005", "journal-title": "Am. J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0117|nyas12016-cit-0117", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1177/1756283X09105462", "article-title": "The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial", "volume": "2", "author": "Shields", "year": "2009", "journal-title": "Ther. Adv. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0118|nyas12016-cit-0118", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1097/MEG.0b013e32832e2baf", "article-title": "Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease", "volume": "22", "author": "Omer", "year": "2010", "journal-title": "Eur. J. Gastroenterol. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0119|nyas12016-cit-0119", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1053/jhep.2003.50420", "article-title": "Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone", "volume": "38", "author": "Neuschwander-Tetri", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0120|nyas12016-cit-0120", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1056/NEJMoa060326", "article-title": "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", "volume": "355", "author": "Belfort", "year": "2006", "journal-title": "N. Engl. J. Med"}, {"key": "10.1111/nyas.12016-BIB0121|nyas12016-cit-0121", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1053/j.gastro.2008.03.078", "article-title": "Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial", "volume": "135", "author": "Ratziu", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0122|nyas12016-cit-0122", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/hep.23270", "article-title": "Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial", "volume": "51", "author": "Ratziu", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0123|nyas12016-cit-0123", "doi-asserted-by": "crossref", "first-page": "1176", "DOI": "10.1053/j.gastro.2008.06.047", "article-title": "Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis", "volume": "135", "author": "Aithal", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0124|nyas12016-cit-0124", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1056/NEJMoa0907929", "article-title": "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis", "volume": "362", "author": "Sanyal", "year": "2010", "journal-title": "N. Engl. J. Med"}, {"key": "10.1111/nyas.12016-BIB0125|nyas12016-cit-0125", "doi-asserted-by": "crossref", "first-page": "66", "DOI": "10.1111/j.1365-2036.2011.04912.x", "article-title": "Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis", "volume": "35", "author": "Boettcher", "year": "2012", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/nyas.12016-BIB0126|nyas12016-cit-0126", "doi-asserted-by": "crossref", "first-page": "1631", "DOI": "10.1002/hep.24558", "article-title": "Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial", "volume": "54", "author": "Torres", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0127|nyas12016-cit-0127", "doi-asserted-by": "crossref", "first-page": "2457", "DOI": "10.1056/NEJMoa072761", "article-title": "Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes", "volume": "356", "author": "Nissen", "year": "2007", "journal-title": "N. Engl. J. Med"}, {"key": "10.1111/nyas.12016-BIB0128|nyas12016-cit-0128", "doi-asserted-by": "crossref", "first-page": "1180", "DOI": "10.1001/jama.298.10.1180", "article-title": "Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials", "volume": "298", "author": "Lincoff", "year": "2007", "journal-title": "JAMA"}, {"key": "10.1111/nyas.12016-BIB0129|nyas12016-cit-0129", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1038/ajg.2010.299", "article-title": "Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial", "volume": "106", "author": "Foster", "year": "2011", "journal-title": "Am. J. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0130|nyas12016-cit-0130", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1016/S0140-6736(10)61272-X", "article-title": "Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis", "volume": "376", "author": "Athyros", "year": "2010", "journal-title": "Lancet"}, {"key": "10.1111/nyas.12016-BIB0131|nyas12016-cit-0131", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1053/j.gastro.2004.02.015", "article-title": "Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity", "volume": "126", "author": "Chalasani", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1111/nyas.12016-BIB0132|nyas12016-cit-0132", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1097/00000441-200502000-00002", "article-title": "Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes", "volume": "329", "author": "Vuppalanchi", "year": "2005", "journal-title": "Am. J. Med. Sci"}, {"key": "10.1111/nyas.12016-BIB0133|nyas12016-cit-0133", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1002/hep.20671", "article-title": "Statins and hepatotoxicity: focus on patients with fatty liver", "volume": "41", "author": "Chalasani", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0134|nyas12016-cit-0134", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1002/hep.21248", "article-title": "Statins and hepatic steatosis: perspectives from the Dallas Heart Study", "volume": "44", "author": "Browning", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0135|nyas12016-cit-0135", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1016/j.jhep.2007.06.020", "article-title": "Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study", "volume": "47", "author": "Zelber-Sagi", "year": "2007", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0136|nyas12016-cit-0136", "doi-asserted-by": "crossref", "first-page": "1179", "DOI": "10.1038/ejcn.2010.139", "article-title": "Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women", "volume": "64", "author": "Oya", "year": "2010", "journal-title": "Eur. J. Clin. Nutr"}, {"key": "10.1111/nyas.12016-BIB0137|nyas12016-cit-0137", "doi-asserted-by": "crossref", "first-page": "1143", "DOI": "10.1111/j.1365-2036.2006.02885.x", "article-title": "Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study", "volume": "23", "author": "Capanni", "year": "2006", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/nyas.12016-BIB0138|nyas12016-cit-0138", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1016/j.dld.2007.10.003", "article-title": "Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease", "volume": "40", "author": "Spadaro", "year": "2008", "journal-title": "Digest. liver Dis"}, {"key": "10.1111/nyas.12016-BIB0139|nyas12016-cit-0139", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1097/MCG.0b013e31815591aa", "article-title": "Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis", "volume": "42", "author": "Tanaka", "year": "2008", "journal-title": "J. Clin. Gastroenterol"}, {"key": "10.1111/nyas.12016-BIB0140|nyas12016-cit-0140", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.3109/09637486.2010.487480", "article-title": "Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study", "volume": "61", "author": "Sofi", "year": "2010", "journal-title": "Inter. J. Food Sci. Nutr"}, {"key": "10.1111/nyas.12016-BIB0141|nyas12016-cit-0141", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1002/hep.20092", "article-title": "Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial", "volume": "39", "author": "Lindor", "year": "2004", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0142|nyas12016-cit-0142", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/j.jhep.2010.08.030", "article-title": "A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis", "volume": "54", "author": "Ratziu", "year": "2011", "journal-title": "J. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0143|nyas12016-cit-0143", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1002/hep.23727", "article-title": "High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial", "volume": "52", "author": "Leuschner", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0144|nyas12016-cit-0144", "doi-asserted-by": "crossref", "first-page": "1972", "DOI": "10.1002/hep.23527", "article-title": "The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", "volume": "51", "author": "Ascha", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0145|nyas12016-cit-0145", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1002/hep.23314", "article-title": "Decreased survival of subjects with elevated liver function tests during a 28-year follow-up", "volume": "51", "author": "S\u00f6derberg", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1111/nyas.12016-BIB0146|nyas12016-cit-0146", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1136/gut.2003.019984", "article-title": "Long term prognosis of fatty liver: risk of chronic liver disease and death", "volume": "53", "author": "Dam-Larsen", "year": "2004", "journal-title": "Gut"}, {"key": "10.1111/nyas.12016-BIB0147|nyas12016-cit-0147", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.cgh.2008.11.005", "article-title": "Long-term follow-up of patients with non-alcoholic fatty liver", "volume": "7", "author": "Rafiq", "year": "2009", "journal-title": "Clin. Gastro. Hepatol"}, {"key": "10.1111/nyas.12016-BIB0148|nyas12016-cit-0148", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1055/s-0032-1306423", "article-title": "Dyslipidemia in patients with nonalcoholic fatty liver disease", "volume": "32", "author": "Chatrath", "year": "2012", "journal-title": "Semin. Liver Dis"}], "container-title": ["Annals of the New York Academy of Sciences"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fnyas.12016", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T02:06:57Z", "timestamp": 1562638017000}, "score": 58.464046, "subtitle": ["Nonalcoholic fatty liver disease"], "issued": {"date-parts": [[2013, 1, 30]]}, "references-count": 148, "journal-issue": {"published-print": {"date-parts": [[2013, 4]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1111/nyas.12016", "relation": {"cites": []}, "ISSN": ["0077-8923"], "issn-type": [{"value": "0077-8923", "type": "print"}], "subject": ["General Biochemistry, Genetics and Molecular Biology", "History and Philosophy of Science"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T15:45:24Z", "timestamp": 1576856724130}, "reference-count": 197, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 6, 1]], "date-time": "2012-06-01T00:00:00Z", "timestamp": 1338508800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2012, 6]]}, "DOI": "10.1053/j.gastro.2012.04.001", "type": "journal-article", "created": {"date-parts": [[2012, 5, 15]], "date-time": "2012-05-15T07:04:00Z", "timestamp": 1337065440000}, "page": "1592-1609", "source": "Crossref", "is-referenced-by-count": 881, "title": ["The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology"], "prefix": "10.1053", "volume": "142", "author": [{"given": "Naga", "family": "Chalasani", "sequence": "first", "affiliation": []}, {"given": "Zobair", "family": "Younossi", "sequence": "additional", "affiliation": []}, {"given": "Joel E.", "family": "Lavine", "sequence": "additional", "affiliation": []}, {"given": "Anna Mae", "family": "Diehl", "sequence": "additional", "affiliation": []}, {"given": "Elizabeth M.", "family": "Brunt", "sequence": "additional", "affiliation": []}, {"given": "Kenneth", "family": "Cusi", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Charlton", "sequence": "additional", "affiliation": []}, {"given": "Arun J.", "family": "Sanyal", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508512004945?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508512004945?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 28]], "date-time": "2019-06-28T18:44:05Z", "timestamp": 1561747445000}, "score": 57.781235, "issued": {"date-parts": [[2012, 6]]}, "references-count": 197, "journal-issue": {"published-print": {"date-parts": [[2012, 6]]}, "issue": "7"}, "alternative-id": ["S0016508512004945"], "URL": "http://dx.doi.org/10.1053/j.gastro.2012.04.001", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 21]], "date-time": "2019-12-21T07:23:16Z", "timestamp": 1576912996757}, "reference-count": 198, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1190, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2012, 6]]}, "DOI": "10.1002/hep.25762", "type": "journal-article", "created": {"date-parts": [[2012, 4, 6]], "date-time": "2012-04-06T11:58:38Z", "timestamp": 1333713518000}, "page": "2005-2023", "source": "Crossref", "is-referenced-by-count": 1613, "title": ["The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association"], "prefix": "10.1002", "volume": "55", "author": [{"given": "Naga", "family": "Chalasani", "sequence": "first", "affiliation": []}, {"given": "Zobair", "family": "Younossi", "sequence": "additional", "affiliation": []}, {"given": "Joel E.", "family": "Lavine", "sequence": "additional", "affiliation": []}, {"given": "Anna Mae", "family": "Diehl", "sequence": "additional", "affiliation": []}, {"given": "Elizabeth M.", "family": "Brunt", "sequence": "additional", "affiliation": []}, {"given": "Kenneth", "family": "Cusi", "sequence": "additional", "affiliation": []}, {"given": "Michael", "family": "Charlton", "sequence": "additional", "affiliation": []}, {"given": "Arun J.", "family": "Sanyal", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 5, 29]]}, "reference": [{"key": "10.1002/hep.25762-BIB1|cit1", "author": "Eddy", "first-page": "1", "year": "1996", "volume-title": "A manual for assessing health practices and designing practice guidelines"}, {"key": "10.1002/hep.25762-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "924", "DOI": "10.1136/bmj.39489.470347.AD", "article-title": "GRADE: an emerging consensus on rating quality of evidence and strength of recommendations", "volume": "336", "author": "Guyatt", "year": "2008", "journal-title": "BMJ"}, {"key": "10.1002/hep.25762-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1002/hep.22603", "article-title": "Nonalcoholic fatty liver disease and non-alcoholic steatohepatitis: selected practical issues in their management", "volume": "49", "author": "Vuppalanchi", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "274", "DOI": "10.1111/j.1365-2036.2011.04724.x", "article-title": "Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults", "volume": "34", "author": "Vernon", "year": "2011", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1002/hep.23719", "article-title": "Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites", "volume": "52", "author": "Neuschwander-Tetri", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "1341", "DOI": "10.1056/NEJMra0912063", "article-title": "Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease", "volume": "363", "author": "Targher", "year": "2010", "journal-title": "N Engl J Med"}, {"issue": "8", "key": "10.1002/hep.25762-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.3109/07853890.2010.518623", "article-title": "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity", "volume": "43", "author": "", "year": "2011", "journal-title": "Annals of Medicine"}, {"key": "10.1002/hep.25762-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1002/hep.23623", "article-title": "A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease", "volume": "52", "author": "Musso", "year": "2010", "journal-title": "Hepatology"}, {"issue": "1", "key": "10.1002/hep.25762-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/hep.20543", "article-title": "Chronological development of elevated aminotransferases in a nonalcoholic population", "volume": "41", "author": "Suzuki", "year": "2005", "journal-title": "Hepatology."}, {"issue": "10", "key": "10.1002/hep.25762-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "722", "DOI": "10.7326/0003-4819-143-10-200511150-00009", "article-title": "The metabolic syndrome as a predictor of non-alcoholic fatty liver disease", "volume": "143", "author": "Hamaguchi", "year": "2005", "journal-title": "Ann Intern Med"}, {"issue": "2", "key": "10.1002/hep.25762-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.7861/clinmedicine.7-2-119", "article-title": "Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs", "volume": "7", "author": "Whalley", "year": "2007", "journal-title": "Clin Med."}, {"issue": "2", "key": "10.1002/hep.25762-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/j.jhep.2007.02.007", "article-title": "Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center", "volume": "47", "author": "Lee", "year": "2007", "journal-title": "J Hepatol."}, {"key": "10.1002/hep.25762-BIB13|cit13", "author": "Marcos", "volume": "69", "first-page": "2410", "year": "2000", "journal-title": "Transplantation", "DOI": "10.1097/00007890-200006150-00034", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.25762-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.1053/j.gastro.2010.09.038", "article-title": "Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study", "volume": "140", "author": "Williams", "year": "2011", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1002/hep.20466", "article-title": "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", "volume": "40", "author": "Browning", "year": "2004", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1148", "DOI": "10.1381/0960892055002347", "article-title": "Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass", "volume": "15", "author": "Boza", "year": "2005", "journal-title": "Obes Surg."}, {"key": "10.1002/hep.25762-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1179/acb.2009.084", "article-title": "Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics", "volume": "64", "author": "Haentjens", "year": "2009", "journal-title": "Acta Clin Belg."}, {"key": "10.1002/hep.25762-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1016/j.jhep.2006.06.013", "article-title": "Hepatic histology in obese patients undergoing bariatric surgery", "volume": "45", "author": "Machado", "year": "2006", "journal-title": "J Hepatol."}, {"key": "10.1002/hep.25762-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1159/000087295", "article-title": "Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy", "volume": "49", "author": "Colicchio", "year": "2005", "journal-title": "Ann Nutr Metab."}, {"key": "10.1002/hep.25762-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1001/archsurg.138.11.1240", "article-title": "Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery", "volume": "138", "author": "Beymer", "year": "2003", "journal-title": "Arch Surg."}, {"key": "10.1002/hep.25762-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1111/j.1478-3231.2008.01718.x", "article-title": "Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus", "volume": "29", "author": "Leite", "year": "2009", "journal-title": "Liver Int."}, {"key": "10.1002/hep.25762-BIB22|cit22", "first-page": "205", "article-title": "Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus", "volume": "57", "author": "Prashanth", "year": "2009", "journal-title": "J Assoc Physicians India."}, {"key": "10.1002/hep.25762-BIB23|cit23", "author": "Assy", "first-page": "1929", "year": "2000", "article-title": "Fatty infiltration of liver in hyperlipidemic patients", "journal-title": "Dig Dis Sci", "DOI": "10.1023/A:1005661516165", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "10.1002/hep.25762-BIB24|cit24", "first-page": "377", "article-title": "Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China", "volume": "8", "author": "Li", "year": "2009", "journal-title": "Hepatobiliary Pancreat Dis Int."}, {"issue": "3", "key": "10.1002/hep.25762-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S1665-2681(19)31922-2", "article-title": "Prevalence of non-alcoholic fatty liver disease: population based study", "volume": "6", "author": "Amarapurkar", "year": "2007", "journal-title": "Ann Hepatol."}, {"issue": "1 Pt 1", "key": "10.1002/hep.25762-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1111/j.1440-1746.2005.04086.x", "article-title": "Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults", "volume": "21", "author": "Park", "year": "2006", "journal-title": "J Gastroenterol Hepatol."}, {"issue": "6", "key": "10.1002/hep.25762-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1159/000235677", "article-title": "Non-alcoholic fatty liver disease in older people", "volume": "55", "author": "Frith", "year": "2009", "journal-title": "Gerontology."}, {"key": "10.1002/hep.25762-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "1482", "DOI": "10.1111/j.1440-1746.2006.04615.x", "article-title": "Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan", "volume": "22", "author": "Chen", "year": "2007", "journal-title": "J Gastroenterol Hepatol."}, {"key": "10.1002/hep.25762-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "608", "DOI": "10.1016/j.jhep.2008.06.018", "article-title": "Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease", "volume": "49", "author": "Ong", "year": "2008", "journal-title": "J Hepatol."}, {"issue": "2", "key": "10.1002/hep.25762-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1016/j.hepres.2005.09.007", "article-title": "The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease", "volume": "33", "author": "Hashimoto", "year": "2005", "journal-title": "Hepatol Res."}, {"key": "10.1002/hep.25762-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1053/j.gastro.2005.04.014", "article-title": "The natural history of nonalcoholic fatty liver disease: a population-based cohort study", "volume": "129", "author": "Adams", "year": "2005", "journal-title": "Gastroenterology."}, {"issue": "8", "key": "10.1002/hep.25762-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "616", "DOI": "10.1631/jzus.B0720016", "article-title": "Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease", "volume": "9", "author": "Chen", "year": "2008", "journal-title": "J Zhejiang Univ Sci B."}, {"key": "10.1002/hep.25762-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "960", "DOI": "10.1111/j.1572-0241.2003.07486.x", "article-title": "The prevalence and etiology of elevated aminotransferase levels in the United States", "volume": "98", "author": "Clark", "year": "2003", "journal-title": "Am J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "1358", "DOI": "10.1007/s10620-008-0234-x", "article-title": "Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides", "volume": "53", "author": "Kallwitz", "year": "2008", "journal-title": "Dig Dis Sci."}, {"key": "10.1002/hep.25762-BIB35|cit35", "first-page": "1240", "article-title": "Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort", "volume": "17", "author": "Wagenknecht", "year": "2009", "journal-title": "Obesity"}, {"key": "10.1002/hep.25762-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "363", "DOI": "10.1038/ajg.2008.57", "article-title": "Chronic liver disease among Alaska-Native people, 2003-2004", "volume": "104", "author": "Fischer", "year": "2009", "journal-title": "Am J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "949", "DOI": "10.1097/MCG.0b013e318054492a", "article-title": "Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003", "volume": "42", "author": "Bialek", "year": "2008", "journal-title": "J Clin Gastroenterol."}, {"issue": "6", "key": "10.1002/hep.25762-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1016/S0016-5085(99)70506-8", "article-title": "Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity", "volume": "116", "author": "Matteoni", "year": "1999", "journal-title": "Gastroenterology."}, {"issue": "5", "key": "10.1002/hep.25762-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1136/gut.2003.019984", "article-title": "Long term prognosis of fatty liver: risk of chronic liver disease and death", "volume": "53", "author": "Dam-Larsen", "year": "2004", "journal-title": "Gut."}, {"key": "10.1002/hep.25762-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1002/hep.21327", "article-title": "Long-term follow-up of patients with NAFLD and elevated liver enzymes", "volume": "44", "author": "Ekstedt", "year": "2006", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "2263", "DOI": "10.1111/j.1572-0241.2008.02034.x", "article-title": "Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-based Cohort Study", "volume": "103", "author": "W", "year": "2008", "journal-title": "Am J of Gastroenterology"}, {"key": "10.1002/hep.25762-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1016/j.cgh.2008.11.005", "article-title": "Long-Term Follow-Up of Patients with Non-Alcoholic Fatty Liver", "volume": "7", "author": "N", "year": "2009", "journal-title": "Clinical Gastro and Hepatology"}, {"issue": "10", "key": "10.1002/hep.25762-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "1236", "DOI": "10.1080/00365520903171284", "article-title": "Final results of a long-term, clinical follow-up in fatty liver patients", "volume": "44", "author": "Dam-Larsen", "year": "2009", "journal-title": "Scand J Gastroenterol."}, {"issue": "10", "key": "10.1002/hep.25762-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "1410", "DOI": "10.1136/gut.2010.213553", "article-title": "Components of metabolic syndrome as independent predictors of mortality in chronic liver disease: A population-based study", "volume": "59", "author": "M", "year": "2010", "journal-title": "Gut."}, {"key": "10.1002/hep.25762-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1002/hep.23314", "article-title": "Decreased survival of subjects with elevated liver function tests during a 28-year follow-up", "volume": "51", "author": "S\u00f6derberg", "year": "2010", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "578", "DOI": "10.1016/j.jhep.2004.02.013", "article-title": "The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease", "volume": "40", "author": "Caldwell", "year": "2004", "journal-title": "J Hepatol."}, {"key": "10.1002/hep.25762-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1111/j.1572-0241.2004.04059.x", "article-title": "Ethnic differences in the prevalence of cryptogenic cirrhosis", "volume": "99", "author": "Browning", "year": "2004", "journal-title": "Am J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "134", "DOI": "10.1053/gast.2002.34168", "article-title": "Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma", "volume": "123", "author": "Bugianesi", "year": "2002", "journal-title": "Gastroenterology."}, {"issue": "Suppl 19", "key": "10.1002/hep.25762-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1007/s00535-008-2262-x", "article-title": "hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", "volume": "44", "author": "Hashimoto", "year": "2009", "journal-title": "J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB50|cit50", "first-page": "291", "article-title": "Steatosis and hepatocellular carcinoma risk", "volume": "9", "author": "Smedile", "year": "2005", "journal-title": "Eur Rev Med Pharmacol Sci."}, {"key": "10.1002/hep.25762-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "1436", "DOI": "10.3748/wjg.v16.i12.1436", "article-title": "Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review", "volume": "16", "author": "Takuma", "year": "2010", "journal-title": "World J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "1972", "DOI": "10.1002/hep.23527", "article-title": "The incidence and risk factor of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis", "volume": "51", "author": "Ascha", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1016/j.cgh.2011.01.023", "article-title": "Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma", "volume": "9", "author": "Yasui", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.25762-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "420", "DOI": "10.1053/jhep.2003.50320", "article-title": "Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C", "volume": "38", "author": "Hui", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB55|cit55", "first-page": "132", "article-title": "Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C", "volume": "42", "author": "Sanyal", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "248", "DOI": "10.1111/j.1440-1746.2008.05640.x", "article-title": "Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C", "volume": "24", "author": "Yatsuji", "year": "2009", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "4", "key": "10.1002/hep.25762-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "1208", "DOI": "10.1002/hep.24491", "article-title": "The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis. An international collaborative study", "volume": "54", "author": "Bhala", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "344", "DOI": "10.1002/hep.24376", "article-title": "End points and clinical trial design for nonalcoholic steatohepatitis", "volume": "54", "author": "Sanyal", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB59|cit59", "author": "Liagnpunsakul", "year": "2012", "article-title": "What do we recommend our patients with NAFLD about alcohol consumption?", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0002-9343(99)00315-0", "article-title": "Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds", "volume": "108", "author": "Struben", "year": "2000", "journal-title": "Am J Med"}, {"key": "10.1002/hep.25762-BIB61|cit61", "doi-asserted-by": "crossref", "first-page": "2957", "DOI": "10.1111/j.1572-0241.2001.04667.x", "article-title": "Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease", "volume": "96", "author": "Willner", "year": "2001", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "1162", "DOI": "10.1016/j.cgh.2006.06.001", "article-title": "Familial aggregation of insulin resistance in first-degree delatives of patients with nonalcoholic fatty liver disease", "volume": "4", "author": "Abdelmalek", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.25762-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "1585", "DOI": "10.1053/j.gastro.2009.01.050", "article-title": "Heritability of nonalcoholic fatty liver disease", "volume": "136", "author": "Schwimmer", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB64|cit64", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1053/j.gastro.2010.01.023", "article-title": "The role of iron in nonalcoholic fatty liver disease: the story continues", "volume": "138", "author": "Kowdley", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1002/hep.24330", "article-title": "Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases", "volume": "54", "author": "Bacon", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB66|cit66", "author": "Vuppalanchi", "year": "2011", "article-title": "Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network", "journal-title": "Hepatol Int"}, {"key": "10.1002/hep.25762-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1053/jhep.2003.50161", "article-title": "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", "volume": "37", "author": "Marchesini", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "2247", "DOI": "10.1111/j.1572-0241.2006.00719.x", "article-title": "Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD", "volume": "101", "author": "Kang", "year": "2006", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "1222", "DOI": "10.2337/diacare.28.5.1222", "article-title": "Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease", "volume": "28", "author": "Ryan", "year": "2005", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.25762-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/hep.21223", "article-title": "In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease", "volume": "44", "author": "Wieckowska", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "846", "DOI": "10.1002/hep.21496", "article-title": "The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD", "volume": "45", "author": "Angulo", "year": "2007", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB72|cit72", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1002/hep.21768", "article-title": "Noninvasis diagnosis and monitoring of nonalcoholic steatohepatitis: present and future", "volume": "46", "author": "Wieckowski", "year": "2007", "journal-title": "HEPATOLOGY"}, {"key": "10.1002/hep.25762-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1016/0168-8278(91)90942-5", "article-title": "Hepatic effects of dietary weight loss in morbidly obese subjects", "volume": "12", "author": "Andersen", "year": "1991", "journal-title": "J Hepatol."}, {"key": "10.1002/hep.25762-BIB74|cit74", "doi-asserted-by": "crossref", "first-page": "1408", "DOI": "10.1016/0016-5085(90)91169-7", "article-title": "Effect of weight reduction on hepatic abnormalities in overweight patients", "volume": "99", "author": "Palmer", "year": "1990", "journal-title": "Gastroenterology."}, {"key": "10.1002/hep.25762-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.3346/jkms.1995.10.6.414", "article-title": "Effect of weight control on hepatic abnormalities in obese patients with fatty liver", "volume": "10", "author": "Park", "year": "1995", "journal-title": "J Korean Med Sci."}, {"key": "10.1002/hep.25762-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0168-8278(97)80287-5", "article-title": "Therapeutic effects of restricted diet and exercise in obese patients with fatty liver", "volume": "27", "author": "Ueno", "year": "1997", "journal-title": "J Hepatol."}, {"key": "10.1002/hep.25762-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1053/jhep.2003.50316", "article-title": "Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E", "volume": "38", "author": "Kugelmas", "year": "2003", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "191", "DOI": "10.1111/j.1440-1746.2005.04233.x", "article-title": "Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis", "volume": "21", "author": "Sreenivasa Baba", "year": "2006", "journal-title": "J Gastroenterol Hepatol."}, {"key": "10.1002/hep.25762-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1136/gut.2003.027581", "article-title": "Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life", "volume": "53", "author": "Hickman", "year": "2004", "journal-title": "Gut."}, {"key": "10.1002/hep.25762-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "1060", "DOI": "10.1016/j.jhep.2005.06.008", "article-title": "Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease", "volume": "43", "author": "Suzuki", "year": "2005", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.25762-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.2337/diabetes.52.3.701", "article-title": "Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content", "volume": "52", "author": "Tiikkainen", "year": "2003", "journal-title": "Diabetes"}, {"key": "10.1002/hep.25762-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "3191", "DOI": "10.1210/jc.2004-1959", "article-title": "Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients", "volume": "90", "author": "Tamura", "year": "2005", "journal-title": "J Clin Endocrinol Metab."}, {"key": "10.1002/hep.25762-BIB83|cit83", "doi-asserted-by": "crossref", "first-page": "2804", "DOI": "10.1210/jc.2004-1983", "article-title": "Dietary fat content modifies liver fat in overweight nondiabetic subjects", "volume": "90", "author": "Westerbacka", "year": "2005", "journal-title": "J Clin Endocrinol Metab."}, {"key": "10.1002/hep.25762-BIB84|cit84", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.2337/diabetes.54.3.603", "article-title": "Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes", "volume": "54", "author": "Petersen", "year": "2005", "journal-title": "Diabetes."}, {"key": "10.1002/hep.25762-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "1337", "DOI": "10.2337/dc05-2565", "article-title": "Effect of calorie restriction with or without exercise on insulin sensitivity, \u25a1-cell function, fat cell size, and ectopic lipid in overweight subjects", "volume": "29", "author": "Larson-Meyer", "year": "2006", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.25762-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "5813", "DOI": "10.3748/wjg.v12.i36.5813", "article-title": "Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease", "volume": "12", "author": "Thomas", "year": "2006", "journal-title": "World J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1038/oby.2007.568", "article-title": "High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention", "volume": "15", "author": "Thamer", "year": "2007", "journal-title": "Obesity"}, {"key": "10.1002/hep.25762-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1111/j.1365-2362.2007.01820.x", "article-title": "Lifestyle intervention in individuals with normal versus impaired glucose tolerance", "volume": "37", "author": "Schafer", "year": "2007", "journal-title": "Eur J Clin Invest"}, {"key": "10.1002/hep.25762-BIB89|cit89", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1002/jmri.21542", "article-title": "Magnetic resonance imaging and spectroscopy for monitoring liver steatosis", "volume": "28", "author": "Cowin", "year": "2008", "journal-title": "J Magn Reson Imaging"}, {"key": "10.1002/hep.25762-BIB90|cit90", "doi-asserted-by": "crossref", "first-page": "1355", "DOI": "10.1038/oby.2008.201", "article-title": "Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function", "volume": "16", "author": "Larson-Meyer", "year": "2008", "journal-title": "Obesity"}, {"key": "10.1002/hep.25762-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1210/jc.2008-1689", "article-title": "Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance", "volume": "94", "author": "Viljanen", "year": "2009", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1002/hep.25762-BIB92|cit92", "doi-asserted-by": "crossref", "first-page": "1281", "DOI": "10.1136/gut.2008.151977", "article-title": "High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease", "volume": "58", "author": "Kantartzis", "year": "2009", "journal-title": "Gut"}, {"key": "10.1002/hep.25762-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "1552", "DOI": "10.1053/j.gastro.2009.01.048", "article-title": "Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction", "volume": "136", "author": "Kirk", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "2156", "DOI": "10.2337/dc10-0856", "article-title": "Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes", "volume": "33", "author": "Lazo", "year": "2010", "journal-title": "Diabetes Care"}, {"key": "10.1002/hep.25762-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1016/S0002-9343(03)00449-2", "article-title": "Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review", "volume": "115", "author": "Wang", "year": "2003", "journal-title": "Am J Med."}, {"key": "10.1002/hep.25762-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1136/gut.51.1.89", "article-title": "Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C", "volume": "51", "author": "Hickman", "year": "2002", "journal-title": "Gut"}, {"key": "10.1002/hep.25762-BIB97|cit97", "doi-asserted-by": "crossref", "first-page": "1072", "DOI": "10.1111/j.1572-0241.2005.41334.x", "article-title": "One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study", "volume": "100", "author": "Huang", "year": "2005", "journal-title": "Amer J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "589", "DOI": "10.1007/s10620-006-9433-5", "article-title": "The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study", "volume": "52", "author": "Tendler", "year": "2007", "journal-title": "Digestive Diseases & Sciences."}, {"key": "10.1002/hep.25762-BIB99|cit99", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1016/j.cgh.2006.02.004", "article-title": "A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease", "volume": "4", "author": "Zelber-Sagi", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol."}, {"key": "10.1002/hep.25762-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1002/hep.22575", "article-title": "Orlistat for overweight subjects with nonalcoholic steatohepatitis (NASH): a randomized prospective trial", "volume": "49", "author": "Harrison", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB101|cit101", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1002/hep.23276", "article-title": "Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis", "volume": "51", "author": "Promrat", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "404", "DOI": "10.1007/s00125-006-0498-7", "article-title": "Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism", "volume": "50", "author": "Shojaee-Moradie", "year": "2007", "journal-title": "Diabetologia"}, {"issue": "Suppl.", "key": "10.1002/hep.25762-BIB103|cit103", "first-page": "806A", "article-title": "The effects of an exercise training intervention on hepatic steatosis [Abstract]", "volume": "48", "author": "Bonekamp", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB104|cit104", "doi-asserted-by": "crossref", "first-page": "1105", "DOI": "10.1002/hep.23129", "article-title": "Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss", "volume": "50", "author": "Johnson", "year": "2009", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB105|cit105", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1038/oby.2009.274", "article-title": "A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents", "volume": "18", "author": "van der Heijden", "year": "2010", "journal-title": "Obesity"}, {"key": "10.1002/hep.25762-BIB106|cit106", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1016/S0140-6736(01)06042-1", "article-title": "Metformin in non-alcoholic steatohepatitis", "volume": "358", "author": "Marchesini", "year": "2001", "journal-title": "Lancet."}, {"key": "10.1002/hep.25762-BIB107|cit107", "doi-asserted-by": "crossref", "first-page": "537", "DOI": "10.1111/j.1365-2036.2004.01888.x", "article-title": "Metformin in the treatment of patients with non-alcoholic steatohepatitis", "volume": "19", "author": "Uygun", "year": "2004", "journal-title": "Aliment Pharmacol Ther."}, {"key": "10.1002/hep.25762-BIB108|cit108", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1111/j.1365-2036.2004.02025.x", "article-title": "Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial", "volume": "20", "author": "Nair", "year": "2004", "journal-title": "Aliment Pharmacol Ther."}, {"key": "10.1002/hep.25762-BIB109|cit109", "doi-asserted-by": "crossref", "first-page": "1082", "DOI": "10.1111/j.1572-0241.2005.41583.x", "article-title": "A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease", "volume": "100", "author": "Bugianesi", "year": "2005", "journal-title": "Am J Gastroenterol."}, {"key": "10.1002/hep.25762-BIB110|cit110", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1111/j.1365-2036.2008.03869.x", "article-title": "Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis", "volume": "29", "author": "Loomba", "year": "2009", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB111|cit111", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1177/1756283X09105462", "article-title": "The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot study", "volume": "2", "author": "Shields", "year": "2009", "journal-title": "Therap Adv Gastroenterol"}, {"key": "10.1002/hep.25762-BIB112|cit112", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1080/00365520902845268", "article-title": "Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial", "volume": "44", "author": "Haukeland", "year": "2009", "journal-title": "Scand J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB113|cit113", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1111/j.1365-2036.2008.03723.x", "article-title": "Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis", "volume": "28", "author": "Idilman", "year": "2008", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB114|cit114", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1016/S1665-2681(19)31902-7", "article-title": "Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions", "volume": "6", "author": "Duseja", "year": "2007", "journal-title": "Ann Hepatol"}, {"key": "10.1002/hep.25762-BIB115|cit115", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/s00592-008-0067-2", "article-title": "The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease", "volume": "46", "author": "Nar", "year": "2009", "journal-title": "Acta Diabetol."}, {"key": "10.1002/hep.25762-BIB116|cit116", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1097/MEG.0b013e32832e2baf", "article-title": "Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease", "volume": "22", "author": "Omer", "year": "2010", "journal-title": "European J Gastroenterol Hepatology."}, {"key": "10.1002/hep.25762-BIB117|cit117", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1053/jhep.2003.50420", "article-title": "Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone", "volume": "38", "author": "Neuschwander-Tetri", "year": "2003", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB118|cit118", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1053/j.gastro.2008.03.078", "article-title": "Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial", "volume": "135", "author": "Ratziu", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB119|cit119", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1002/hep.23270", "article-title": "Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial", "volume": "51", "author": "Ratziu", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB120|cit120", "doi-asserted-by": "crossref", "first-page": "2297", "DOI": "10.1056/NEJMoa060326", "article-title": "A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis", "volume": "355", "author": "Belfort", "year": "2006", "journal-title": "N Engl J Med."}, {"key": "10.1002/hep.25762-BIB121|cit121", "doi-asserted-by": "crossref", "first-page": "1176", "DOI": "10.1053/j.gastro.2008.06.047", "article-title": "Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis", "volume": "135", "author": "Aithal", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB122|cit122", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1056/NEJMoa0907929", "article-title": "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis", "volume": "362", "author": "Sanyal", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB123|cit123", "doi-asserted-by": "crossref", "first-page": "1180", "DOI": "10.1001/jama.298.10.1180", "article-title": "Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus. A meta-analysis of randomized trials", "volume": "298", "author": "Lincoff", "year": "2007", "journal-title": "JAMA"}, {"key": "10.1002/hep.25762-BIB124|cit124", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1046/j.1365-2036.2001.01083.x", "article-title": "Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis: a pilot study", "volume": "15", "author": "Hasegawa", "year": "2001", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB125|cit125", "doi-asserted-by": "crossref", "first-page": "2485", "DOI": "10.1111/j.1572-0241.2003.08699.x", "article-title": "Vitamin E and vitamin C treatment improves fibrosis is patients with nonalcoholic steatohepatitis", "volume": "98", "author": "Harrison", "year": "2003", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB126|cit126", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1016/j.cgh.2006.09.025", "article-title": "Swiss Association for the Study of the Liver. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis", "volume": "4", "author": "Dufour", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.25762-BIB127|cit127", "doi-asserted-by": "crossref", "first-page": "1107", "DOI": "10.1016/S1542-3565(04)00457-4", "article-title": "A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis", "volume": "2", "author": "Sanyal", "year": "2004", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.25762-BIB128|cit128", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1111/j.1445-5994.2006.01295.x", "article-title": "Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis, results of a pilot study", "volume": "37", "author": "Yakaryilamz", "year": "2007", "journal-title": "Intern Med J"}, {"key": "10.1002/hep.25762-BIB129|cit129", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1111/j.1365-2036.2010.04371.x", "article-title": "Meta-analysis: antioxidant supplements for liver disease - the Cochrane Hepato-Biliary Group", "volume": "32", "author": "Bjelakovic", "year": "2010", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB130|cit130", "doi-asserted-by": "crossref", "first-page": "1659", "DOI": "10.1001/jama.2011.520", "article-title": "Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial", "volume": "305", "author": "Lavine", "year": "2011", "journal-title": "JAMA."}, {"key": "10.1002/hep.25762-BIB131|cit131", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.7326/0003-4819-142-1-200501040-00110", "article-title": "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality", "volume": "142", "author": "Miller", "year": "2005", "journal-title": "Ann Intern Med"}, {"issue": "8", "key": "10.1002/hep.25762-BIB132|cit132", "doi-asserted-by": "crossref", "first-page": "842", "DOI": "10.1001/jama.297.8.842", "article-title": "Mortality in randomized trials of antioxidant supplements of primary and secondary prevention: systematic review and meta-analysis", "volume": "297", "author": "Bjelakovic", "year": "2007", "journal-title": "JAMA."}, {"key": "10.1002/hep.25762-BIB133|cit133", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1177/1740774508101279", "article-title": "Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality", "volume": "6", "author": "Berry", "year": "2009", "journal-title": "Clin Trials"}, {"issue": "Suppl", "key": "10.1002/hep.25762-BIB134|cit134", "first-page": "1111", "article-title": "The questionable association of vitamin E supplementation and mortality - inconsistent results of different meta-analytic approaches", "volume": "55", "author": "Gerss", "year": "2009", "journal-title": "Cell Mol Biol"}, {"key": "10.1002/hep.25762-BIB135|cit135", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/j.atherosclerosis.2008.12.019", "article-title": "Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role?", "volume": "205", "author": "Dietrich", "year": "2009", "journal-title": "Atherosclerosis"}, {"key": "10.1002/hep.25762-BIB136|cit136", "first-page": "1549", "article-title": "Vitamin E and the risk of prostate cancer", "volume": "306", "author": "Klein", "year": "2011", "journal-title": "The selenium and vitamin E cancer prevention trial (SELECT). JAMA"}, {"key": "10.1002/hep.25762-BIB137|cit137", "doi-asserted-by": "crossref", "first-page": "1464", "DOI": "10.1002/hep.510230624", "article-title": "Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic induced steatohepatitis: a pilot study", "volume": "23", "author": "Laurin", "year": "1996", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB138|cit138", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1002/hep.23727", "article-title": "High-dose Ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial", "volume": "52", "author": "Leushner", "year": "2010", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB139|cit139", "doi-asserted-by": "crossref", "first-page": "770", "DOI": "10.1002/hep.20092", "article-title": "Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial", "volume": "39", "author": "Lindor", "year": "2004", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB140|cit140", "doi-asserted-by": "crossref", "first-page": "1011", "DOI": "10.1016/j.jhep.2010.08.030", "article-title": "A randomized controlled trial of hig-dose ursogeoxycholic acid for nonalcoholic steatohepatitis", "volume": "54", "author": "Ratziu", "year": "2011", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.25762-BIB141|cit141", "doi-asserted-by": "crossref", "first-page": "1143", "DOI": "10.1111/j.1365-2036.2006.02885.x", "article-title": "Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study", "volume": "23", "author": "Capanni", "year": "2006", "journal-title": "Alimentary pharmacology & therapeutics"}, {"key": "10.1002/hep.25762-BIB142|cit142", "doi-asserted-by": "crossref", "first-page": "679", "DOI": "10.1111/j.1365-2036.2009.04230.x", "article-title": "Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease", "volume": "31", "author": "Masterton", "year": "2010", "journal-title": "Alimentary pharmacology & therapeutics"}, {"key": "10.1002/hep.25762-BIB143|cit143", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1053/j.gastro.2009.04.052", "article-title": "Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced liver disease", "volume": "137", "author": "Mathurin", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB144|cit144", "doi-asserted-by": "crossref", "first-page": "1396", "DOI": "10.1016/j.cgh.2008.08.012", "article-title": "Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis", "volume": "6", "author": "Mummadi", "year": "2008", "journal-title": "Clinical Gastro and Hepatol"}, {"key": "10.1002/hep.25762-BIB145|cit145", "author": "Chavez-Tapia", "issue": "1", "year": "2010", "article-title": "Bariatric surgery for non-alcoholic steatohepatitis in obese patients", "journal-title": "Cochrane Database of Systematic Reviews", "DOI": "10.1002/14651858.CD007340.pub2", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.25762-BIB146|cit146", "unstructured": "http://rethinkingdrinking.niaaa.nih.gov/IsYourDrinkingPatternRisky/WhatsAtRiskOrHeavyDrinking.asp"}, {"key": "10.1002/hep.25762-BIB147|cit147", "doi-asserted-by": "crossref", "first-page": "1947", "DOI": "10.1002/hep.22292", "article-title": "Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease", "volume": "47", "author": "Dunn", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB148|cit148", "doi-asserted-by": "crossref", "first-page": "2189", "DOI": "10.1038/ajg.2009.361", "article-title": "Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population", "volume": "104", "author": "Gunji", "year": "2009", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB149|cit149", "doi-asserted-by": "crossref", "first-page": "1912", "DOI": "10.1111/j.1572-0241.2007.01274.x", "article-title": "Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia", "volume": "102", "author": "Suzuki", "year": "2007", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB150|cit150", "doi-asserted-by": "crossref", "first-page": "378", "DOI": "10.1111/j.1365-2036.2010.04520.x", "article-title": "Alcohol consumption appears to protect against non-alcoholic steatohepatitis", "volume": "33", "author": "Moriya", "year": "2011", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB151|cit151", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1053/gast.2001.25540", "article-title": "Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese", "volume": "121", "author": "Dixon", "year": "2001", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB152|cit152", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1097/MEG.0b013e328328f3ec", "article-title": "Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients", "volume": "21", "author": "Cotrim", "year": "2009", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "10.1002/hep.25762-BIB153|cit153", "author": "Dunn", "volume": "50", "year": "2009", "article-title": "Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with nonalcoholic fatty liver disease (NAFLD)", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB154|cit154", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1055/s-0032-1306423", "article-title": "Dyslipidemia in patients with nonalcoholic fatty liver disease", "volume": "32", "author": "Chatrath", "year": "2012", "journal-title": "Seminars in Liver Disease"}, {"key": "10.1002/hep.25762-BIB155|cit155", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1053/j.gastro.2004.02.015", "article-title": "Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity", "volume": "128", "author": "Chalasani", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB156|cit156", "doi-asserted-by": "crossref", "first-page": "62", "DOI": "10.1097/00000441-200502000-00002", "article-title": "Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes", "volume": "329", "author": "Vuppalanchi", "year": "2005", "journal-title": "Am J Med Sci"}, {"key": "10.1002/hep.25762-BIB157|cit157", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1002/hep.20671", "article-title": "Statin hepatotoxicity: focus on statin usage in nonalcoholic fatty liver disease", "volume": "41", "author": "Chalasani", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB158|cit158", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1002/hep.21248", "article-title": "Statins and hepatic steatosis: perspectives from the Dallas Heart Study", "volume": "44", "author": "Browning", "year": "2006", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB159|cit159", "doi-asserted-by": "crossref", "first-page": "1453", "DOI": "10.1002/hep.21848", "article-title": "Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial", "volume": "46", "author": "Lewis", "year": "2007", "journal-title": "Hepatology."}, {"issue": "Supplement", "key": "10.1002/hep.25762-BIB160|cit160", "first-page": "2767", "article-title": "Atorvastatin for the treatment of NASH", "volume": "120", "author": "Horlander", "year": "2001", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB161|cit161", "doi-asserted-by": "crossref", "first-page": "1643", "DOI": "10.1111/j.1365-2036.2006.02926.x", "article-title": "A pilot study of atorvastatin treatment in dyslipid, non-alcoholic fatty liver patients", "volume": "23", "author": "Gomer-Dominguez", "year": "2006", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB162|cit162", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/j.atherosclerosis.2005.08.021", "article-title": "Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients", "volume": "184", "author": "Antonopoulos", "year": "2006", "journal-title": "Atherosclerosis"}, {"key": "10.1002/hep.25762-BIB163|cit163", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1038/ajg.2010.299", "article-title": "Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: The St. Francis Heart Study Randomized Clinical Trial", "volume": "106", "author": "Foster", "year": "2011", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB164|cit164", "doi-asserted-by": "crossref", "first-page": "872", "DOI": "10.1185/030079906X104696", "article-title": "Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomized study", "volume": "22", "author": "Athyros", "year": "2006", "journal-title": "Curr Med Res Opin"}, {"key": "10.1002/hep.25762-BIB165|cit165", "author": "Athyros", "volume": "376", "first-page": "1916", "year": "2010", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(10)61272-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.25762-BIB166|cit166", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/j.jhep.2007.02.013", "article-title": "Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study", "volume": "47", "author": "Ekstedt", "year": "2007", "journal-title": "J Hepatol"}, {"key": "10.1002/hep.25762-BIB167|cit167", "doi-asserted-by": "crossref", "first-page": "990", "DOI": "10.1097/MCG.0b013e31819c392e", "article-title": "A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial", "volume": "43", "author": "Nelson", "year": "2009", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1002/hep.25762-BIB168|cit168", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1097/01.MP.0000042420.21088.C7", "article-title": "Concurrence of histological features of steatohepatitis with other forms of chronic liver disease", "volume": "16", "author": "Brunt", "year": "2003", "journal-title": "Mod Pathol"}, {"key": "10.1002/hep.25762-BIB169|cit169", "doi-asserted-by": "crossref", "first-page": "1636", "DOI": "10.1053/j.gastro.2006.03.014", "article-title": "Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data", "volume": "130", "author": "Leandro", "year": "2006", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB170|cit170", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1111/j.1478-3231.2011.02453.x", "article-title": "Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV", "volume": "31", "author": "Petta", "year": "2011", "journal-title": "Liver Int"}, {"key": "10.1002/hep.25762-BIB171|cit171", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1111/j.1365-2036.2011.04716.x", "article-title": "Meta-analysis: insulin resistance and sustained virological response in hepatitis C", "volume": "34", "author": "Eslam", "year": "2011", "journal-title": "Alimen Pharmacol Ther"}, {"key": "10.1002/hep.25762-BIB172|cit172", "doi-asserted-by": "crossref", "first-page": "1053", "DOI": "10.1007/s00535-010-0249-x", "article-title": "Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis", "volume": "45", "author": "Sorrentino", "year": "2010", "journal-title": "J Gastroenterol"}, {"key": "10.1002/hep.25762-BIB173|cit173", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1053/j.gastro.2004.12.049", "article-title": "Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients", "volume": "128", "author": "Romero-Gomez", "year": "2005", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB174|cit174", "first-page": "129", "article-title": "Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin", "volume": "15", "author": "Reddy", "year": "2008", "journal-title": "J Viral Hepa"}, {"key": "10.1002/hep.25762-BIB175|cit175", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1111/j.1365-2893.2009.01186.x", "article-title": "Impact of obesity, steatosis and insulin resistance on progression and response to therapy to hepatitis C", "volume": "16", "author": "Negro", "year": "2009", "journal-title": "J Viral Hepat"}, {"key": "10.1002/hep.25762-BIB176|cit176", "doi-asserted-by": "crossref", "first-page": "2405", "DOI": "10.1056/NEJMoa1012912", "article-title": "Telaprevir for previously untreated chronic hepatitis C virus infection", "volume": "364", "author": "Jacobson", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB177|cit177", "doi-asserted-by": "crossref", "first-page": "2417", "DOI": "10.1056/NEJMoa1013086", "article-title": "Telaprevir for retreatment of HCV infection", "volume": "364", "author": "Zeuzam", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB178|cit178", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1056/NEJMoa1009482", "article-title": "Boceprevir for previously treated chronic HCV genotype 1 infection", "volume": "364", "author": "Bacon", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB179|cit179", "doi-asserted-by": "crossref", "first-page": "1195", "DOI": "10.1056/NEJMoa1010494", "article-title": "Boceprevir for untreated chronic HCV genotype 1 infection", "volume": "364", "author": "Poordad", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB180|cit180", "doi-asserted-by": "crossref", "first-page": "1014", "DOI": "10.1056/NEJMoa1014463", "article-title": "Response-guided telaprevir combination treatment for hepatitis C virus infection", "volume": "365", "author": "Sherman", "year": "2011", "journal-title": "N Engl J Med"}, {"key": "10.1002/hep.25762-BIB181|cit181", "doi-asserted-by": "crossref", "first-page": "2086", "DOI": "10.1111/j.1572-0241.2007.01481.x", "article-title": "Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", "volume": "102", "author": "Garcia-Tsao", "year": "2007", "journal-title": "Am J Gastroenterol"}, {"issue": "3", "key": "10.1002/hep.25762-BIB182|cit182", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1002/hep.24199", "article-title": "Management of Hepatocellular carcinoma: An update", "volume": "53", "author": "Bruix", "year": "2011", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB183|cit183", "doi-asserted-by": "crossref", "first-page": "1388", "DOI": "10.1542/peds.2006-1212", "article-title": "Prevalence of fatty liver in children and adolescents", "volume": "118", "author": "Schwimmer", "year": "2006", "journal-title": "Pediatrics."}, {"key": "10.1002/hep.25762-BIB184|cit184", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1002/hep.20842", "article-title": "Histopathology of pediatric nonalcoholic fatty liver disease", "volume": "42", "author": "Schwimmer", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB185|cit185", "doi-asserted-by": "crossref", "first-page": "1538", "DOI": "10.1136/gut.2008.171280", "article-title": "The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years", "volume": "58", "author": "Feldstein", "year": "2009", "journal-title": "Gut."}, {"key": "10.1002/hep.25762-BIB186|cit186", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1016/j.jpeds.2005.07.020", "article-title": "Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists", "volume": "147", "author": "Riley", "year": "2005", "journal-title": "J Pediatr."}, {"key": "10.1002/hep.25762-BIB187|cit187", "doi-asserted-by": "crossref", "first-page": "1961", "DOI": "10.1053/j.gastro.2008.08.050", "article-title": "Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis (NASH)", "volume": "135", "author": "Patton", "year": "2008", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB188|cit188", "doi-asserted-by": "crossref", "first-page": "S164", "DOI": "10.1542/peds.2007-2329C", "article-title": "Expert Committee Recommendations Regarding the Preventions, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report", "volume": "120", "author": "Barlow", "year": "2007", "journal-title": "Pediatrics"}, {"key": "10.1002/hep.25762-BIB189|cit189", "doi-asserted-by": "crossref", "first-page": "1282", "DOI": "10.1002/hep.23119", "article-title": "Advances in pediatric nonalcoholic fatty liver disease", "volume": "50", "author": "Loomba", "year": "2009", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB190|cit190", "doi-asserted-by": "crossref", "first-page": "150", "DOI": "10.1016/j.cgh.2010.09.015", "article-title": "A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis", "volume": "9", "author": "Alkhouri", "year": "2011", "journal-title": "Clin Gastroenterol Hepatol."}, {"key": "10.1002/hep.25762-BIB191|cit191", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1053/j.gastro.2008.09.013", "article-title": "Performance oof ELF serum markers in predicting serum fibrosis stage in pediatric non-alcoholic fatty liver disease", "volume": "136", "author": "Nobili", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1002/hep.25762-BIB192|cit192", "doi-asserted-by": "crossref", "first-page": "1313", "DOI": "10.1002/hep.20701", "article-title": "Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease", "volume": "41", "author": "Kleiner", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB193|cit193", "doi-asserted-by": "crossref", "first-page": "1113", "DOI": "10.1002/hep.23133", "article-title": "Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study", "volume": "50", "author": "Carter-Kent", "year": "2009", "journal-title": "Hepatology."}, {"key": "10.1002/hep.25762-BIB194|cit194", "doi-asserted-by": "crossref", "first-page": "2225", "DOI": "10.1007/s10620-009-0949-3", "article-title": "Clinical and histological features of nonalcoholic fatty liver disease in children", "volume": "54", "author": "Ko", "year": "2009", "journal-title": "Dig Dis Sci."}, {"key": "10.1002/hep.25762-BIB195|cit195", "author": "Nobili", "first-page": "458", "year": "2006", "article-title": "NAFLD in children: A prospective clinical-pathological study and effect of lifestyle", "journal-title": "HEPATOLOGY", "DOI": "10.1002/hep.21262", "doi-asserted-by": "crossref"}, {"key": "10.1002/hep.25762-BIB196|cit196", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1002/hep.22336", "article-title": "Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial", "volume": "48", "author": "Nobili", "year": "2008", "journal-title": "Hepatology"}, {"key": "10.1002/hep.25762-BIB197|cit197", "first-page": "236", "article-title": "Management of child and adolescent obesity: summary and recommendations based on reports from pediatricians, pediatric nurse practitioners, and registered dietitians", "volume": "110", "author": "Barlow", "year": "2002", "journal-title": "Pediatrics"}, {"issue": "17", "key": "10.1002/hep.25762-BIB198|cit198", "doi-asserted-by": "crossref", "first-page": "2735", "DOI": "10.1161/CIRCULATIONAHA.105.169404", "article-title": "Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement", "volume": "112", "author": "Grundy", "journal-title": "Circulation."}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.25762", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/hep.25762", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 27]], "date-time": "2019-06-27T00:46:40Z", "timestamp": 1561596400000}, "score": 57.781235, "issued": {"date-parts": [[2012, 5, 29]]}, "references-count": 198, "journal-issue": {"published-print": {"date-parts": [[2012, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/hep.25762", "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:04:07Z", "timestamp": 1574370247429}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2008, 6, 1]], "date-time": "2008-06-01T00:00:00Z", "timestamp": 1212278400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gastroenterology"], "published-print": {"date-parts": [[2008, 6]]}, "DOI": "10.1053/j.gastro.2008.05.016", "type": "journal-article", "created": {"date-parts": [[2008, 5, 16]], "date-time": "2008-05-16T17:19:53Z", "timestamp": 1210958393000}, "page": "2178-2179", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Obstructive Sleep Apnea and Nonalcoholic Fatty Liver Disease: Causal Association or Just a Coincidence?"], "prefix": "10.1053", "volume": "134", "author": [{"given": "Vijay L.", "family": "Misra", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Gastroenterology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0016508508007816?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0016508508007816?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 28]], "date-time": "2018-12-28T17:51:46Z", "timestamp": 1546019506000}, "score": 56.91887, "issued": {"date-parts": [[2008, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 6]]}, "issue": "7"}, "alternative-id": ["S0016508508007816"], "URL": "http://dx.doi.org/10.1053/j.gastro.2008.05.016", "ISSN": ["0016-5085"], "issn-type": [{"value": "0016-5085", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:56:26Z", "timestamp": 1574402186501}, "publisher-location": "Cambridge", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521684897", "type": "print"}, {"value": "9780511547416", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9780511547416.012", "type": "book-chapter", "created": {"date-parts": [[2009, 12, 24]], "date-time": "2009-12-24T14:38:10Z", "timestamp": 1261665490000}, "page": "174-194", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Drug-Induced Liver Disease (DILI)"], "prefix": "10.1017", "author": [{"given": "Julie", "family": "Polson", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["Practical Management of Liver Diseases"], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T00:33:19Z", "timestamp": 1523579599000}, "score": 56.43915, "editor": [{"given": "Zobair M.", "family": "Younossi", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[null]]}, "ISBN": ["9780511547416", "9780521684897"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511547416.012"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T05:21:39Z", "timestamp": 1575264099225}, "reference-count": 84, "publisher": "Elsevier BV", "issue": "7", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 7, 1]], "date-time": "2014-07-01T00:00:00Z", "timestamp": 1404172800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Gastroenterology and Hepatology"], "published-print": {"date-parts": [[2014, 7]]}, "DOI": "10.1016/j.cgh.2013.08.014", "type": "journal-article", "created": {"date-parts": [[2013, 8, 17]], "date-time": "2013-08-17T06:17:37Z", "timestamp": 1376720257000}, "page": "1077-1084", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease"], "prefix": "10.1016", "volume": "12", "author": [{"given": "Kathleen E.", "family": "Corey", "sequence": "first", "affiliation": []}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Gastroenterology and Hepatology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1542356513011944?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1542356513011944?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 21]], "date-time": "2019-07-21T08:12:57Z", "timestamp": 1563696777000}, "score": 56.41887, "issued": {"date-parts": [[2014, 7]]}, "references-count": 84, "journal-issue": {"published-print": {"date-parts": [[2014, 7]]}, "issue": "7"}, "alternative-id": ["S1542356513011944"], "URL": "http://dx.doi.org/10.1016/j.cgh.2013.08.014", "ISSN": ["1542-3565"], "issn-type": [{"value": "1542-3565", "type": "print"}], "subject": ["Hepatology", "Gastroenterology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:46:52Z", "timestamp": 1574873212999}, "reference-count": 11, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2019, 1, 1]], "date-time": "2019-01-01T00:00:00Z", "timestamp": 1546300800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2019, 1, 7]], "date-time": "2019-01-07T00:00:00Z", "timestamp": 1546819200000}, "delay-in-days": 6, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hepatology"], "published-print": {"date-parts": [[2019, 1]]}, "DOI": "10.1002/hep.30245", "type": "journal-article", "created": {"date-parts": [[2018, 9, 3]], "date-time": "2018-09-03T06:05:10Z", "timestamp": 1535954710000}, "page": "9-11", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Advice Regarding Alcohol Use by Individuals With Nonalcoholic Fatty Liver Disease:Primumnon nocere"], "prefix": "10.1002", "volume": "69", "author": [{"given": "Winston", "family": "Dunn", "sequence": "first", "affiliation": [{"name": "The University of Kansas Medical Center; Kansas City KS"}]}, {"given": "Naga", "family": "Chalasani", "sequence": "additional", "affiliation": [{"name": "Indiana University School of Medicine; Indianapolis IN"}]}], "member": "311", "published-online": {"date-parts": [[2019, 1, 7]]}, "reference": [{"key": "10.1002/hep.30245-BIB0001|hep30245-cit-0001", "first-page": "361", "article-title": "The diagnosis and management of nonalcoholic fatty liver disease. Practice guidance by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and American Gastroenterology Association", "volume": "68", "author": "Chalasani", "year": "2018", "journal-title": "Hepatology"}, {"key": "10.1002/hep.30245-BIB0002|hep30245-cit-0002", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1136/gutjnl-2013-305718", "article-title": "Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: A meta-analysis of 43,175 individuals", "volume": "63", "author": "Sookoian", "year": "2014", "journal-title": "Gut"}, {"key": "10.1002/hep.30245-BIB0003|hep30245-cit-0003", "doi-asserted-by": "crossref", "first-page": "2090", "DOI": "10.1002/hep.29055", "article-title": "Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review", "volume": "65", "author": "Ajmera", "year": "2017", "journal-title": "Hepatology"}, {"key": "10.1002/hep.30245-BIB0004|hep30245-cit-0004", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1002/hep.30170", "article-title": "Non-heavy drinking and worsening of non-invasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study", "volume": "69", "author": "Chang", "year": "2019", "journal-title": "Hepatology"}, {"key": "10.1002/hep.30245-BIB0005|hep30245-cit-0005", "doi-asserted-by": "crossref", "first-page": "1224", "DOI": "10.1111/apt.13828", "article-title": "Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease", "volume": "44", "author": "Sookoian", "year": "2016", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1002/hep.30245-BIB0006|hep30245-cit-0006", "doi-asserted-by": "crossref", "first-page": "1511", "DOI": "10.1016/j.cgh.2018.01.026", "article-title": "Among patients with nonalcoholic fatty liver disease, modest alcohol use is associated with less improvement in histologic steatosis and steatohepatitis", "volume": "16", "author": "Ajmera", "year": "2018", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1002/hep.30245-BIB0007|hep30245-cit-0007", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1093/annonc/mds337", "article-title": "Light alcohol drinking and cancer: A meta-analysis", "volume": "24", "author": "Bagnardi", "year": "2013", "journal-title": "Ann Oncol"}, {"issue": "Suppl. 1", "key": "10.1002/hep.30245-BIB0008|hep30245-cit-0008", "doi-asserted-by": "crossref", "first-page": "S67", "DOI": "10.1016/j.canep.2015.01.007", "article-title": "European Code Against Cancer 4th edition: alcohol drinking and cancer", "volume": "39", "author": "Scocciianti", "year": "2015", "journal-title": "Cancer Epidemiol"}, {"key": "10.1002/hep.30245-BIB0009|hep30245-cit-0009", "doi-asserted-by": "crossref", "first-page": "911", "DOI": "10.1001/jamapsychiatry.2017.2161", "article-title": "Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions", "volume": "74", "author": "Grant", "year": "2017", "journal-title": "JAMA Psychiatry"}, {"key": "10.1002/hep.30245-BIB0010|hep30245-cit-0010", "unstructured": "Yoon YH Chen CM Liver cirrhosis mortality in the United States: national, state, and regional trends, 2000-2013 https://pubs.niaaa.nih.gov/publications/surveillance105/Cirr13.pdf 2016"}, {"key": "10.1002/hep.30245-BIB0011|hep30245-cit-0011", "doi-asserted-by": "crossref", "first-page": "k2817", "DOI": "10.1136/bmj.k2817", "article-title": "Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study", "volume": "362", "author": "Tapper", "year": "2018", "journal-title": "BMJ"}], "container-title": ["Hepatology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.30245", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.30245/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 23]], "date-time": "2019-10-23T12:03:07Z", "timestamp": 1571832187000}, "score": 55.06038, "issued": {"date-parts": [[2019, 1]]}, "references-count": 11, "journal-issue": {"published-print": {"date-parts": [[2019, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1002/hep.30245", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-9139"], "issn-type": [{"value": "0270-9139", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}